http://www.cardiobrief.org/2009/01/02/palmaz-wsj-article/2009-04-15T12:16:18-04:00http://www.cardiobrief.org/2009/01/05/npy-gene-linked-to-early-cv-disease/2009-01-05T14:41:02-05:00http://www.cardiobrief.org/2009/01/06/has-courage-been-vindicated/2009-01-06T13:34:44-05:00http://www.cardiobrief.org/2009/01/06/court-dismisses-complaint-against-medtronic-over-fidelis-leads/2009-01-06T13:46:25-05:00http://www.cardiobrief.org/2009/01/08/too-many-cardiology-journals-bill-roberts-ajc-editor-speaks-out/2009-01-08T10:57:42-05:00http://www.cardiobrief.org/2009/01/08/45-years-in-the-business-bill-roberts-part-2/2009-01-08T12:12:03-05:00http://www.cardiobrief.org/2009/01/08/hiv-infected-cardiothoracic-surgeon/2009-01-08T12:53:04-05:00http://www.cardiobrief.org/2009/01/08/boston-scientific-acquires-company-with-biodegradable-polymer-des-technology/2009-01-08T13:33:55-05:00http://www.cardiobrief.org/2009/01/08/after-a-year-long-review-fda-finds-nothing-new-about-vytorim/2009-01-12T18:37:58-05:00http://www.cardiobrief.org/2009/01/12/medtronic-acquires-another-af-ablation-company/2009-01-12T11:23:28-05:00http://www.cardiobrief.org/2009/01/13/experts-remain-convinced-of-benefits-despite-negative-lifestyle-trials/2009-01-14T15:48:53-05:00http://www.cardiobrief.org/2009/01/13/exercise-found-beneficial-in-pad-patients/2009-01-13T23:37:37-05:00http://www.cardiobrief.org/2009/01/14/fame-pubbed-in-nejm-is-ffr-ready-to-step-into-the-spotlight/2009-01-15T21:39:15-05:00http://www.cardiobrief.org/2009/01/14/newer-antipsychotic-agents-also-cause-scd/2009-01-13T12:40:03-05:00http://www.cardiobrief.org/2009/01/18/gene-variant-found-to-increase-risk-of-cardiomyopathy-seven-fold-in-south-asians/2009-01-13T15:20:45-05:00http://www.cardiobrief.org/2009/01/14/senate-investigation-revealing-new-details-in-avandia-case-wsj-reports/2009-01-14T15:48:03-05:00http://www.cardiobrief.org/2009/01/14/more-headaches-for-pfo-closure-devices/2009-01-14T15:47:37-05:00http://www.cardiobrief.org/2009/01/15/acc-preannouncement-season-begins-with-small-companys-press-release/2009-01-16T13:32:08-05:00http://www.cardiobrief.org/2009/01/20/diastolic-dysfunction-associated-with-reduced-exercise-capacity/2009-01-16T18:40:03-05:00http://www.cardiobrief.org/2009/01/19/califf-reportedly-still-in-running-for-fda-commssioner/2009-01-19T19:21:42-05:00http://www.cardiobrief.org/2009/01/21/nissen-gives-advice-to-new-president/2009-01-21T10:23:14-05:00http://www.cardiobrief.org/2009/01/21/how-does-the-media-report-on-cardiovascular-genetics/2015-12-30T15:28:14-05:00http://www.cardiobrief.org/2009/01/21/abbotts-xience-v-claims-bragging-rights-as-top-selling-stent/2009-01-21T15:58:49-05:00http://www.cardiobrief.org/2009/01/22/pascal-goldschmidt-cant-stop-running/2009-01-22T10:12:19-05:00http://www.cardiobrief.org/2009/01/22/pooled-analysis-shows-ezetimibe-enhances-crp-reduction/2009-01-22T12:03:32-05:00http://www.cardiobrief.org/2009/01/23/drug-eluting-stents-are-they-cost-effective/2009-01-23T12:14:07-05:00http://www.cardiobrief.org/2009/01/23/stun-guns-study-raises-questions-about-safety/2009-01-23T12:27:53-05:00http://www.cardiobrief.org/2009/01/26/innovative-stent-company-seeks-emergency-intervention/2009-01-26T10:27:48-05:00http://www.cardiobrief.org/2009/01/26/combination-of-aerobic-and-strength-exercise-found-best-for-elderly-obese-adults/2009-01-26T23:58:02-05:00http://www.cardiobrief.org/2009/01/26/danish-researchers-recommend-avoiding-nsaids-in-hf/2009-01-26T23:56:34-05:00http://www.cardiobrief.org/2009/01/27/time-chf-bnp-guided-therapy-misses-the-boat/2009-01-28T11:24:14-05:00http://www.cardiobrief.org/2009/01/26/fda-announces-ongoing-safety-review-of-clopidogrel/2009-01-26T15:30:25-05:00http://www.cardiobrief.org/2009/01/26/krumholz-weighs-in-on-nsaids-in-chf/2009-01-26T23:33:06-05:00http://www.cardiobrief.org/2009/01/28/cv-therapeutics-rejects-buyout-offer-from-astellas-pharma/2009-01-28T09:41:17-05:00http://www.cardiobrief.org/2009/01/27/uric-acid-and-insulin-levels-linked-to-risk-of-hypertension/2009-01-27T10:40:59-05:00http://www.cardiobrief.org/2009/01/27/thrombectomy-found-useful-adjunct-in-primary-pci/2009-01-27T14:42:39-05:00http://www.cardiobrief.org/2009/01/28/fda-warning-dietary-supplement-contains-sibutramine/2009-01-28T11:21:29-05:00http://www.cardiobrief.org/2009/01/28/spect-mpi-may-be-useful-in-new-onset-hf/2009-01-28T14:04:52-05:00http://www.cardiobrief.org/2009/01/29/lancet-editorial-orlistat-should-not-be-available-over-the-counter/2009-01-30T12:20:56-05:00http://www.cardiobrief.org/2009/01/28/generic-metoprolol-succinate-shortage-causing-problems/2009-01-28T18:29:41-05:00http://www.cardiobrief.org/2009/01/29/urine-test-for-cad-in-the-future/2009-01-29T14:17:20-05:00http://www.cardiobrief.org/2009/01/29/wikidoc-news-ppis-may-interfere-with-clopidogrel-lead-to-repeat-mi/2009-01-29T20:16:10-05:00http://www.cardiobrief.org/2009/01/30/prasugrel-outlook-appears-brighter/2009-02-02T11:28:45-05:00http://www.cardiobrief.org/2009/01/30/more-on-prasugrel-what-the-fda-doesnt-want-you-to-know/2009-02-02T13:47:08-05:00http://www.cardiobrief.org/2009/02/02/atorvastatin-finds-its-own-planetoid/2009-02-03T09:30:38-05:00http://www.cardiobrief.org/2009/02/02/get-your-original-unscrubbed-fda-prasugrel-review-document-right-here/2009-02-02T13:53:02-05:00http://www.cardiobrief.org/2009/02/02/sanjay-kaul-removed-from-prasugrels-fda-advisory-panel/2009-02-02T16:41:38-05:00http://www.cardiobrief.org/2009/02/03/radiation-in-cardiology-comes-under-increased-scrutiny/2009-02-03T16:32:23-05:00http://www.cardiobrief.org/2009/02/03/t-wave-alternans-may-help-identify-some-patients-who-dont-need-an-icd/2009-02-03T13:02:18-05:00http://www.cardiobrief.org/2009/02/03/califf-reportedly-still-in-running-to-be-fda-commissioner/2009-02-03T15:11:07-05:00http://www.cardiobrief.org/2009/02/08/5-new-studies-shed-new-light-on-the-genetics-of-mi/2009-02-03T14:03:26-05:00http://www.cardiobrief.org/2009/02/03/fda-panel-unanimously-recommends-approval-of-prasugrel/2009-02-03T23:29:55-05:00http://www.cardiobrief.org/2009/02/04/outspoken-critic-prasugrel-hearing-was-a-family-picnic/2009-02-05T10:40:48-05:00http://www.cardiobrief.org/2009/02/05/new-des-studies-add-new-understanding-about-clopidogrel-duration-lad-usage-and-isr/2009-02-05T12:13:58-05:00http://www.cardiobrief.org/2009/02/09/pci-for-mi-experienced-hospitals-and-physicians-are-best/2009-02-05T12:38:04-05:00http://www.cardiobrief.org/2009/02/05/sir-james-black-pioneer-of-propranolol-decries-state-of-pharma/2009-02-05T19:21:18-05:00http://www.cardiobrief.org/2009/02/05/gordon-tomaselli-named-director-of-cardiology-at-johns-hopkins/2009-02-05T19:35:05-05:00http://www.cardiobrief.org/2009/02/05/early-study-finds-anacetrapib-safe-and-effective/2009-02-05T19:53:27-05:00http://www.cardiobrief.org/2009/02/06/alderman-questions-nyc-efforts-to-cut-salt-in-ny-times-opinion-piece/2009-02-06T10:36:21-05:00http://www.cardiobrief.org/2009/02/06/do-beta-blockers-inhibit-the-anti-inflammatory-effect-of-statins/2009-02-06T10:56:48-05:00http://www.cardiobrief.org/2009/02/09/expensive-urine-multivitamins-have-no-effect-on-major-endpoints/2009-02-09T12:19:23-05:00http://www.cardiobrief.org/2009/02/09/study-finds-lower-risk-of-death-for-primary-prevention-use-of-statins/2009-02-09T12:18:06-05:00http://www.cardiobrief.org/2009/02/11/athena-published-in-nejm-dronedarone-benefits-af-patients/2009-02-13T08:48:16-05:00http://www.cardiobrief.org/2009/02/06/fda-approves-2-ablation-catheters-for-af/2009-02-06T16:55:39-05:00http://www.cardiobrief.org/2009/02/09/editorial-prasugrel-and-fda-incompetence/2015-08-26T10:34:45-04:00http://www.cardiobrief.org/2009/02/09/mass-general-under-scrutiny-for-high-mortality-rate-in-cath-lab/2009-02-09T12:09:13-05:00http://www.cardiobrief.org/2009/02/11/contrast-echo-found-useful-in-technically-difficult-cases/2009-02-11T10:02:58-05:00http://www.cardiobrief.org/2009/02/10/david-sabiston-jr-pioneering-surgeon-dead-at-84/2009-02-10T10:10:23-05:00http://www.cardiobrief.org/2009/02/10/list-of-acc-2009-late-breakers-published/2009-02-10T12:08:47-05:00http://www.cardiobrief.org/2009/02/15/researchers-identify-first-common-genes-variants-that-regulate-blood-pressure/2009-02-10T14:14:20-05:00http://www.cardiobrief.org/2009/02/10/spirit-iii-trial-published/2009-02-10T19:44:22-05:00http://www.cardiobrief.org/2009/02/11/prasugrel-now-the-real-work-starts/2009-02-11T19:32:24-05:00http://www.cardiobrief.org/2009/02/11/fda-provides-explanation-for-sanjay-kauls-absence/2009-02-11T19:33:20-05:00http://www.cardiobrief.org/2009/02/12/after-fame-new-study-offers-clues-to-utility-of-ffr/2009-02-12T12:12:48-05:00http://www.cardiobrief.org/2009/02/12/registry-sheds-light-on-takotsubo-cardiomyopathy/2009-02-12T12:24:48-05:00http://www.cardiobrief.org/2009/02/16/pfo-and-migraine-the-next-chapter/2009-09-05T11:18:16-04:00http://www.cardiobrief.org/2009/02/16/elderly-in-cardiogenic-shock-benefit-from-early-pci/2009-02-12T13:47:58-05:00http://www.cardiobrief.org/2009/02/12/judge-who-ruled-in-favor-of-medtronic-failed-to-disclose-family-link-to-company/2009-02-12T23:00:03-05:00http://www.cardiobrief.org/2009/02/13/fda-advisory-committee-to-consider-dronedarone-in-march/2009-02-14T10:59:40-05:00http://www.cardiobrief.org/2009/02/18/syntax-published-in-nejm/2009-02-18T15:05:52-05:00http://www.cardiobrief.org/2009/02/18/pharmacogenetics-a-better-path-to-warfarin-dosing/2009-02-13T12:45:27-05:00http://www.cardiobrief.org/2009/02/18/oat-no-improved-quality-of-life-found-for-late-opening-of-occluded-arteries/2009-02-18T14:36:48-05:00http://www.cardiobrief.org/2009/02/13/heartwire-story-provides-most-detailed-account-yet-of-prasugrel-hearing/2009-02-13T20:13:08-05:00http://www.cardiobrief.org/2009/02/13/stent-wars-abbott-wins-and-medtronic-loses/2009-02-13T20:18:03-05:00http://www.cardiobrief.org/2009/02/14/salt-ii-letter-writers-react-to-aldermans-ny-times-op-ed-piece/2009-02-14T10:58:24-05:00http://www.cardiobrief.org/2009/02/17/new-data-on-sudden-death-in-young-athletes-published/2010-03-01T14:44:52-05:00http://www.cardiobrief.org/2009/02/17/new-analysis-casts-doubt-on-hdl-as-target-for-therapy/2009-02-17T13:59:39-05:00http://www.cardiobrief.org/2009/02/23/anger-increases-risk-for-sudden-death/2009-02-25T10:14:12-05:00http://www.cardiobrief.org/2009/02/19/questions-raised-over-globalization-of-clinical-research/2009-02-19T10:04:38-05:00http://www.cardiobrief.org/2009/02/19/599/2009-02-19T22:33:28-05:00http://www.cardiobrief.org/2009/02/19/the-uninvited-part-2-fda-offers-more-detailed-explanation-for-kauls-absence-on-prasugrel-committee/2009-02-19T22:35:05-05:00http://www.cardiobrief.org/2009/02/19/us-justice-dept-joins-lawsuit-against-sciosjj/2009-02-19T22:34:05-05:00http://www.cardiobrief.org/2009/02/24/accaha-guidelines-not-enough-evidence/2009-02-24T11:59:39-05:00http://www.cardiobrief.org/2009/02/25/no-difference-in-weight-loss-after-2-years-in-weight-loss-diets/2009-02-23T13:09:49-05:00http://www.cardiobrief.org/2009/02/20/jupiter-substudy-stroke-cut-in-half-by-rosuvastatin/2009-02-20T15:23:24-05:00http://www.cardiobrief.org/2009/02/23/jeffrey-moses-ranks-8-on-chronicles-salary-list/2009-02-23T09:41:27-05:00http://www.cardiobrief.org/2009/02/23/prasugrel-gains-european-approval/2009-02-23T10:14:43-05:00http://www.cardiobrief.org/2009/02/23/medtronic-gobbles-up-2-aortic-valve-companies/2009-02-23T10:53:17-05:00http://www.cardiobrief.org/2009/02/23/chronology-of-prasugrel-controversy/2009-10-28T23:40:20-04:00http://www.cardiobrief.org/2009/02/24/cardiology-mt-sinais-samin-sharma-tops-columbias-moses/2015-08-26T10:37:35-04:00http://www.cardiobrief.org/2009/02/24/sprint-fiedlis-leads-is-the-risk-greater-than-feared/2009-02-25T10:15:31-05:00http://www.cardiobrief.org/2009/02/25/califf-now-reportedly-out-of-running-for-fda-commissioner/2009-02-25T16:51:30-05:00http://www.cardiobrief.org/2009/02/25/meta-analysis-lowering-bp-in-dialysis-patients-reduces-cv-events-and-deaths/2009-02-25T10:37:59-05:00http://www.cardiobrief.org/2009/02/26/679/2009-02-25T12:37:22-05:00http://www.cardiobrief.org/2009/02/26/transcript-of-fda-february-23-news-conference-on-prasugrel-advisory-panel/2009-02-26T11:38:13-05:00http://www.cardiobrief.org/2009/02/26/speaking-of-prasugrel-triton-timi-38-stemi-substudy-published-in-lancet/2009-02-27T10:29:05-05:00http://www.cardiobrief.org/2009/02/27/astellas-launches-hostile-takeover-for-cv-therapeutics/2009-02-27T09:42:30-05:00http://www.cardiobrief.org/2009/02/27/flap-over-prasugrel-advisory-committee-leads-to-2-congressional-inquiries/2009-02-27T11:06:42-05:00http://www.cardiobrief.org/2009/02/27/ny-times-why-is-the-icd-registry-languishing/2009-02-27T18:10:42-05:00http://www.cardiobrief.org/2009/03/03/ppis/2009-06-22T15:24:37-04:00http://www.cardiobrief.org/2009/03/02/public-reporting-of-pci-outcomes-unintended-consequences/2009-03-02T13:08:23-05:00http://www.cardiobrief.org/2009/03/02/fda-approves-new-magnetically-steered-irrigated-tip-rf-ablation-catheter/2009-03-02T16:59:22-05:00http://www.cardiobrief.org/2009/03/03/comment-if-prasugrel-is-delayed-who-is-to-blame/2009-05-28T10:21:37-04:00http://www.cardiobrief.org/2009/03/03/samin-sharma-reveals-the-secret-behind-1500-cases-and-26-million-per-year/2009-03-03T19:53:51-05:00http://www.cardiobrief.org/2009/03/04/mtwa-may-help-low-risk-patients-avoid-icd-implantation/2009-03-04T11:55:27-05:00http://www.cardiobrief.org/2009/03/11/statins-reduce-energy-and-interest-in-activty-new-study-suggests/2010-05-26T17:32:53-04:00http://www.cardiobrief.org/2009/03/05/philip-poole-wilson-leading-british-cardiologist-dies-suddenly/2009-03-05T10:13:00-05:00http://www.cardiobrief.org/2009/03/06/generic-simvastatin-cost-effective-in-wider-population-than-current-guidelines-indicate/2009-03-06T11:29:34-05:00http://www.cardiobrief.org/2009/03/06/treating-flu-with-oseltamivir-reduces-cv-events-military-study-finds/2009-03-06T11:54:06-05:00http://www.cardiobrief.org/2009/03/08/us-investigates-medtronics-marketing-of-ablation-devices/2009-03-08T20:26:29-04:00http://www.cardiobrief.org/2009/03/09/texas-legislature-to-consider-shape-bill-to-require-reimbursement-for-mi-screening/2009-03-09T11:35:47-04:00http://www.cardiobrief.org/2009/03/09/jupiter-usa-65-million-adults-could-benefit-from-statins/2009-03-09T17:19:26-04:00http://www.cardiobrief.org/2009/03/09/angry-men-and-bad-hearts/2009-03-09T17:20:39-04:00http://www.cardiobrief.org/2009/03/09/depression-and-antidepressants-tied-to-cardiac-events/2009-03-09T17:21:55-04:00http://www.cardiobrief.org/2009/03/09/aha-denies-it-supports-texas-shape-legislation-2/2015-08-26T10:42:33-04:00http://www.cardiobrief.org/2009/03/10/fda-posts-transcript-and-minutes-of-prasugrel-hearing/2009-03-10T13:09:27-04:00http://www.cardiobrief.org/2009/03/10/ahas-robertson-legislation-is-a-very-blunt-instrument/2009-03-10T14:15:56-04:00http://www.cardiobrief.org/2009/03/10/dronedarone-post-mi-hyperoxygenation-system-face-fda-panels-next-week/2009-03-11T15:20:05-04:00http://www.cardiobrief.org/2009/03/11/sprint-fidelis-judge-wont-step-down-from-case/2009-03-11T13:37:14-04:00http://www.cardiobrief.org/2009/03/12/absorb-this-bioabsorbable-stent-remains-promising-at-2-years/2009-03-11T14:08:20-04:00http://www.cardiobrief.org/2009/03/12/pci-no-impact-on-mortality-or-mi-no-surprise/2009-03-11T14:27:56-04:00http://www.cardiobrief.org/2009/03/12/europe-losing-battle-against-heart-disease/2009-03-11T15:00:14-04:00http://www.cardiobrief.org/2009/03/13/new-diabetes-drugs-juggled-by-fda/2009-10-22T14:12:09-04:00http://www.cardiobrief.org/2009/03/11/new-test-can-diagnose-arvc-2/2009-03-11T17:13:57-04:00http://www.cardiobrief.org/2009/03/12/gilead-topping-astellas-to-acquire-cv-therapeutics/2009-03-12T09:21:42-04:00http://www.cardiobrief.org/2009/03/12/phase-2-data-on-scherings-tra-published-in-lancet/2009-03-12T19:37:45-04:00http://www.cardiobrief.org/2009/03/13/nyc-contd-rose-gets-a-raise-at-mt-sinai/2009-03-13T10:48:49-04:00http://www.cardiobrief.org/2009/03/13/demolition-derby-jama-bmj-and-wall-street-journal-health-blog/2009-03-13T15:24:21-04:00http://www.cardiobrief.org/2009/03/13/number-of-deaths-linked-to-sprint-fidelis-leads-rises-to-13/2009-03-13T19:13:22-04:00http://www.cardiobrief.org/2009/03/16/normal-abi-isnt-really-normal/2009-03-14T09:20:17-04:00http://www.cardiobrief.org/2009/03/16/exercise-dont-stop-or-you-just-might-drop/2009-03-14T09:46:24-04:00http://www.cardiobrief.org/2009/03/17/no-surprise-acat-inhibitor-fails-again/2009-03-14T10:15:57-04:00http://www.cardiobrief.org/2009/03/18/young-blacks-more-likely-to-develop-heart-failure/2009-03-20T13:08:50-04:00http://www.cardiobrief.org/2009/03/18/cardiovascular-research-does-pharma-see-a-future/2009-03-18T17:02:46-04:00http://www.cardiobrief.org/2009/03/14/statins-may-help-fight-severe-asthma-attacks/2009-03-14T12:31:00-04:00http://www.cardiobrief.org/2009/03/16/fda-reviewers-give-green-light-for-dronedarone/2009-03-16T10:56:16-04:00http://www.cardiobrief.org/2009/03/17/rivaroxaban-may-face-tough-questions-about-bleeding-risk/2009-03-17T16:31:06-04:00http://www.cardiobrief.org/2009/03/17/editorial-shape-is-skating-on-thin-ice/2015-08-26T10:45:06-04:00http://www.cardiobrief.org/2009/03/18/have-the-results-of-the-aurora-study-been-leaked/2009-03-18T11:57:19-04:00http://www.cardiobrief.org/2009/03/18/dronedarone-gets-cautious-nod-from-fda-advisory-panel/2009-03-18T20:29:42-04:00http://www.cardiobrief.org/2009/03/19/meta-analysis-cabg-beats-pci-in-diabetics-and-elderly/2009-03-19T19:43:04-04:00http://www.cardiobrief.org/2009/03/19/fda-panel-votes-15-2-in-favor-of-rivaroxaban/2009-03-20T13:07:54-04:00http://www.cardiobrief.org/2009/03/24/lamp2-mutation-causes-severe-cardiomyopathy-in-young-patients/2009-03-20T11:51:23-04:00http://www.cardiobrief.org/2009/03/23/very-low-ldl-normal-bp-good-ivus-outcome/2009-03-20T11:35:33-04:00http://www.cardiobrief.org/2009/03/24/nice-sugar-intensive-glucose-control-in-icu-found-harmful/2009-03-24T07:38:52-04:00http://www.cardiobrief.org/2009/03/20/fda-panel-turns-down-therox-aqueous-oxygen-system-in-9-5-vote/2009-03-20T13:25:48-04:00http://www.cardiobrief.org/2009/03/25/nejm-letter-warns-about-icd-shocks-caused-by-current-leaks/2009-03-20T14:10:03-04:00http://www.cardiobrief.org/2009/03/21/a-shape-board-member-responds-to-critical-editorial/2015-08-26T10:44:21-04:00http://www.cardiobrief.org/2009/03/22/jama-editors-take-strong-stance-against-conflict-of-interest-and-free-speech/2015-08-26T10:43:08-04:00http://www.cardiobrief.org/2009/03/25/case-reports-link-stress-cardiomyopathy-to-catecholamines-and-beta-agonists/2009-03-24T12:52:02-04:00http://www.cardiobrief.org/2009/03/26/remembering-philip-poole-wilson/2009-03-26T12:50:19-04:00http://www.cardiobrief.org/2009/03/26/acc-and-aha-release-updated-heart-failure-guidelines/2009-03-26T13:45:10-04:00http://www.cardiobrief.org/2009/03/26/mehmet-oz-wants-to-tell-you-your-real-age/2009-03-26T10:06:40-04:00http://www.cardiobrief.org/2009/03/27/acc-in-orlando-march-madness-starts-saturday/2009-03-26T10:32:05-04:00http://www.cardiobrief.org/2009/03/29/more-jupiter-rosuvastatin-also-prevents-vte/2009-03-28T21:24:15-04:00http://www.cardiobrief.org/2009/03/30/aurora-no-new-dawn-for-hemodialysis-patients-taking-rosuvastatin/2009-03-30T12:36:13-04:00http://www.cardiobrief.org/2009/03/26/boston-scientific-issues-product-advisories-on-new-icds/2009-03-26T20:05:13-04:00http://www.cardiobrief.org/2009/03/29/stich-svr-provides-no-added-benefit-to-cabg/2009-03-29T09:53:14-04:00http://www.cardiobrief.org/2009/03/30/early-acs-no-benefit-and-increased-bleeding-with-early-eptifibatide/2009-03-30T09:34:32-04:00http://www.cardiobrief.org/2009/03/29/pre-relax-ahf-phase-ii-study-suggests-relaxin-may-be-beneficial-in-hf/2009-03-28T21:19:30-04:00http://www.cardiobrief.org/2009/03/29/more-jupiter-crp-and-ldl-equally-influence-outcome/2009-03-30T09:38:28-04:00http://www.cardiobrief.org/2009/03/30/study-shows-proof-of-concept-of-renal-denervation-for-resistant-hypertension/2009-03-30T11:26:30-04:00http://www.cardiobrief.org/2009/03/30/tips-promising-phase-ii-trial-for-polypill/2009-03-30T12:31:32-04:00http://www.cardiobrief.org/2009/03/28/ncdr-registry-supports-des-over-bms-in-elderly-patients/2009-03-29T15:06:34-04:00http://www.cardiobrief.org/2009/03/28/protect-af-new-device-may-offer-alternative-to-warfarin-for-af-patients/2009-03-28T20:37:06-04:00http://www.cardiobrief.org/2009/03/28/syntax-pci-begins-to-gain-over-cabg-in-new-analysis/2009-03-28T20:35:13-04:00http://www.cardiobrief.org/2009/03/28/jama-editors-now-subject-of-ama-investigation/2009-03-28T19:21:28-04:00http://www.cardiobrief.org/2009/03/29/fix-hf-5-trial-misses-endpoint-but-hope-remains-for-cardiac-contractility-modulation-in-hf/2009-03-29T10:42:19-04:00http://www.cardiobrief.org/2009/03/30/arena-reports-postive-phase-3-results-for-locaserin/2009-03-30T09:31:37-04:00http://www.cardiobrief.org/2009/03/31/active-a-clopidogrel-aspirin-better-than-aspirin-alone-in-af/2009-03-31T10:03:43-04:00http://www.cardiobrief.org/2009/03/31/jama-writers-call-for-medical-groups-to-sever-financial-ties-to-industry/2009-04-01T13:21:43-04:00http://www.cardiobrief.org/2009/04/01/article-explores-complexity-of-pci-public-reporting-in-massachusett/2009-04-01T14:52:18-04:00http://www.cardiobrief.org/2009/04/02/too-much-grapefruit-nearly-causes-loss-of-leg/2009-04-01T11:14:15-04:00http://www.cardiobrief.org/2009/04/01/fda-advisory-panel-saxagliptin-passes-cardiac-stress-test/2009-04-01T23:30:07-04:00http://www.cardiobrief.org/2009/04/02/yusuf-kaul-launch-rocket-attack-at-jupiter-ridker-responds/2009-04-02T11:45:16-04:00http://www.cardiobrief.org/2009/04/02/fda-panel-gives-split-decision-to-diabetes-drug-liraglutide/2009-04-02T19:38:21-04:00http://www.cardiobrief.org/2009/04/03/new-study-provides-best-proof-yet-of-myocardial-regeneration/2009-04-03T10:09:40-04:00http://www.cardiobrief.org/2009/04/03/fda-bungles-posting-of-seroquel-briefing-documents-and-raises-concerns-about-cv-effects/2009-04-06T10:56:03-04:00http://www.cardiobrief.org/2009/04/06/uh-oh-cigarette-smoking-found-to-enhance-clopidogrel-clinical-benefits/2009-04-06T18:57:46-04:00http://www.cardiobrief.org/2009/04/07/presto-chango-hf-action-shows-benefits-of-exercise-in-heart-failure/2009-04-07T14:25:39-04:00http://www.cardiobrief.org/2009/04/07/psaty-raises-more-questions-about-conflict-of-interest-in-jama-commentary/2009-04-08T15:26:33-04:00http://www.cardiobrief.org/2009/04/07/ny-times-difficult-decisions-about-sprint-fidelis-leads/2009-04-07T10:36:50-04:00http://www.cardiobrief.org/2009/04/08/prasugrel-makes-worldwide-debut-in-united-kingdom/2009-04-08T10:41:37-04:00http://www.cardiobrief.org/2009/04/08/brown-adipose-tissue-jack-sprat-had-it-his-wife-didnt/2009-04-08T17:05:02-04:00http://www.cardiobrief.org/2009/04/09/nejm-lancet-stop-the-soda-madness/2009-04-09T12:14:36-04:00http://www.cardiobrief.org/2009/04/13/heart-failure-more-likely-in-cad-patients-who-are-depressed/2009-04-13T10:44:45-04:00http://www.cardiobrief.org/2009/04/13/merck-and-cardiome-to-collaborate-on-oral-vernakalant/2009-04-13T10:36:21-04:00http://www.cardiobrief.org/2009/04/13/statins-may-have-caused-the-financial-breakdown-according-to-completely-unreliable-experts/2015-08-26T10:49:12-04:00http://www.cardiobrief.org/2009/04/14/1279/2009-04-14T11:57:22-04:00http://www.cardiobrief.org/2009/04/14/cardiology-residents-a-tale-of-two-houses-and-3-cities/2009-04-15T12:14:24-04:00http://www.cardiobrief.org/2009/04/14/francis-collins-reported-to-be-next-nih-director/2009-04-14T13:40:47-04:00http://www.cardiobrief.org/2009/04/15/mr-angiography-continues-to-advance-but-still-limited/2009-04-15T12:35:17-04:00http://www.cardiobrief.org/2009/04/15/gissi-af-valsartan-fails-to-prevent-af-recurrence/2009-04-15T12:34:42-04:00http://www.cardiobrief.org/2009/04/16/courage-oat-persistent-doubts-among-interventionalists/2009-04-16T12:23:54-04:00http://www.cardiobrief.org/2009/04/17/jama-imbroglio-the-shrink-strikes-back/2009-04-17T11:09:18-04:00http://www.cardiobrief.org/2009/04/20/jacc-white-paper-clarifies-role-of-cardiovascular-mr-in-myocarditis/2009-04-20T10:19:09-04:00http://www.cardiobrief.org/2009/04/20/stemi-networks-key-to-rapid-reperfusion/2009-04-20T10:36:29-04:00http://www.cardiobrief.org/2009/04/21/electricians-do-it-better/2009-04-21T10:20:43-04:00http://www.cardiobrief.org/2009/04/21/bring-it-on-stanford-cardiology-fellows-challenge-49ers-to-push-up-contest/2009-04-21T10:09:59-04:00http://www.cardiobrief.org/2009/04/22/acc-defends-partnership-with-industry-group-to-separate-clinical-and-cost-effectiveness-studies/2009-04-22T15:44:57-04:00http://www.cardiobrief.org/2009/04/22/fda-is-it-time-for-the-watchman/2009-04-22T19:11:45-04:00http://www.cardiobrief.org/2009/04/23/fda-extends-review-of-saxagliptin-until-july-30/2009-04-23T09:57:11-04:00http://www.cardiobrief.org/2009/04/23/two-radically-different-approaches-to-financial-incentives/2009-04-23T20:12:13-04:00http://www.cardiobrief.org/2009/04/23/fda-panel-gives-cautious-nod-to-the-watchman/2009-04-24T09:30:06-04:00http://www.cardiobrief.org/2009/04/24/is-the-party-over-phrma-publishes-new-guidelines-on-clinical-trials/2009-04-24T10:40:43-04:00http://www.cardiobrief.org/2009/04/29/dronedarone-debut-will-it-be-successful/2009-04-30T12:09:39-04:00http://www.cardiobrief.org/2009/04/27/good-kitty-romicat-ct-to-rule-out-mi/2009-04-24T11:35:36-04:00http://www.cardiobrief.org/2009/04/26/football-moms-go-red/2009-04-26T18:54:17-04:00http://www.cardiobrief.org/2009/04/26/statins-linked-to-reduced-incidence-of-prostate-cancer/2009-04-27T00:13:25-04:00http://www.cardiobrief.org/2009/04/28/dual-antiplatelet-therapy-linked-to-more-post-cabg-infections/2009-04-27T14:04:58-04:00http://www.cardiobrief.org/2009/04/28/conflicts-of-interest-threaten-publics-trust-in-medicine-iom-report/2009-04-28T10:07:13-04:00http://www.cardiobrief.org/2009/04/29/new-imaging-technique-may-help-monitor-vulnerable-plaque/2009-04-29T19:56:12-04:00http://www.cardiobrief.org/2009/04/28/pfizer-reports-drop-in-lipitor-sales/2009-04-28T11:20:54-04:00http://www.cardiobrief.org/2009/04/30/meta-analysis-increased-mortality-in-cancer-patients-treated-with-epoetin-and-darbepoetin/2009-04-29T23:04:21-04:00http://www.cardiobrief.org/2009/04/30/on-the-radar-bari-2d-could-be-the-next-courage/2009-04-30T10:54:05-04:00http://www.cardiobrief.org/2009/05/01/confessions-of-a-repentant-cardiologist/2016-03-07T10:17:37-05:00http://www.cardiobrief.org/2009/05/04/record-4-rivaroxaban-beats-enoxaparin-after-knee-replacement/2009-05-04T12:46:05-04:00http://www.cardiobrief.org/2009/05/06/scai-clopidogrelppi-wed-1130am/2009-06-22T15:23:01-04:00http://www.cardiobrief.org/2009/05/05/1473/2009-05-05T09:59:06-04:00http://www.cardiobrief.org/2009/05/06/2-studied-in-nejm-offer-comforting-support-for-des/2009-05-10T23:43:36-04:00http://www.cardiobrief.org/2009/05/05/prasugrel-not-affected-by-common-cyp-genetic-variations/2009-05-05T11:20:01-04:00http://www.cardiobrief.org/2009/05/07/new-mitral-annuloplasty-device-shows-promise-in-early-trial/2009-05-10T23:42:47-04:00http://www.cardiobrief.org/2009/05/08/new-pfo-closure-device-may-be-safe-and-effective/2009-05-10T23:40:53-04:00http://www.cardiobrief.org/2009/05/08/1529/2009-05-10T23:41:37-04:00http://www.cardiobrief.org/2009/05/10/bp-genes-small-variations-lead-to-large-increases-in-risk/2009-05-11T11:24:32-04:00http://www.cardiobrief.org/2009/05/11/tacagrelor-bests-clopidogrel-in-l8000-patient-acs-trial-astrazeneca-claims/2009-08-30T02:16:52-04:00http://www.cardiobrief.org/2009/05/11/archives-new-reports-from-allhat-wise-and-dash/2009-05-11T14:05:39-04:00http://www.cardiobrief.org/2009/05/12/acc-takes-firm-stand-against-lanyards-and-tote-bags/2009-05-12T11:23:41-04:00http://www.cardiobrief.org/2009/05/11/aha-position-on-comparative-effectiveness-differs-from-acc-position/2009-05-11T13:44:34-04:00http://www.cardiobrief.org/2009/05/12/your-mother-was-wrong-dont-take-vitamins-before-exercise/2009-05-12T19:58:49-04:00http://www.cardiobrief.org/2009/05/13/the-medicines-company-discontinues-phase-3-champion-clinical-trial-program-of-cangrelor/2009-05-13T10:16:46-04:00http://www.cardiobrief.org/2009/05/13/both-high-and-low-estradiol-levels-linked-to-higher-mortality-in-men-with-hf/2009-05-13T13:06:19-04:00http://www.cardiobrief.org/2009/05/14/madit-ii-at-8-years-1-life-saved-for-every-six-patients/2009-05-14T11:43:29-04:00http://www.cardiobrief.org/2009/05/14/psychotropic-drugs-increase-risk-of-sudden-death-in-acs/2009-05-14T10:49:38-04:00http://www.cardiobrief.org/2009/05/15/icds-in-the-real-world-good-survival-but-many-shocks/2009-05-15T10:16:55-04:00http://www.cardiobrief.org/2009/05/19/jama-this-week-bone-marrow-cell-therapy-cardiorespiratory-fitness/2009-05-19T14:39:19-04:00http://www.cardiobrief.org/2009/05/20/timacs-nejm-wed-5-pm/2009-05-20T19:41:31-04:00http://www.cardiobrief.org/2009/05/18/obesity-paradox-more-cv-disease-but-better-outcome/2009-05-18T11:37:20-04:00http://www.cardiobrief.org/2009/05/18/jacc-publishes-revised-appropriate-use-criteria-for-radionuclide-imaging/2009-05-18T11:03:46-04:00http://www.cardiobrief.org/2009/05/19/ohio-cardiologist-sues-heart-center-alleging-abuse-of-patients-and-medicare-fraud/2009-05-19T10:55:27-04:00http://www.cardiobrief.org/2009/05/20/renaissance-man-eric-topol-rock-star-model-wireless-expert-skit-subject/2011-12-27T15:04:18-05:00http://www.cardiobrief.org/2009/05/21/lancet-meta-analysis-revives-hope-for-coronary-benefits-of-intensive-glucose-control-in-type-2-diabetics/2009-05-21T11:10:38-04:00http://www.cardiobrief.org/2009/05/21/zipes-testifies-in-australian-vioxx-trial/2009-05-21T11:44:14-04:00http://www.cardiobrief.org/2009/05/21/field-fenofibrates-cuts-amputation-in-type-2-diabetics/2009-05-21T12:52:32-04:00http://www.cardiobrief.org/2009/05/26/arterial-damage-found-in-teens-and-young-adults-with-obesity-or-type-2-diabetes/2009-05-26T13:44:44-04:00http://www.cardiobrief.org/2009/05/26/is-bigger-really-better-study-compares-nfl-players-to-the-rest-of-us/2009-05-24T18:01:45-04:00http://www.cardiobrief.org/2009/05/22/the-super-bowl-really-does-mean-life-or-death/2009-05-22T12:46:34-04:00http://www.cardiobrief.org/2009/05/25/study-raises-concerns-about-coronary-aneurysms-after-des-implantation/2009-05-24T15:22:18-04:00http://www.cardiobrief.org/2009/05/23/robert-furchgott-nobel-winner-for-no-dead-at-92/2009-05-23T10:55:22-04:00http://www.cardiobrief.org/2009/05/27/explosive-increase-in-type-1-diabetes-predicted/2009-05-27T11:09:47-04:00http://www.cardiobrief.org/2009/05/28/antithrombotic-trialists-collaboration-questions-value-of-aspirin-in-primary-prevention/2009-05-28T20:19:49-04:00http://www.cardiobrief.org/2009/05/29/study-finds-no-benefit-in-routine-ecg-screening-for-young-athletes/2009-05-29T11:42:27-04:00http://www.cardiobrief.org/2009/05/31/new-yorker-%e2%80%9cwe-took-a-wrong-turn-when-doctors-stopped-being-doctors-and-became-businessmen-%e2%80%9d/2009-05-31T23:08:31-04:00http://www.cardiobrief.org/2009/06/01/krumholz-systematic-and-continuous-measuring-of-performance-is-not-part-of-the-culture-of-medicine/2009-06-01T11:35:46-04:00http://www.cardiobrief.org/2009/06/02/hecht-editorial-ct-angiography-is-ready-for-prime-time/2009-06-02T13:28:31-04:00http://www.cardiobrief.org/2009/06/02/fda-rejects-bucindolol-and-questions-trial-integrity/2009-06-02T11:01:11-04:00http://www.cardiobrief.org/2009/06/02/taubman-new-ceo-in-rochester-after-spinal-injury-to-predecessor-berk/2009-06-02T11:32:37-04:00http://www.cardiobrief.org/2009/06/03/dallas-heart-study-calcium-screening-adds-little-to-traditional-risk-factors/2009-06-03T16:33:28-04:00http://www.cardiobrief.org/2009/06/03/serebruany-and-wolfe-ask-fda-to-halt-review-of-prasugrel/2009-06-03T16:31:55-04:00http://www.cardiobrief.org/2009/06/04/high-healthcare-costs-more-bankruptcies-and-unfilled-prescriptions/2009-06-04T12:19:34-04:00http://www.cardiobrief.org/2009/06/05/1828/2009-06-22T15:24:56-04:00http://www.cardiobrief.org/2009/06/05/record-and-bari-2d-to-be-presented-this-weekend-at-ada/2009-06-05T10:18:28-04:00http://www.cardiobrief.org/2009/06/05/cardiologists-in-the-news-1-sentenced-to-jail-1-buys-icds-from-girlfriend/2009-06-05T11:11:51-04:00http://www.cardiobrief.org/2009/06/07/bari-2d-will-it-fortify-courage/2009-06-09T11:36:14-04:00http://www.cardiobrief.org/2009/06/08/bring-it-on-the-battle-over-bari-2d/2009-06-22T14:49:26-04:00http://www.cardiobrief.org/2009/06/10/study-in-jama-explores-cutting-radiation-exposure-in-ct-angiography/2009-06-10T09:44:21-04:00http://www.cardiobrief.org/2009/06/08/lancetada-promising-phase-2-studies-for-liraglutide-and-aleglitazar/2009-06-08T19:48:27-04:00http://www.cardiobrief.org/2009/06/09/uks-nice-favors-restricted-approval-for-prasugrel/2009-06-09T10:13:56-04:00http://www.cardiobrief.org/2009/06/09/research-suggests-sleep-blood-pressure-link/2009-06-09T13:47:06-04:00http://www.cardiobrief.org/2009/06/10/lipoproteina-associated-with-mi/2009-06-10T09:47:30-04:00http://www.cardiobrief.org/2009/06/11/bmc-therapy-still-alive-after-5-years/2009-06-10T09:45:31-04:00http://www.cardiobrief.org/2009/06/09/study-shows-it-may-be-possible-to-diagnose-diabetes-sooner/2009-06-09T15:02:20-04:00http://www.cardiobrief.org/2009/06/11/enrollment-resumed-in-controversial-nih-chelation-trial/2009-06-11T12:59:55-04:00http://www.cardiobrief.org/2009/06/12/what-do-fda-insiders-really-think-of-prasugrel/2009-06-22T14:34:58-04:00http://www.cardiobrief.org/2009/06/12/lilly-responds-to-serebruany-attack-on-triton-timi-38/2009-06-22T15:24:27-04:00http://www.cardiobrief.org/2009/06/15/pioglitazone-to-reduce-restenosis-the-next-frontier/2009-06-15T19:24:18-04:00http://www.cardiobrief.org/2009/06/16/study-links-psoriasis-and-atherosclerosis/2009-06-15T15:32:03-04:00http://www.cardiobrief.org/2009/06/17/lowering-bp-small-steps-big-results/2009-06-17T10:05:34-04:00http://www.cardiobrief.org/2009/06/18/bp-complex-interplay-between-genes-and-environment/2009-06-17T11:08:48-04:00http://www.cardiobrief.org/2009/06/16/rivaroxaban-in-acs-more-bleeding-no-benefit-over-dual-therapy/2009-06-16T23:31:34-04:00http://www.cardiobrief.org/2009/06/15/dr-barack-obama-speaks-out-on-cardiology/2009-06-15T17:22:49-04:00http://www.cardiobrief.org/2009/06/16/triple-antiplatelet-therapy-for-primary-pci/2009-06-16T11:31:01-04:00http://www.cardiobrief.org/2009/06/19/fda-official-defends-integrity-of-prasugrel-review/2009-06-19T11:44:16-04:00http://www.cardiobrief.org/2009/06/24/framingham-first-degree-av-block-not-benign/2009-06-24T15:16:10-04:00http://www.cardiobrief.org/2009/06/24/new-percutaneous-mitral-repair-device-appears-promising-in-small-study/2009-06-24T10:14:51-04:00http://www.cardiobrief.org/2009/06/22/braunwald-japanese-cta-study-may-be-future-landmark/2009-06-23T14:55:36-04:00http://www.cardiobrief.org/2009/06/18/court-transcripts-show-cardiologists-debating-vioxx-in-australian-court/2009-06-18T22:28:02-04:00http://www.cardiobrief.org/2009/06/19/no-recession-in-cardiology-starting-salaries-for-new-cardiologists-remain-strong/2009-06-19T19:44:26-04:00http://www.cardiobrief.org/2009/06/21/europace-update-af-in-athletes-drivers-with-icds-more/2009-06-19T10:21:51-04:00http://www.cardiobrief.org/2009/06/25/transfer-ami-definitive-endorsement-of-early-pci-after-fibrinolysis/2009-06-25T09:46:29-04:00http://www.cardiobrief.org/2009/06/23/shape-bill-passes-in-texas-requiring-reimbursement-for-mi-screening/2009-06-23T14:36:45-04:00http://www.cardiobrief.org/2009/06/23/boston-scientific-says-madit-crt-meets-primary-endpoint-crt-slows-hf-progression/2009-06-23T10:48:51-04:00http://www.cardiobrief.org/2009/06/29/jacc-white-paper-urges-cautious-approach-to-triple-antithrombotic-therapy/2009-06-29T13:12:44-04:00http://www.cardiobrief.org/2009/06/25/doug-zipes-on-michael-jacksons-death/2009-06-26T18:47:16-04:00http://www.cardiobrief.org/2009/06/30/jama-studies-raise-questions-about-crp-and-other-biomarkers/2009-07-01T13:00:57-04:00http://www.cardiobrief.org/2009/06/26/easd-raises-concerns-about-possible-link-between-lantus-insulin-and-cancer/2009-06-26T18:50:39-04:00http://www.cardiobrief.org/2009/06/27/takedas-alogliptin-delayed-for-at-least-2-years/2009-06-27T15:50:40-04:00http://www.cardiobrief.org/2009/06/27/michael-jacksons-doctor-cardiologist-or-not/2009-06-27T19:58:17-04:00http://www.cardiobrief.org/2009/07/01/armyda-recapture-shows-benefits-of-statin-reload-before-pci/2009-07-01T13:57:53-04:00http://www.cardiobrief.org/2009/07/04/cost-effectiveness-research-priorities-in-cardiovascular-medicine-from-the-iom-recommendations/2009-07-02T11:44:40-04:00http://www.cardiobrief.org/2009/07/01/fda-adds-boxed-warnings-to-varenicline-and-buproprion/2009-07-01T16:33:02-04:00http://www.cardiobrief.org/2009/07/02/dronedarone-approved-by-fda-for-atrial-fibrillation-or-atrial-flutter/2009-07-02T10:43:24-04:00http://www.cardiobrief.org/2009/07/05/hypertension-pioneer-and-rebel-proposes-a-different-treatment-approach/2009-07-02T12:45:25-04:00http://www.cardiobrief.org/2009/07/05/lancet-famotidine-cuts-upper-gi-risk-in-patients-taking-low-dose-aspirin/2009-07-05T18:11:13-04:00http://www.cardiobrief.org/2009/07/07/jama-letter-writers-debate-value-of-accaha-guidelines/2009-07-07T16:46:55-04:00http://www.cardiobrief.org/2009/07/08/ahrq-gives-mixed-reviews-for-rf-catheter-ablation-of-af/2009-07-08T12:28:38-04:00http://www.cardiobrief.org/2009/07/07/who-brought-the-dogs-in-jama-editors-morph-from-pitbulls-to-lapdogs/2009-07-09T23:03:22-04:00http://www.cardiobrief.org/2009/07/07/chronology-of-the-jama-editors-controversy/2009-09-06T11:33:35-04:00http://www.cardiobrief.org/2009/07/08/arbiter-6-halts-trial-comparing-ezetimibe-and-niacin-terminated-early-by-steering-committee/2009-11-02T09:40:21-05:00http://www.cardiobrief.org/2009/07/11/lock-and-load-acc-takes-aim-at-proposed-cms-cuts-to-cardiologists/2009-07-10T14:49:05-04:00http://www.cardiobrief.org/2009/07/09/cms-hospital-compare-website-adds-mi-and-hf-readmission-data/2009-07-09T21:08:04-04:00http://www.cardiobrief.org/2009/07/10/down-the-memory-hole-jama-editors-rewrite-history-and-remove-original-editorial/2009-07-10T00:26:39-04:00http://www.cardiobrief.org/2009/07/12/barcelona-list-of-esc-hot-lines-clinical-trial-updates-and-science-hot-lines/2009-07-13T12:38:11-04:00http://www.cardiobrief.org/2009/07/15/nejm-open-vein-graft-harvesting-preferable-to-endoscopic-harvesting/2009-07-15T15:50:58-04:00http://www.cardiobrief.org/2009/07/13/study-estimates-cancer-risks-for-widespread-calcium-screening/2009-07-14T14:20:24-04:00http://www.cardiobrief.org/2009/07/10/congressman-fda-admits-kaul-should-not-have-been-dismissed-from-prasugrel-panel/2009-07-10T14:11:32-04:00http://www.cardiobrief.org/2009/07/10/fda-approves-prasugrel/2009-07-10T17:08:09-04:00http://www.cardiobrief.org/2009/07/13/teenage-girl-thriving-after-late-donor-cardiectomy-10-years-after-heterotopic-transplant/2009-07-13T15:37:34-04:00http://www.cardiobrief.org/2009/07/22/cardiology-strikes-back-bove-lewin-weber-black-defend-ties-to-industry/2009-07-22T16:37:38-04:00http://www.cardiobrief.org/2009/07/14/prasugrel-approval-aftermath-now-the-real-battle-begins/2009-07-14T18:31:49-04:00http://www.cardiobrief.org/2009/07/17/courage-results-get-support-from-angiography-study-and-califf-editorial/2009-07-17T22:09:03-04:00http://www.cardiobrief.org/2009/07/15/nejm-bhatt-editorial-evaluates-prasugrel-in-clinical-practice/2009-07-15T16:58:33-04:00http://www.cardiobrief.org/2009/07/16/prasugrel-priced-18-more-than-clopidogrel-in-us-by-lillydaiichi-sankyo/2009-07-16T11:03:37-04:00http://www.cardiobrief.org/2009/07/16/cleveland-clinic-again-leads-us-news-world-report-list-for-heart-hospitals/2009-07-16T22:18:55-04:00http://www.cardiobrief.org/2009/07/21/shocking-studies-in-jama-show-benefits-of-healthy-lifestyles/2009-07-21T13:58:51-04:00http://www.cardiobrief.org/2009/07/20/salt-studies/2009-07-21T08:45:19-04:00http://www.cardiobrief.org/2009/07/21/2434/2009-07-21T13:57:49-04:00http://www.cardiobrief.org/2009/07/22/fda-panel-recommends-approval-of-medtronics-melody-transcatheter-pulmonary-valve/2009-07-23T23:40:33-04:00http://www.cardiobrief.org/2009/07/23/best-selling-cardiovascular-drugs-of-t2008/2009-07-23T23:39:54-04:00http://www.cardiobrief.org/2009/07/24/fda-briefing-documents-binodenoson-in-for-some-tough-questions/2009-07-24T13:18:20-04:00http://www.cardiobrief.org/2009/07/27/fda-review-raises-questions-about-expanded-indication-for-telmisartan/2009-07-27T15:13:01-04:00http://www.cardiobrief.org/2009/07/28/des-usage-plunged-immediately-following-warnings-at-esc-2006/2009-07-28T14:31:34-04:00http://www.cardiobrief.org/2009/07/28/senate-committee-to-hold-hearings-on-cme/2009-07-28T15:30:55-04:00http://www.cardiobrief.org/2009/07/28/dronedarone-multaq-to-cost-9day/2009-07-28T10:36:00-04:00http://www.cardiobrief.org/2009/07/28/fda-cardiorenal-panel-votes-against-binodenoson/2009-07-28T23:38:37-04:00http://www.cardiobrief.org/2009/07/29/senate-hearings-lay-groundwork-for-assault-on-cme/2009-07-30T09:48:39-04:00http://www.cardiobrief.org/2009/07/29/fda-advisory-panel-gives-mixed-response-to-telmisartan/2009-07-29T23:58:06-04:00http://www.cardiobrief.org/2009/08/05/apixaban-advances-or-does-it/2009-08-05T22:55:44-04:00http://www.cardiobrief.org/2009/07/31/extreme-cardiology-culture-califf-harrington-topol-teirstein/2015-08-26T11:01:26-04:00http://www.cardiobrief.org/2009/07/31/fda-approves-saxagliptin-onglyza/2009-08-05T22:52:06-04:00http://www.cardiobrief.org/2009/08/03/new-review-bolsters-evidence-for-benefits-of-fish-oil/2009-08-05T22:52:53-04:00http://www.cardiobrief.org/2009/08/03/pitavastatin-gains-fda-approval/2009-08-05T22:53:41-04:00http://www.cardiobrief.org/2009/08/04/pitavastatin-prescribing-information-released-by-fda/2009-08-10T16:58:16-04:00http://www.cardiobrief.org/2009/08/05/prasugrel-finally-hits-the-street/2009-08-14T10:21:15-04:00http://www.cardiobrief.org/2009/08/07/questions-raised-about-ucla-cardiologists-endorsement-of-nutritional-supplement/2009-08-09T13:33:11-04:00http://www.cardiobrief.org/2009/08/09/antioxidants-for-radiation-protection-ehrlich-versus-harrington/2009-08-09T19:53:27-04:00http://www.cardiobrief.org/2009/08/10/antioxidant-supplements-round-3-harrington-remains-naturally-skeptical/2009-08-10T15:49:41-04:00http://www.cardiobrief.org/2009/08/11/large-study-increases-concerns-over-tzd-fracture-risk/2009-08-11T15:00:55-04:00http://www.cardiobrief.org/2009/08/11/fda-official-on-prasugrel-approval-this-has-not-been-a-well-managed-review-process/2009-08-13T14:37:06-04:00http://www.cardiobrief.org/2009/08/12/nejm-califf-et-al-seek-to-shed-light-on-the-ezetimibe-cancer-controversy/2009-08-13T14:35:14-04:00http://www.cardiobrief.org/2009/08/14/2681/2009-08-14T13:58:29-04:00http://www.cardiobrief.org/2009/08/13/cardio-sis-in-the-lancet-is-130-the-new-140/2009-08-13T19:34:25-04:00http://www.cardiobrief.org/2009/08/15/charm-substudy-in-lancet-spotlights-albuminuria-in-hf/2009-08-15T09:21:59-04:00http://www.cardiobrief.org/2009/08/14/saxagliptin-now-available-in-the-us/2009-08-14T10:23:52-04:00http://www.cardiobrief.org/2009/08/18/jama-papers-mi-outcomes-improving-hf-not-so-much/2009-08-18T13:35:40-04:00http://www.cardiobrief.org/2009/08/18/wall-street-guesses-arbiter-6-will-be-aha-late-breaker/2009-11-02T09:43:00-05:00http://www.cardiobrief.org/2009/08/18/get-ready-for-the-esc-in-barcelona/2009-08-18T16:18:51-04:00http://www.cardiobrief.org/2009/08/19/is-it-time-to-change-the-guidelines-for-unprotected-left-main-disease/2009-08-19T21:05:51-04:00http://www.cardiobrief.org/2009/08/25/editorial-prescription-for-medical-education-sunshine/2009-08-25T23:13:54-04:00http://www.cardiobrief.org/2009/08/18/bmj-study-questions-whether-ongoing-use-of-rosiglitazone-is-justified-in-any-circumstance/2009-08-18T23:39:40-04:00http://www.cardiobrief.org/2009/08/20/shanghai-cardiology-conference-putting-the-con-back-in-the-word-conference/2009-08-20T10:51:41-04:00http://www.cardiobrief.org/2009/09/04/esc-the-shady-side-of-af-treatments/2009-09-07T23:02:49-04:00http://www.cardiobrief.org/2009/09/03/fame-at-esc-benefits-of-ffr-hold-up-at-18-months/2009-09-03T11:46:26-04:00http://www.cardiobrief.org/2009/08/25/jama-researchers-identify-genetic-variation-that-hinders-clopidogrel-effectiveness/2009-08-24T20:09:35-04:00http://www.cardiobrief.org/2009/08/25/jama-risk-of-death-after-acs-diff-in-men-women/2009-08-21T12:34:56-04:00http://www.cardiobrief.org/2009/08/20/cardiologist-in-mcallen-texas-sentenced-to-4-years-in-prison/2009-08-21T10:58:56-04:00http://www.cardiobrief.org/2009/08/24/testosterone-may-be-beneficial-in-hf/2009-08-24T18:51:15-04:00http://www.cardiobrief.org/2009/08/26/sensitive-troponin-assays-enter-the-fray/2009-08-25T23:03:14-04:00http://www.cardiobrief.org/2009/08/26/topol-and-teirstein-argue-about-stents-on-nprs-all-things-considered/2009-08-27T19:24:56-04:00http://www.cardiobrief.org/2009/08/28/routine-use-of-stenting-in-carotid-stenosis-can-no-longer-be-justified/2009-08-29T10:25:14-04:00http://www.cardiobrief.org/2009/09/02/jama-all-aboard-for-pci-but-no-need-to-rush/2009-09-01T17:34:48-04:00http://www.cardiobrief.org/2009/08/30/esc-bivalirudin-and-otamixaban-in-acs/2009-08-30T12:15:44-04:00http://www.cardiobrief.org/2009/08/27/arbiter-6-scheduled-as-aha-late-breaker-kastelein-to-be-discussant/2009-11-02T09:42:32-05:00http://www.cardiobrief.org/2009/08/30/esc-ticagrelor-shows-potent-antiplatelet-effect-in-plato/2009-08-30T12:18:21-04:00http://www.cardiobrief.org/2009/08/30/re-ly-at-esc-dabigatran-in-warfarin-finally-on-the-way-out/2009-08-30T19:58:13-04:00http://www.cardiobrief.org/2009/08/31/esc-reassurance-on-concomitant-use-of-ppis-and-antiplatelets/2009-08-31T11:05:21-04:00http://www.cardiobrief.org/2009/08/30/esc-high-dose-clopidogrel-aids-pci-for-acs-current-oasis-7/2009-08-30T19:55:44-04:00http://www.cardiobrief.org/2009/08/30/aaa-at-esc-aspirin-not-beneficial-in-asymptomatic-patients-with-low-abi/2009-08-30T11:07:26-04:00http://www.cardiobrief.org/2009/08/30/1st-day-esc-hot-lines-68415-randomized-patients/2009-08-30T04:35:40-04:00http://www.cardiobrief.org/2009/09/01/esc-icdmadit-crt/2009-09-01T04:24:49-04:00http://www.cardiobrief.org/2009/09/02/fda-reviewer-reviews-his-own-prasugrel-review-in-nejm/2009-09-02T15:50:19-04:00http://www.cardiobrief.org/2009/09/01/hiding-in-plain-sight-clinical-trial-registration-isnt-working-as-intended/2009-09-02T16:56:41-04:00http://www.cardiobrief.org/2009/08/31/jupiter-at-esc-large-absolute-benefit-with-rosuvastatin-in-elderly-patients/2009-08-31T21:04:55-04:00http://www.cardiobrief.org/2009/08/31/esc-grace-documents-growing-use-of-pci-for-left-main-disease-in-acs/2009-08-31T18:51:51-04:00http://www.cardiobrief.org/2009/09/01/kyoto-heart-at-esc-have-arbs-finally-come-of-age/2009-09-01T15:13:22-04:00http://www.cardiobrief.org/2009/09/02/syntax-at-esc-at-2-years-mis-in-pci-patients-begin-to-accumulate/2009-09-02T14:16:55-04:00http://www.cardiobrief.org/2009/09/03/are-low-carb-high-fat-diets-fads/2009-09-07T23:02:03-04:00http://www.cardiobrief.org/2009/09/05/circulation-publishes-lengthy-correction-of-mist-paper/2009-09-07T23:02:27-04:00http://www.cardiobrief.org/2009/09/06/dr-nobody-in-jama-editors-flap-speaks-his-mind/2009-09-07T23:02:37-04:00http://www.cardiobrief.org/2009/09/08/dronedarone-less-effective-but-safer-than-amiodarone-study-suggests/2009-09-08T10:50:00-04:00http://www.cardiobrief.org/2009/09/08/lifetime-exposure-to-lead-linked-to-increased-cv-risk/2009-09-08T14:12:33-04:00http://www.cardiobrief.org/2009/09/09/phentermine-and-topiramate-a-slimming-combination/2012-07-18T14:32:15-04:00http://www.cardiobrief.org/2009/09/10/acc-survey-finds-critical-shortage-of-cardiologists-now-and-in-the-future/2009-09-11T10:55:32-04:00http://www.cardiobrief.org/2009/09/13/endothelin-receptor-blocker-darusentan-effective-in-resistant-hypertension/2009-09-12T19:09:01-04:00http://www.cardiobrief.org/2009/09/10/abbott-to-acquire-evalve-developer-of-minimally-invasive-mitral-valve-repair-devices/2009-09-11T10:55:42-04:00http://www.cardiobrief.org/2009/09/14/icds-in-women-a-new-meta-analysis-sparks-criticism/2009-09-14T16:17:57-04:00http://www.cardiobrief.org/2009/09/14/study-sheds-light-on-stroke-following-cardiac-surgery/2009-09-16T14:41:39-04:00http://www.cardiobrief.org/2009/09/11/editor-insists-prasugrel-ghostwriter-go-public/2015-08-26T14:40:18-04:00http://www.cardiobrief.org/2009/09/16/nejm-writers-make-case-for-soda-tax/2009-09-17T10:14:10-04:00http://www.cardiobrief.org/2009/09/14/everybody-in-the-risk-pool-survey-finds-frightening-increase-in-cv-risk/2009-09-14T16:21:14-04:00http://www.cardiobrief.org/2009/09/16/senate-investigation-uncovers-huge-expenditures-for-vytorin-cme/2009-09-16T15:16:52-04:00http://www.cardiobrief.org/2009/09/18/uk-study-high-risk-associated-with-10-15-year-cut-in-life-expectancy/2009-09-17T11:54:45-04:00http://www.cardiobrief.org/2009/09/21/circ-smoking-ban/2009-09-21T16:03:29-04:00http://www.cardiobrief.org/2009/09/18/company-and-wall-street-disagree-over-trial-results-of-diet-drug-lorcaserin/2009-09-18T17:34:47-04:00http://www.cardiobrief.org/2009/09/21/flu-vaccine-may-prevent-flu-triggered-mis/2009-09-23T12:23:33-04:00http://www.cardiobrief.org/2009/09/22/accaha-publish-new-performance-measures-to-prevent-cv-disease/2009-09-23T12:23:17-04:00http://www.cardiobrief.org/2009/09/21/wall-street-analyst-calls-prasugrel-launch-muted/2009-09-21T16:10:52-04:00http://www.cardiobrief.org/2009/09/22/senators-ask-columbia-did-martin-leon-fail-to-disclose-millions-of-dollars-received-from-industry/2009-09-23T12:23:06-04:00http://www.cardiobrief.org/2009/09/23/tct-xience-outperforms-taxus-in-spirit-iv-but-no-difference-in-diabetics/2009-09-23T20:29:03-04:00http://www.cardiobrief.org/2009/09/23/gregg-stone-no-longer-chairman-of-cardiovascular-research-foundation/2009-09-23T20:29:16-04:00http://www.cardiobrief.org/2009/09/24/tct-fame-extends-its-15-minutes-out-to-2-years/2009-09-25T13:33:12-04:00http://www.cardiobrief.org/2009/09/24/3280/2009-09-24T17:51:18-04:00http://www.cardiobrief.org/2009/09/24/tct-cogent-provides-reassurance-on-use-of-ppis-with-clopidogrel/2009-09-25T14:20:55-04:00http://www.cardiobrief.org/2009/09/25/cholesterol-prescriptions-from-senators-schumer-grassley-and-nelson/2009-09-25T14:21:32-04:00http://www.cardiobrief.org/2009/09/28/home-care-for-acute-decompensated-heart-failure/2009-09-28T10:35:48-04:00http://www.cardiobrief.org/2009/09/25/fda-adds-pancreatitis-warning-to-januvia-label/2009-09-25T14:22:23-04:00http://www.cardiobrief.org/2009/09/29/invitation-to-readers-my-mighty-team/2009-09-29T19:55:19-04:00http://www.cardiobrief.org/2009/09/29/fish-and-heart-failure-the-one-that-got-away/2009-09-29T20:32:53-04:00http://www.cardiobrief.org/2009/09/30/reverse-at-2-years-crt-may-help-prevent-progression-in-early-hf/2009-09-30T19:50:40-04:00http://www.cardiobrief.org/2009/10/01/lancet-review-will-most-babies-born-now-live-to-100/2009-10-01T11:40:33-04:00http://www.cardiobrief.org/2009/10/01/fda-alert-heparin-shipped-after-october-8-will-be-10-less-potent/2009-10-01T16:24:48-04:00http://www.cardiobrief.org/2009/10/02/1st-patient-enrolled-in-dapt-study-testing-duration-of-antiplatelet-therapy-after-des/2009-10-02T12:08:25-04:00http://www.cardiobrief.org/2009/10/05/onglyza-saxagliptin-gains-european-approval/2009-10-05T11:09:49-04:00http://www.cardiobrief.org/2009/10/05/hypertension-in-china/2009-10-06T23:14:57-04:00http://www.cardiobrief.org/2009/10/05/fda-posts-full-drug-approval-package-for-prasugrel/2009-10-05T13:35:27-04:00http://www.cardiobrief.org/2009/10/06/9-nontraditional-risk-factors-fail-to-gain-uspstf-recommendations-crp-comes-close/2009-10-06T15:28:30-04:00http://www.cardiobrief.org/2009/10/06/elizabeth-taylor-twitters-the-news-shes-about-to-get-an-evalve-mitraclip-mitral-valve/2009-10-09T00:10:52-04:00http://www.cardiobrief.org/2009/10/07/october-thought-experiment-suppose-the-world-series-were-covered-like-the-nobel-prizes/2015-10-16T09:56:38-04:00http://www.cardiobrief.org/2009/10/08/erosions-and-late-stage-thrombi-more-prevalent-in-women-and-younger-sudden-death-victims/2009-10-08T14:56:04-04:00http://www.cardiobrief.org/2009/10/08/lancet-retracts-cooperate-trial-of-dual-ras-inhibition-and-spanks-lead-author-for-serious-misconduct/2009-10-08T17:55:35-04:00http://www.cardiobrief.org/2009/10/12/study-finds-increased-use-of-glucose-lowering-treatments-at-the-expense-of-statins-and-antihypertensives/2009-10-12T16:12:11-04:00http://www.cardiobrief.org/2009/10/13/10-years-after-columbia-heart-surgery-study-still-causing-problems/2009-10-12T19:16:34-04:00http://www.cardiobrief.org/2009/10/13/brave-new-world-zen-trial-to-test-des-for-ed/2009-10-13T15:54:23-04:00http://www.cardiobrief.org/2009/10/14/meta-analysis-suggests-statins-may-help-fight-infections/2009-10-14T12:16:43-04:00http://www.cardiobrief.org/2009/10/15/iom-report-smoking-bans-cut-heart-attacks-in-smokers-and-nonsmokers/2009-10-15T12:50:20-04:00http://www.cardiobrief.org/2009/10/16/crestor-gains-pediatric-fh-indication-from-fda/2009-10-16T09:18:06-04:00http://www.cardiobrief.org/2009/10/16/study-raises-concerns-about-trauma-treatment-in-growing-population-on-warfarin/2009-10-16T10:29:21-04:00http://www.cardiobrief.org/2009/10/16/more-allegations-about-enhance-fiasco-laid-out-in-vytorin-lawsuit-complaint/2009-10-16T14:15:26-04:00http://www.cardiobrief.org/2009/10/19/telmisartan-gets-fda-approval-for-cv-prevention-in-acei-intolerant-patients/2009-10-23T09:39:21-04:00http://www.cardiobrief.org/2009/10/20/medco-launches-14000-patient-head-to-head-comparison-of-clopidogrel-and-prasugrel/2009-10-20T19:23:46-04:00http://www.cardiobrief.org/2009/10/20/hospitals-getting-with-the-guidelines-are-not-getting-with-aldosterone-antagonism/2009-10-20T14:33:09-04:00http://www.cardiobrief.org/2009/10/21/fda-turns-down-kings-nda-for-corvue-binodenoson/2009-10-21T16:18:18-04:00http://www.cardiobrief.org/2009/10/22/betsy-nabel-to-leave-nhlbi-to-become-president-of-the-brigham/2009-10-22T20:26:56-04:00http://www.cardiobrief.org/2009/10/22/lancet-liraglutide-shows-considerable-promise-in-weight-loss-trial/2009-10-22T16:34:39-04:00http://www.cardiobrief.org/2009/10/24/duke-cardiologist-to-be-new-president-of-gladstone-institutes/2009-10-24T18:03:07-04:00http://www.cardiobrief.org/2009/10/26/women-and-mi-increasing-incidence-but-improved-survival/2009-10-26T16:48:28-04:00http://www.cardiobrief.org/2009/10/26/fda-advisory-committee-to-review-primary-prevention-indication-for-crestor-rosuvastatin/2009-10-27T10:37:43-04:00http://www.cardiobrief.org/2009/10/27/senator-queries-nih-about-ballantyne-and-other-nih-grantees-who-took-vytorin-money/2009-10-27T15:52:02-04:00http://www.cardiobrief.org/2009/10/27/medicare-advisory-committee-delivers-mixed-review-for-af-catheter-ablation/2009-10-27T13:54:49-04:00http://www.cardiobrief.org/2009/10/28/review-article-highlights-differences-between-european-and-north-american-stemi-guidelines/2009-10-28T15:02:02-04:00http://www.cardiobrief.org/2009/10/28/uks-nice-allows-limited-use-of-prasugrel/2009-10-28T23:36:45-04:00http://www.cardiobrief.org/2009/10/29/study-suggests-statins-may-prevent-flu-deaths/2009-10-29T15:00:19-04:00http://www.cardiobrief.org/2009/10/29/halloween-to-arrive-early-this-year-with-presentation-of-treat/2009-10-29T16:50:26-04:00http://www.cardiobrief.org/2009/11/02/arbiter-6-wall-street-chorus-predicts-outcome-publication-and-editorials/2009-11-02T15:20:45-05:00http://www.cardiobrief.org/2009/10/30/halloween-trick-dont-treat-diabetes-with-esas/2009-10-30T21:55:27-04:00http://www.cardiobrief.org/2009/10/30/astrazeneca-update-on-ticagrelor-brilinta-raises-questions-about-reduced-efficacy-with-high-dose-aspirin/2009-10-30T13:30:05-04:00http://www.cardiobrief.org/2009/11/02/exenatide-byetta-gains-first-line-indication-from-fda-but-also-a-warning/2009-11-02T15:43:43-05:00http://www.cardiobrief.org/2009/11/02/beta-blockers-for-noncardiac-surgery-deemphasized-in-revised-accaha-guidelines/2009-11-02T10:58:07-05:00http://www.cardiobrief.org/2009/11/02/fda-refuses-to-file-merck-application-for-ezetimibeatorvastatin-combination/2009-11-02T16:13:05-05:00http://www.cardiobrief.org/2009/11/02/small-niacin-imaging-study-looms-large-in-the-run-up-to-arbiter-6/2009-11-02T18:40:35-05:00http://www.cardiobrief.org/2009/11/02/massachusetts-cardiologist-sues-lahey-clinic-after-being-fired-claims-hospital-had-close-ties-to-medtronic/2009-11-02T19:34:46-05:00http://www.cardiobrief.org/2009/11/03/cheerleading-for-science-anybody-have-a-better-idea/2009-11-03T13:31:44-05:00http://www.cardiobrief.org/2009/11/04/nejm-on-pump-cabg-beats-off-pump-cabg-at-one-year/2009-11-04T15:25:29-05:00http://www.cardiobrief.org/2009/11/05/heartmate-ii-bypasses-fda-panel-and-may-get-destination-therapy-indication-soon/2009-11-05T13:06:37-05:00http://www.cardiobrief.org/2009/11/08/play-the-cme-game-at-home-or-at-the-aha/2009-11-06T21:07:56-05:00http://www.cardiobrief.org/2009/11/05/ny-times-why-icds-are-like-maseratis-and-not-hondas/2009-11-05T20:49:13-05:00http://www.cardiobrief.org/2009/11/06/boston-scientific-closes-one-case-for-296-million-and-discloses-a-new-subpoena/2009-11-06T12:36:07-05:00http://www.cardiobrief.org/2009/11/06/donald-baim-interventional-cardiologist-and-boston-scientific-executive-dead-at-59/2009-11-07T08:54:55-05:00http://www.cardiobrief.org/2009/11/09/observational-study-finds-increased-adverse-outcomes-with-increased-usage-of-carotid-stenting/2009-11-09T16:13:38-05:00http://www.cardiobrief.org/2009/11/09/boston-scientific-issues-statement-on-the-death-of-donald-baim/2009-11-09T16:19:19-05:00http://www.cardiobrief.org/2009/11/10/arbiter-6-family-feud-and-the-survey-says/2009-11-10T08:40:29-05:00http://www.cardiobrief.org/2009/11/10/jama-statins-reduce-gallstones-simplified-lipid-assessment-without-fasting/2009-11-10T16:04:22-05:00http://www.cardiobrief.org/2009/11/11/nejm-study-finds-risks-but-no-benefits-for-renal-revascularization/2009-11-11T17:03:45-05:00http://www.cardiobrief.org/2009/11/11/fda-sends-warning-letter-to-ucla-cardiologist-charles-mckay/2009-11-12T14:56:48-05:00http://www.cardiobrief.org/2009/11/12/william-ganz-co-inventor-of-catheter-and-early-promoter-of-thrombolysis-dead-at-90/2009-11-12T20:18:29-05:00http://www.cardiobrief.org/2009/11/15/niacin-to-take-center-stage-as-it-beats-ezetimibe-in-arbiter-6/2009-11-16T07:04:36-05:00http://www.cardiobrief.org/2009/11/13/get-ready-for-the-aha-in-orlando/2009-11-12T20:14:55-05:00http://www.cardiobrief.org/2009/11/18/ahaaccscai-release-updated-stemi-and-pci-guidelines/2009-11-18T16:12:19-05:00http://www.cardiobrief.org/2009/11/13/26000-patients-enrolled-in-timi-50-trial-of-novel-antiplatelet-agent/2009-11-13T12:56:05-05:00http://www.cardiobrief.org/2009/11/13/editorial-why-arbiter-6-is-important-and-not-important/2009-11-13T17:46:26-05:00http://www.cardiobrief.org/2009/11/14/the-empire-strikes-back-mercks-richard-pasternak-downgrades-arbiter-6/2009-11-14T17:07:50-05:00http://www.cardiobrief.org/2009/11/15/aha-cangrelor-fails-to-find-a-championship-season/2009-11-15T11:44:20-05:00http://www.cardiobrief.org/2009/11/15/aha-ticagrelor-found-beneficial-in-stemi-subset-of-plato/2009-11-15T09:43:57-05:00http://www.cardiobrief.org/2009/11/15/aha-biventricular-pacing-preserves-lv-shape-and-function/2009-11-15T13:54:32-05:00http://www.cardiobrief.org/2009/11/16/aha-arbiters-sunday-roller-coaster-ride-in-orlando/2015-08-26T14:50:58-04:00http://www.cardiobrief.org/2009/11/16/aha-early-repolarization-on-ecg-associated-with-increased-risk-of-cardiac-death/2009-11-16T14:00:20-05:00http://www.cardiobrief.org/2009/11/16/new-warnings-added-to-plavix-clopidogrel-label/2009-11-16T23:23:20-05:00http://www.cardiobrief.org/2009/11/17/aha-58-survival-rate-at-2-years-with-heartmate-ii-continuous-flow-lvad/2010-01-20T13:05:13-05:00http://www.cardiobrief.org/2009/11/17/fda-issues-public-health-advisory-on-interaction-between-clopidogrel-and-omeprazole/2009-11-17T18:31:53-05:00http://www.cardiobrief.org/2009/11/17/ken-baughman-dies-after-a-traffic-accident-in-orlando-during-aha/2009-11-17T13:59:24-05:00http://www.cardiobrief.org/2009/11/19/astrazeneca-submits-nda-for-brilinta-ticagrelor-and-fills-in-details-about-how-it-works/2009-11-19T09:09:46-05:00http://www.cardiobrief.org/2009/11/20/einstein-at-ash-rivaroxaban-xarelto-prevents-recurrent-vte-but-bleeding-may-be-a-concern/2009-12-04T13:01:23-05:00http://www.cardiobrief.org/2009/11/20/emea-investigating-increased-cardiovascular-risk-with-sibutramine/2009-11-20T14:13:33-05:00http://www.cardiobrief.org/2009/11/20/fda-also-announces-safety-review-of-sibutramine-meridia/2009-11-20T18:40:46-05:00http://www.cardiobrief.org/2009/11/22/one-week-later-the-arbiter-6-aftermath/2009-11-22T17:16:52-05:00http://www.cardiobrief.org/2009/11/23/vioxx-what-did-merck-know-and-when-did-it-know-it/2009-11-23T16:08:03-05:00http://www.cardiobrief.org/2009/11/23/did-medicaid-pay-for-all-those-plavix-ads-on-the-news/2009-11-23T17:38:44-05:00http://www.cardiobrief.org/2009/11/24/jama-high-primary-pci-volume-doesnt-translate-into-lower-mortality/2009-11-24T13:38:57-05:00http://www.cardiobrief.org/2009/11/24/report-new-niacin-scrips-rise-41-in-week-following-arbiter-6/2009-11-24T17:41:55-05:00http://www.cardiobrief.org/2009/11/25/nejm-very-low-troponin-t-levels-in-stable-cad-associated-with-death-and-hf-but-not-mi/2009-11-25T14:18:33-05:00http://www.cardiobrief.org/2009/11/30/dronedarone-multaq-gains-eu-approval-for-atrial-fibrillation/2009-11-30T08:51:13-05:00http://www.cardiobrief.org/2009/11/30/circulation-exercise-may-help-slow-aging-process-by-protecting-telomeres/2009-11-30T16:06:19-05:00http://www.cardiobrief.org/2009/12/01/susan-shurin-to-serve-as-acting-director-of-nhlbi/2009-12-01T08:37:42-05:00http://www.cardiobrief.org/2009/12/01/ama-its-hard-to-beat-the-framingham-risk-score/2009-12-01T15:00:55-05:00http://www.cardiobrief.org/2009/12/02/roches-taspoglutide-beats-sitagliptin-in-phase-iii-trial/2010-02-11T14:35:16-05:00http://www.cardiobrief.org/2009/12/03/bmj-large-observational-study-finds-excess-cv-risk-for-sulphonylureas-but-benign-outcomes-for-tzds/2009-12-03T18:56:20-05:00http://www.cardiobrief.org/2009/12/04/bmj-risk-of-vte-after-surgery-is-higher-and-lasts-longer-than-expected/2009-12-04T10:13:45-05:00http://www.cardiobrief.org/2009/12/03/us-justice-dept-weighing-criminal-charges-against-jj-over-natrecor-marketing/2009-12-03T13:25:49-05:00http://www.cardiobrief.org/2009/12/06/re-cover-at-ash-dabigatran-equals-warfarin-for-vte-treatment/2009-12-06T12:41:21-05:00http://www.cardiobrief.org/2009/12/05/industry-academic-researchers-and-clinical-trials-the-slippery-slope/2015-08-26T15:01:44-04:00http://www.cardiobrief.org/2009/12/06/rivaroxaban-einstein-at-ash-and-another-rock-on-the-road-to-approval/2009-12-07T08:28:00-05:00http://www.cardiobrief.org/2009/12/08/new-mri-technique-uncovers-differences-in-mens-and-womens-hearts/2009-12-07T19:15:52-05:00http://www.cardiobrief.org/2009/12/07/cardiorenal-advisory-panel-to-take-up-nebivolol-for-heart-failure-in-january/2009-12-07T11:10:23-05:00http://www.cardiobrief.org/2009/12/08/many-dialysis-patients-undergoing-pci-receive-contraindicated-antithrombotics/2009-12-07T19:38:59-05:00http://www.cardiobrief.org/2009/12/10/wired-david-eddys-efforts-to-replace-human-trials-with-computer-models/2009-12-10T13:34:55-05:00http://www.cardiobrief.org/2009/12/10/lancet-bleeding-risk-in-mi-patients-increases-with-dual-and-triple-therapy/2009-12-16T12:33:41-05:00http://www.cardiobrief.org/2009/12/09/gao-fda-fails-to-make-adequate-changes-in-drug-safety-monitoring/2009-12-09T15:32:34-05:00http://www.cardiobrief.org/2009/12/09/medtronic-cardiac-rhythm-device-unit-under-investigation-in-california/2009-12-09T18:28:33-05:00http://www.cardiobrief.org/2009/12/11/fda-sets-stage-for-tuesdays-crestor-rosuvastatin-advisory-panel/2009-12-11T13:38:08-05:00http://www.cardiobrief.org/2009/12/14/are-ct-scans-the-wild-west-of-todays-medicine/2009-12-15T12:57:38-05:00http://www.cardiobrief.org/2009/12/15/review-finds-no-consistent-or-reproducible-treatment-effect-of-serial-calcium-scans/2009-12-15T13:28:30-05:00http://www.cardiobrief.org/2009/12/15/fda-advisory-panel-backs-expanded-indication-for-crestor-rosuvastatin/2009-12-15T18:44:40-05:00http://www.cardiobrief.org/2009/12/17/aha-cv-disease-will-cost-500-billion-in-2010/2009-12-17T14:58:39-05:00http://www.cardiobrief.org/2009/12/16/tcfa-the-most-relevant-form-of-human-disease-in-the-history-of-mankind/2009-12-16T16:38:40-05:00http://www.cardiobrief.org/2009/12/17/roche-announces-positive-results-for-2-more-taspoglutide-trials/2009-12-17T08:58:38-05:00http://www.cardiobrief.org/2009/12/17/cardiome-says-vernakalant-bests-amiodarone-in-acute-conversion-of-af/2009-12-17T19:04:14-05:00http://www.cardiobrief.org/2009/12/18/primary-pci-without-surgical-backup-deemed-safe-in-nys-study/2009-12-18T10:21:29-05:00http://www.cardiobrief.org/2009/12/21/lancet-huge-metaanalysis-finds-no-causative-role-of-crp/2009-12-23T18:54:46-05:00http://www.cardiobrief.org/2009/12/23/nejm-1-in-6-persons-have-lpa-variant-associated-with-increased-cad-risk/2009-12-23T11:12:15-05:00http://www.cardiobrief.org/2009/12/21/niacin-helps-restore-hdl-protective-effects-in-diabetics/2009-12-21T15:32:48-05:00http://www.cardiobrief.org/2009/12/22/fda-says-cancer-risk-of-vytorin-and-zetia-is-unlikely/2009-12-22T12:26:47-05:00http://www.cardiobrief.org/2009/12/22/genes-stem-cells-ticagrelor-and-dabigatran-among-ahas-top-10-for-2009/2009-12-22T13:43:50-05:00http://www.cardiobrief.org/2009/12/22/medicines-company-buys-apoa-1-milano-from-pfizer/2009-12-23T10:51:53-05:00http://www.cardiobrief.org/2009/12/29/jama-review-finds-lack-of-rigor-in-fda-approval-of-cv-devices/2009-12-29T17:24:59-05:00http://www.cardiobrief.org/2009/12/24/study-finds-sprint-fidelis-lead-fractures-increasing-exponentially/2009-12-24T11:09:58-05:00http://www.cardiobrief.org/2009/12/28/ahj-editorial-calls-for-something-equivalent-to-fluoride-in-the-drinking-water-to-fight-scd/2009-12-28T10:42:58-05:00http://www.cardiobrief.org/2009/12/29/acc-files-lawsuit-against-hhs-secretary-sebelius-over-medicare-cuts/2009-12-29T15:31:27-05:00http://www.cardiobrief.org/2009/12/29/second-study-on-approval-of-cv-devices-largely-confirms-fda-deficiencies/2009-12-29T20:38:47-05:00http://www.cardiobrief.org/2009/12/30/ictus-at-5-years-still-fails-to-find-benefit-for-early-invasive-strategy-in-acs/2009-12-30T15:22:23-05:00http://www.cardiobrief.org/2009/12/31/leading-israeli-cardiologists-blocking-their-countrys-participation-in-planned-nih-funded-ischemia-trial/2009-12-31T14:33:20-05:00http://www.cardiobrief.org/2010/01/04/braunwald-in-all-fairness-what-was-ok-three-years-ago-is-not-ok-now-%e2%80%9d/2015-08-26T14:57:08-04:00http://www.cardiobrief.org/2010/01/06/nejm-fda-to-reevaluate-esas-in-treatment-of-anemia/2010-01-06T15:21:25-05:00http://www.cardiobrief.org/2010/01/07/note-to-readers-cardiobrief-editor-to-join-forces-with-nejms-cardioexchange/2010-01-07T15:12:58-05:00http://www.cardiobrief.org/2010/01/07/fda-staff-recommends-against-heart-failure-indication-for-bystolic-nebivolol/2010-01-07T13:29:36-05:00http://www.cardiobrief.org/2010/01/07/compare-investigators-in-the-lancet-paclitaxel-eluting-stents-should-no-longer-be-used-in-everyday-clinical-practice/2010-01-08T11:40:05-05:00http://www.cardiobrief.org/2010/01/08/reevaluating-esas-too-little-too-late/2010-01-08T17:35:38-05:00http://www.cardiobrief.org/2010/01/08/completion-of-improve-it-now-delayed-until-june-2013/2010-01-08T10:19:47-05:00http://www.cardiobrief.org/2010/01/11/archives-not-all-guidelines-are-created-equal/2010-01-11T14:35:34-05:00http://www.cardiobrief.org/2010/01/13/syntax-have-drug-eluting-stents-removed-the-death-penalty-associated-with-diabetes-and-multivessel-pci/2010-01-13T15:25:03-05:00http://www.cardiobrief.org/2010/01/11/fdas-cardiorenal-panel-unanimously-rejects-nebivolol-for-hf/2010-01-11T17:43:46-05:00http://www.cardiobrief.org/2010/01/12/increasing-adherence-to-statins-would-save-twice-the-number-of-lives-as-expanding-eligibility/2010-01-12T14:15:42-05:00http://www.cardiobrief.org/2010/01/13/the-introduction-of-ticagrelor-a-more-potent-and-effective-agent-which-is-as-safe-as-its-predecessor-is-a-landmark-event-that-should-redefine-the-care-of-patients-with-acute-coronary-syndromes/2010-01-14T15:28:34-05:00http://www.cardiobrief.org/2010/01/12/cocaine-plays-role-in-3-of-sudden-deaths-in-spain/2010-01-12T17:09:23-05:00http://www.cardiobrief.org/2010/01/14/new-research-links-radiation-exposure-to-cv-disease/2010-01-14T15:23:01-05:00http://www.cardiobrief.org/2010/01/13/judge-rejects-acc-lawsuit-against-hhs-secretary-sebelius-over-medicare-cuts/2010-01-13T23:28:04-05:00http://www.cardiobrief.org/2010/01/15/maryland-hospital-tells-hundreds-of-heart-patients-their-stents-may-have-been-unnecessary/2010-01-15T21:10:38-05:00http://www.cardiobrief.org/2010/01/19/study-suggests-fixed-doses-of-statins-may-be-better-than-treating-to-target/2010-01-19T14:37:51-05:00http://www.cardiobrief.org/2010/01/20/heartmate-ii-lvas-gains-destination-therapy-indication/2010-01-20T13:09:13-05:00http://www.cardiobrief.org/2010/01/20/nih-puts-baylor-on-a-tight-leash-after-failing-to-disclose-merck-payments-to-ballantyne/2010-01-21T08:44:10-05:00http://www.cardiobrief.org/2010/01/20/nejm-study-and-editorial-advocate-widespread-salt-reductions/2010-01-22T12:21:03-05:00http://www.cardiobrief.org/2010/01/21/generic-clopidogrel-besilate-makes-inroads-into-european-plavix-market/2010-01-22T14:38:19-05:00http://www.cardiobrief.org/2010/01/21/fda-sibutramine-now-contraindicated-in-people-with-cardiovascular-disease/2010-01-21T12:54:23-05:00http://www.cardiobrief.org/2010/01/21/european-medicines-agency-recommends-suspension-of-sibutramine/2010-01-21T17:55:49-05:00http://www.cardiobrief.org/2010/01/22/sandoz-starts-to-prepare-for-generic-enoxaparin-in-the-us/2010-01-22T13:46:01-05:00http://www.cardiobrief.org/2010/01/25/fda-approves-first-percutaneous-heart-valve-medtronics-melody-pulmonary-valve/2010-01-25T14:43:04-05:00http://www.cardiobrief.org/2010/01/25/fda-approves-liraglutide-victoza-for-type-2-diabetes/2010-01-26T10:32:14-05:00http://www.cardiobrief.org/2010/01/26/jama-rf-ablation-superior-to-drugs-in-multicenter-af-trial/2010-01-26T10:25:33-05:00http://www.cardiobrief.org/2010/01/26/cath-lab-coming-attractions-3d-images-of-the-coronary-arteries/2010-01-27T08:18:28-05:00http://www.cardiobrief.org/2010/01/26/lancet-researchers-find-goldilocks-effect-in-glucose-control-for-diabetes/2010-01-26T14:48:40-05:00http://www.cardiobrief.org/2010/01/27/study-identifies-shortcut-to-diagnosing-long-qt-syndrome/2010-01-27T13:33:52-05:00http://www.cardiobrief.org/2010/01/28/acc-10-i2-summit-in-atlanta-late-breaking-clinical-trials/2010-01-27T19:34:45-05:00http://www.cardiobrief.org/2010/01/28/lilly-reports-modest-sales-figures-for-effient-prasugrel/2010-01-28T12:33:26-05:00http://www.cardiobrief.org/2010/01/29/guest-post-chantix-and-cardiovascular-risk-another-weak-safety-study/2010-01-29T15:16:21-05:00http://www.cardiobrief.org/2010/02/01/boston-scientific-pays-1-725-to-jj-to-settle-three-patent-disputes-over-stents/2010-02-01T15:20:23-05:00http://www.cardiobrief.org/2010/02/02/alderman-in-jama-universal-sodium-reductions-are-a-rash-route/2010-02-02T12:11:10-05:00http://www.cardiobrief.org/2010/02/02/live-af-ablation-broadcast-on-today-show-whats-wrong-with-this-picture/2013-03-17T21:57:06-04:00http://www.cardiobrief.org/2010/02/05/more-adverse-events-seen-in-patients-on-ppis-after-des/2010-02-05T12:46:51-05:00http://www.cardiobrief.org/2010/02/08/study-finds-significant-lesions-in-one-fifth-of-patients-with-zero-calcium-scores/2010-03-08T19:30:01-05:00http://www.cardiobrief.org/2010/02/06/the-two-sides-of-aspirin-too-much-and-not-enough/2010-02-06T15:17:26-05:00http://www.cardiobrief.org/2010/02/08/new-concerns-raised-about-boston-scientific-icds/2010-02-08T18:48:28-05:00http://www.cardiobrief.org/2010/02/08/rosuvastatin-crestor-gains-expanded-primary-prevention-indication/2010-02-09T14:23:36-05:00http://www.cardiobrief.org/2010/02/10/boston-scientific-and-william-maisel-clash-over-icd-flaws/2010-02-10T22:53:28-05:00http://www.cardiobrief.org/2010/02/11/roche-announces-more-positive-results-for-taspoglutide-but/2010-02-11T14:55:29-05:00http://www.cardiobrief.org/2010/02/12/boston-scientific-ceo-were-the-reports-of-icd-flaws-tied-to-attempts-to-drive-down-the-stock-price/2010-02-13T16:54:40-05:00http://www.cardiobrief.org/2010/02/16/jama-studies-find-little-evidence-to-support-genetic-testing-to-improve-cv-risk-assessment/2010-02-16T16:04:44-05:00http://www.cardiobrief.org/2010/02/16/lancet-large-meta-analysis-confirms-small-increase-in-diabetes-with-statins/2010-02-17T17:44:40-05:00http://www.cardiobrief.org/2010/02/17/arts-ii-at-5-years-what-have-we-learned/2010-02-17T15:43:24-05:00http://www.cardiobrief.org/2010/02/17/accomplish-amlodopine-may-or-may-not-be-better-than-hydrochlorothiazide-in-combo-with-benazepril-to-slow-progression-of-kidney-disease/2010-02-17T19:13:15-05:00http://www.cardiobrief.org/2010/02/22/study-finds-increased-rate-of-stent-thrombosis-in-primary-pci-patients-who-get-distal-protection/2010-02-19T17:59:38-05:00http://www.cardiobrief.org/2010/02/20/ny-times-fda-and-senate-reports-slam-continued-availability-of-avandia-rosiglitazone/2010-02-20T00:21:32-05:00http://www.cardiobrief.org/2010/02/20/senate-releases-avandia-report-gsk-responds-to-attacks/2010-02-20T15:32:14-05:00http://www.cardiobrief.org/2010/02/22/more-avandia-action-nissen-recorded-gsk-execs-fda-announces-safety-review/2010-02-22T21:47:10-05:00http://www.cardiobrief.org/2010/02/23/jama-study-questions-value-of-platelet-function-tests-in-pci-patients/2010-02-23T18:27:08-05:00http://www.cardiobrief.org/2010/02/24/avandia-a-plaque-on-both-your-houses/2010-02-24T17:03:30-05:00http://www.cardiobrief.org/2010/02/25/carotid-endarterectomy-beats-stenting-in-first-results-from-icss/2010-02-25T18:50:12-05:00http://www.cardiobrief.org/2010/02/26/crest-finds-carotid-stenting-broadly-equivalent-to-endarterectomy/2010-02-26T11:42:17-05:00http://www.cardiobrief.org/2010/03/01/screening-young-athletes-to-ecg-or-not-to-ecg/2010-03-01T16:32:15-05:00http://www.cardiobrief.org/2010/03/02/icd-implantation-may-cause-cognitive-problems-small-study-suggests/2010-03-02T13:58:58-05:00http://www.cardiobrief.org/2010/03/04/guest-post-sanjay-kaul-answers-questions-about-rosiglitazone/2010-03-04T08:47:04-05:00http://www.cardiobrief.org/2010/03/04/advance-2-apixaban-study-published-in-lancet/2010-03-04T13:48:27-05:00http://www.cardiobrief.org/2010/03/08/calcium-scans-do-they-now-come-with-a-warranty/2010-03-08T15:41:40-05:00http://www.cardiobrief.org/2010/03/08/redberg-critical-of-obamas-coronary-calcium-scan/2010-03-08T19:34:07-05:00http://www.cardiobrief.org/2010/03/10/nejm-study-finds-low-diagnostic-yield-for-coronary-angiography/2010-03-10T17:13:56-05:00http://www.cardiobrief.org/2010/03/11/landslide-of-lancet-papers-suggest-importance-of-blood-pressure-variability/2010-03-11T19:10:24-05:00http://www.cardiobrief.org/2010/03/13/mipomersen-cuts-ldl-by-25-in-homozygous-fh-but-safety-concerns-remain/2010-03-11T19:31:55-05:00http://www.cardiobrief.org/2010/03/14/navigator-provides-little-guidance-in-diabetes/2010-03-14T15:19:38-04:00http://www.cardiobrief.org/2010/03/12/plavix-label-gets-black-box-warning-about-poor-metabolizers/2010-03-12T14:41:52-05:00http://www.cardiobrief.org/2010/03/14/accord-fails-to-find-benefits-for-fenofibrate-or-lower-blood-pressure-target/2010-03-14T11:36:11-04:00http://www.cardiobrief.org/2010/03/13/the-countdown-begins/2010-03-15T11:50:02-04:00http://www.cardiobrief.org/2010/03/13/acc-duke-study-links-stock-market-to-cardiac-events/2010-03-13T11:26:03-05:00http://www.cardiobrief.org/2010/03/14/everest-ii-catheter-based-mitral-repair-system-reaches-new-peak/2010-03-14T15:13:39-04:00http://www.cardiobrief.org/2010/03/15/race-ii-dont-rush-to-slow-down/2010-03-14T11:45:58-04:00http://www.cardiobrief.org/2010/03/15/optimal-duration-of-dual-antiplatelet-therapy-still-unresolved/2010-03-14T13:30:22-04:00http://www.cardiobrief.org/2010/03/15/sort-out-iii-chucks-out-zotarolimus-eluting-stents/2010-03-15T11:49:05-04:00http://www.cardiobrief.org/2010/03/15/boston-scientific-reportedly-suspends-icd-sales-due-to-administrative-errors/2010-03-15T10:22:43-04:00http://www.cardiobrief.org/2010/03/15/fda-says-it-will-review-the-accord-data/2010-03-15T13:00:01-04:00http://www.cardiobrief.org/2010/03/15/us-attorneys-office-investigating-medtronic-over-ties-to-lahey-clinic-cardiologists/2010-03-15T13:38:50-04:00http://www.cardiobrief.org/2010/03/16/cabg-in-platos-cave-is-the-reduction-in-mortality-real-or-an-illusion/2010-03-16T15:50:44-04:00http://www.cardiobrief.org/2010/03/17/ahaacc-release-thoracic-aortic-disease-guidelines/2010-03-17T12:42:24-04:00http://www.cardiobrief.org/2010/03/17/fda-panel-set-to-review-expanded-indication-for-crt-d-and-first-mri-safe-pacing-system-new-mri/2010-03-17T13:45:19-04:00http://www.cardiobrief.org/2010/03/18/guest-post-freezing-in-af-ablation-not-so-fast-you-all/2010-03-18T14:08:49-04:00http://www.cardiobrief.org/2010/03/18/more-details-emerge-about-boston-scientifics-suspension-of-icd-sales/2010-03-18T15:35:29-04:00http://www.cardiobrief.org/2010/03/18/fda-watchman-device-will-need-to-wait-a-bit-longer/2010-03-18T17:35:16-04:00http://www.cardiobrief.org/2010/03/18/fda-panel-supports-expanded-indication-for-crt-ds/2010-03-18T22:45:17-04:00http://www.cardiobrief.org/2010/03/19/fda-warns-about-increased-risk-of-myopathy-with-80-mg-simvastatin/2010-03-19T11:38:34-04:00http://www.cardiobrief.org/2010/03/22/why-is-there-a-red-dress-on-diet-coke-cans/2015-08-26T15:05:10-04:00http://www.cardiobrief.org/2010/03/20/fda-panel-recommends-approval-of-medtronics-mri-safe-pacemaker/2010-03-20T14:20:01-04:00http://www.cardiobrief.org/2010/03/22/james-black-nobel-laureate-who-invented-beta-blockers-dead-at-85/2010-03-22T14:58:29-04:00http://www.cardiobrief.org/2010/03/23/avandia-again-nissen-and-jama-editors-spin-record-round-and-round/2010-03-23T18:03:37-04:00http://www.cardiobrief.org/2010/03/25/pieces-of-a-puzzle-multaq-sanofi-acc-hrs-prystowsky-af-guidelines/2015-08-26T15:09:50-04:00http://www.cardiobrief.org/2010/03/26/wtf-now-you-can-diagnose-your-own-heart-attack-right-at-home/2010-03-26T16:50:02-04:00http://www.cardiobrief.org/2010/03/26/more-multaq-prystowsky-whack-a-mole-acc-responds-sanofi-overtures-to-eps/2010-03-31T16:22:35-04:00http://www.cardiobrief.org/2010/03/27/ny-times-most-nitroglycerin-in-the-us-is-in-regulatory-limbo/2010-03-27T16:52:17-04:00http://www.cardiobrief.org/2010/03/29/archimedes-the-computer-model-not-the-greek-supports-screening-for-diabetes/2010-03-29T17:31:47-04:00http://www.cardiobrief.org/2010/03/30/fda-delays-approval-of-certriad-rosuvastatinfenofibric-acid-combo/2010-03-30T12:07:13-04:00http://www.cardiobrief.org/2010/03/30/sec-and-doj-looking-into-boston-scientific-icd-recall/2010-03-30T17:46:08-04:00http://www.cardiobrief.org/2010/03/30/uks-nice-plays-a-bit-nicer-with-multaq-dronedarone/2010-03-30T13:29:17-04:00http://www.cardiobrief.org/2010/03/31/new-york-times-broader-indication-for-rosuvastatin-once-again-raises-risk-vs-benefit-in-healthy-population/2010-03-30T23:08:07-04:00http://www.cardiobrief.org/2010/03/31/prystowsky-lectures-resurfaces-this-time-with-coi-disclosures/2010-03-31T17:38:58-04:00http://www.cardiobrief.org/2010/04/05/waiting-for-improve-it/2010-04-05T17:04:12-04:00http://www.cardiobrief.org/2010/04/06/experts-disagree-on-when-to-use-dronedarone-multaq/2010-04-06T15:40:40-04:00http://www.cardiobrief.org/2010/04/06/guest-post-the-ipad-goes-live-at-bidmc-2/2010-04-07T08:46:11-04:00http://www.cardiobrief.org/2010/04/07/survival-after-cabg-isn%e2%80%99t-about-skin-color-or-gender-it%e2%80%99s-about-being-poor/2010-04-07T15:23:17-04:00http://www.cardiobrief.org/2010/04/08/more-pieces-of-the-multaq-puzzle/2010-04-08T20:13:35-04:00http://www.cardiobrief.org/2010/04/11/nejm-trials-find-few-long-term-benefits-for-endovascular-aaa-repair/2010-04-10T14:44:17-04:00http://www.cardiobrief.org/2010/04/12/guest-post-running-on-empty/2010-04-12T15:19:58-04:00http://www.cardiobrief.org/2010/04/13/promising-early-results-for-valve-in-valve-approach-to-failing-bioprosthetic-valves/2010-04-13T12:24:01-04:00http://www.cardiobrief.org/2010/04/14/final-results-of-arbiter-6-halts-confirm-cimt-benefit-with-niacin-and-no-benefit-with-ezetimibe/2010-04-14T12:50:01-04:00http://www.cardiobrief.org/2010/04/15/even-more-questions-about-multaq-and-prystowsky-alas/2010-04-15T16:12:41-04:00http://www.cardiobrief.org/2010/04/15/boston-scientific-resumes-sales-of-cognis-and-teligen-icds/2010-04-15T20:34:04-04:00http://www.cardiobrief.org/2010/04/18/residual-risk-reduction-initiative-promotion-or-education/2010-04-18T21:16:03-04:00http://www.cardiobrief.org/2010/04/20/small-steps-lead-to-big-reduction-in-risk-for-overweight-mayo-clinic-cardiologist/2010-04-20T10:10:43-04:00http://www.cardiobrief.org/2010/04/20/iom-report-heralds-new-fda-initiative-to-gradually-cut-salt-in-processed-foods/2010-04-20T14:51:49-04:00http://www.cardiobrief.org/2010/04/21/guest-post-the-long-afterlife-of-joshua-oukrop/2010-04-21T14:48:22-04:00http://www.cardiobrief.org/2010/04/22/guest-post-medical-societies-new-ethics-code-secret-qa-document-revealed/2010-04-22T15:38:51-04:00http://www.cardiobrief.org/2010/04/26/ppis-and-clopidogrel-new-study-finds-evidence-that-pantoprazole-may-also-be-a-problem/2010-04-26T16:01:35-04:00http://www.cardiobrief.org/2010/04/27/calcium-screening-another-positive-study-another-critical-editorial/2010-04-27T15:27:35-04:00http://www.cardiobrief.org/2010/04/27/us-judge-rejects-guidant-296-million-plea-agreement/2010-04-27T20:16:44-04:00http://www.cardiobrief.org/2010/04/28/vitamin-b-and-steroids-monuments-to-human-folly/2010-04-28T12:41:23-04:00http://www.cardiobrief.org/2010/04/29/roche-announces-more-positive-results-for-taspoglutide/2010-04-29T09:21:34-04:00http://www.cardiobrief.org/2010/04/29/tmi-personal-genome-used-in-clinical-assessment/2010-04-29T16:49:54-04:00http://www.cardiobrief.org/2010/04/30/the-survey-says-uphill-battle-for-effient-plavix-remains-strong-anticipation-grows-for-brillinta/2010-04-30T14:08:10-04:00http://www.cardiobrief.org/2010/04/30/ehj-editors-rebuffed-gsk-efforts-to-suppress-nissen-editorial-on-rosiglitazone/2010-05-03T09:06:56-04:00http://www.cardiobrief.org/2010/05/04/the-wealth-gap-are-cardiologists-high-salaries-standing-in-the-way-of-primary-care/2015-08-26T15:14:34-04:00http://www.cardiobrief.org/2010/05/05/stentapalooza-wednesday-spirit-iv-and-main-compare/2010-05-05T16:31:22-04:00http://www.cardiobrief.org/2010/05/05/hong-kong-authorities-issue-warning-about-medtronic-icds/2010-05-05T19:34:35-04:00http://www.cardiobrief.org/2010/05/07/vioxx-avandia-vytorin-absolute-risk-versus-relative-risk/2010-05-17T09:29:57-04:00http://www.cardiobrief.org/2010/05/07/medtronic-tells-physicians-about-rare-software-issue-with-its-icds/2010-05-07T21:13:43-04:00http://www.cardiobrief.org/2010/05/10/lancet-meta-analysis-finds-some-benefits-for-fibrates/2010-05-10T16:38:26-04:00http://www.cardiobrief.org/2010/05/12/gust-bardy-answers-questions-about-the-entirely-subcutaneous-icd/2010-05-12T18:01:53-04:00http://www.cardiobrief.org/2010/05/12/topol-vs-gurbel-experts-split-on-routine-genotyping-for-dapt/2010-05-12T19:37:41-04:00http://www.cardiobrief.org/2010/05/14/guest-post-shocking-revelations-at-the-hrs/2010-07-21T12:15:45-04:00http://www.cardiobrief.org/2010/05/14/guest-post-badness-in-baltimore-can-peer-review-catch-rogue-doctors/2010-05-14T17:25:26-04:00http://www.cardiobrief.org/2010/05/18/why-we-shouldnt-kill-all-the-lawyers-just-yet/2010-05-18T17:01:27-04:00http://www.cardiobrief.org/2010/05/17/good-morning-american-segment-lands-some-hard-punches-on-the-aha/2010-06-05T09:07:44-04:00http://www.cardiobrief.org/2010/05/20/is-time-starting-to-run-out-for-tide-and-avandia/2010-05-20T00:39:33-04:00http://www.cardiobrief.org/2010/05/24/francis-collins-proposes-new-conflict-of-interest-rules-for-nih-funded-researchers-and-institutions/2010-05-24T10:41:22-04:00http://www.cardiobrief.org/2010/05/24/guest-post-do-hundreds-of-left-atrial-burns-reduce-dementia-risk/2010-07-21T12:15:31-04:00http://www.cardiobrief.org/2010/05/26/guest-post-steve-nissen-and-jack-lewin-debate-interactions-with-industry/2010-05-26T09:06:28-04:00http://www.cardiobrief.org/2010/05/27/eplerenone-trial-stopped-early-after-reaching-its-primary-endpoint/2010-05-27T09:07:10-04:00http://www.cardiobrief.org/2010/05/28/even-more-people-may-have-received-unnecessary-stents-at-st-josephs/2010-05-28T13:10:29-04:00http://www.cardiobrief.org/2010/05/28/over-3-years-4000-echocardiograms-went-unread-at-nycs-harlem-hospital/2010-05-28T13:43:25-04:00http://www.cardiobrief.org/2010/05/28/think-about-it-4000-echocardiograms-were-not-only-unread-but-unmissed/2010-05-28T20:40:08-04:00http://www.cardiobrief.org/2010/05/29/at-least-200-patients-with-unread-echocardiograms-have-died/2010-05-29T19:36:26-04:00http://www.cardiobrief.org/2010/05/31/can-we-trust-athena/2010-05-31T15:25:37-04:00http://www.cardiobrief.org/2010/06/01/handicapping-the-july-fda-panel-on-avandia/2010-06-01T15:56:35-04:00http://www.cardiobrief.org/2010/06/02/fda-schedules-july-advisory-panel-for-brilinta-ticagrelor/2010-06-03T09:07:22-04:00http://www.cardiobrief.org/2010/06/02/listening-to-industry-whats-the-roi-of-medical-education/2010-06-02T15:38:16-04:00http://www.cardiobrief.org/2010/06/03/up-the-avandia-creek-without-a-paddle-canoe/2010-06-03T10:56:25-04:00http://www.cardiobrief.org/2010/06/04/fda-schedules-avandia-advisory-panel-for-july-13-14/2010-06-07T18:49:02-04:00http://www.cardiobrief.org/2010/06/06/investigators-in-maryland-expand-investigation-of-unnecessary-stenting/2010-06-06T17:02:42-04:00http://www.cardiobrief.org/2010/06/08/atrial-fibrillation-a-big-messy-problem/2010-06-08T11:50:29-04:00http://www.cardiobrief.org/2010/06/09/cardiobriefs-mis-decline-over-past-decade-smoke-free-legislation-reduces-mi-admissions-in-england/2010-06-09T23:44:09-04:00http://www.cardiobrief.org/2010/06/10/new-unpublished-study-may-help-tighten-the-noose-around-avandias-neck/2010-06-10T17:16:11-04:00http://www.cardiobrief.org/2010/06/10/trial-comparing-apixaban-to-aspirin-in-af-stopped-for-efficacy/2010-06-10T18:56:48-04:00http://www.cardiobrief.org/2010/06/11/chicago-cardiologist-morton-arnsdorf-dies-in-car-crash/2010-06-11T09:32:32-04:00http://www.cardiobrief.org/2010/06/11/fda-reviewing-safety-of-olmesartan-benicar/2010-06-11T12:10:13-04:00http://www.cardiobrief.org/2010/06/13/meta-analysis-finds-increased-risk-of-cancer-associated-with-arbs/2010-06-13T15:15:48-04:00http://www.cardiobrief.org/2010/06/15/hdl-and-cancer-study-finds-strong-inverse-relationship/2010-06-15T11:41:34-04:00http://www.cardiobrief.org/2010/06/16/industry-employees-no-longer-allowed-to-speak-at-aha-scientific-sessions/2010-06-16T18:13:51-04:00http://www.cardiobrief.org/2010/06/16/cardiobriefs-new-generation-stent-tested-bms-versus-des-for-stemi/2010-06-16T16:05:20-04:00http://www.cardiobrief.org/2010/06/16/esc-posts-hot-line-trials-for-2010-congress-in-stockholm/2010-06-16T17:15:54-04:00http://www.cardiobrief.org/2010/06/17/trial-of-pfo-closure-fails-to-meet-primary-endpoint/2010-06-17T16:00:02-04:00http://www.cardiobrief.org/2010/06/18/new-delays-for-taspoglutide-renewed-cancer-concerns-for-insulin-glargine/2010-06-18T09:57:29-04:00http://www.cardiobrief.org/2010/06/18/interstroke-accounting-for-stroke/2010-06-18T11:27:00-04:00http://www.cardiobrief.org/2010/06/18/german-committee-recommends-against-reimbursement-for-avandia-and-actos/2010-06-18T15:47:01-04:00http://www.cardiobrief.org/2010/06/19/what-do-outside-cardiologists-think-about-the-unread-echocardiograms-at-harlem-hospital/2010-06-20T20:53:47-04:00http://www.cardiobrief.org/2010/06/22/cardiobriefs-aggrenox-study-fails-livalo-launched-ny-times-spotlights-icds-with-benefits/2010-06-22T14:25:19-04:00http://www.cardiobrief.org/2010/06/23/cardiobriefs-eas-to-recommend-niacin-and-lpa-screening-lowering-homocysteine-fails-again/2010-06-23T17:17:34-04:00http://www.cardiobrief.org/2010/07/02/why-was-an-abbott-marketing-study-published-in-the-american-journal-of-cardiology-2/2015-08-26T15:16:24-04:00http://www.cardiobrief.org/2010/06/23/accme-reverses-rule-that-would-have-prevented-industry-employees-from-speaking-at-scientific-sessions/2010-06-23T20:00:31-04:00http://www.cardiobrief.org/2010/06/24/milwaukee-hospital-misreads-30-of-echocardiograms/2010-06-24T10:35:44-04:00http://www.cardiobrief.org/2010/06/24/ada-kicks-off-with-lancet-papers-on-cv-deaths-in-diabetes-once-weekly-exenatide-and-dapagliflozin/2010-06-25T09:48:32-04:00http://www.cardiobrief.org/2010/06/25/chmp-recommends-european-approval-for-vernakalant-for-recent-onset-af/2010-06-25T09:26:09-04:00http://www.cardiobrief.org/2010/06/26/once-weekly-exenatide-performs-well-in-duration-2/2010-06-25T18:01:54-04:00http://www.cardiobrief.org/2010/06/28/acc-and-aha-respond-to-boxed-warning-on-clopidogrel/2010-06-28T14:20:16-04:00http://www.cardiobrief.org/2010/06/28/tightening-the-noose-yet-again-on-avandia/2010-06-28T10:05:07-04:00http://www.cardiobrief.org/2010/06/28/meta-analysis-questions-value-of-statins-for-primary-prevention-jupiter-comes-under-attack/2010-06-29T08:05:17-04:00http://www.cardiobrief.org/2010/06/29/accord-analyses-find-a-few-faint-glimmers-of-hope/2010-06-29T20:05:53-04:00http://www.cardiobrief.org/2010/06/29/authors-of-jupiter-attack-are-members-of-obscure-anti-cholesterol-group/2010-06-29T14:59:06-04:00http://www.cardiobrief.org/2010/06/30/prasugrel-critics-once-again-raise-cancer-concerns/2010-06-30T15:30:46-04:00http://www.cardiobrief.org/2010/07/01/trial-raises-concerns-over-cv-safety-of-testosterone-gel/2010-07-01T15:07:21-04:00http://www.cardiobrief.org/2010/07/06/study-finds-no-benefit-for-tight-bp-control-in-diabetics-with-cad/2010-07-07T11:43:18-04:00http://www.cardiobrief.org/2010/07/07/nejm-editors-were-not-fully-aware-of-gsk-and-merck-manipulation-of-avandia-and-vytorin-dsmbs/2010-07-07T18:32:24-04:00http://www.cardiobrief.org/2010/07/08/authors-of-jupiter-attack-committed-self-plagiarism/2010-07-08T18:35:11-04:00http://www.cardiobrief.org/2010/07/09/fda-posts-avandia-briefing-documents-ahead-of-next-weeks-advisory-panel-meeting/2010-07-11T15:23:50-04:00http://www.cardiobrief.org/2010/07/09/5-different-ways-of-spinning-record/2010-07-09T12:56:01-04:00http://www.cardiobrief.org/2010/07/09/pioglitazone-beats-rosiglitazone-in-fda-review-of-controlled-epidemiologic-studies/2010-07-09T14:53:26-04:00http://www.cardiobrief.org/2010/07/12/handicapping-the-avandia-fda-panel/2010-07-12T15:47:05-04:00http://www.cardiobrief.org/2010/07/12/effient-and-verifynow-a-match-made-in-heaven/2010-07-12T18:54:24-04:00http://www.cardiobrief.org/2010/07/13/ny-times-gsk-concealed-negative-avandia-study/2010-07-13T13:18:08-04:00http://www.cardiobrief.org/2010/07/13/day-1-of-the-fda-avandia-panel-live-blogging/2010-07-14T09:46:41-04:00http://www.cardiobrief.org/2010/07/13/day-1-of-the-fda-avandia-panel-live-blogging-the-afternoon/2010-07-13T22:13:10-04:00http://www.cardiobrief.org/2010/07/14/day-2-of-the-fda-avandia-panel-live-blogging-the-morning/2010-07-14T12:03:32-04:00http://www.cardiobrief.org/2010/07/14/day-2-of-the-fda-avandia-panel-live-blogging-the-end/2010-07-21T19:29:56-04:00http://www.cardiobrief.org/2010/07/14/gsk-issues-statement-in-response-to-fda-avandia-panel/2010-07-14T17:15:01-04:00http://www.cardiobrief.org/2010/07/14/dick-cheney-receives-an-lvad/2010-07-14T18:22:55-04:00http://www.cardiobrief.org/2010/07/15/fda-announces-safety-review-of-arbs-and-cancer/2010-07-15T14:36:19-04:00http://www.cardiobrief.org/2010/07/16/avandia-aftermath-who-are-the-winners-and-losers/2015-08-28T07:10:50-04:00http://www.cardiobrief.org/2010/07/15/cleveland-clinic-retains-top-position-on-usnwr-list-of-top-heart-hospitalis/2010-07-15T23:38:00-04:00http://www.cardiobrief.org/2010/07/20/avandia-panel-member-received-speaking-fees-from-gsk/2010-07-20T16:57:22-04:00http://www.cardiobrief.org/2010/07/20/2-avandia-panel-members-found-to-have-received-money-from-gsk-and-takeda/2010-07-20T16:59:35-04:00http://www.cardiobrief.org/2010/07/21/guest-post-prophylactic-icds-may-not-benefit-women/2010-07-21T12:15:18-04:00http://www.cardiobrief.org/2010/07/21/fda-puts-tide-on-partial-clinical-hold/2010-07-21T12:54:25-04:00http://www.cardiobrief.org/2010/07/21/jupiter-hdl-doesnt-predict-residual-risk-in-statin-treated-patients-with-low-ldl-levels/2010-07-21T14:56:26-04:00http://www.cardiobrief.org/2010/07/23/fda-approves-first-generic-low-molecular-weight-heparin/2010-07-23T19:39:44-04:00http://www.cardiobrief.org/2010/07/25/is-it-safe/2015-08-28T07:11:34-04:00http://www.cardiobrief.org/2010/07/23/fda-refers-avandia-panelist-conflict-of-interest-case-to-hhs-inspector-general/2010-07-23T20:52:13-04:00http://www.cardiobrief.org/2010/07/26/fda-finally-posts-briefing-documents-for-brilinta-ticagrelor-advisory-panel/2010-07-26T17:40:05-04:00http://www.cardiobrief.org/2010/07/26/dc-storm-causes-delay-in-release-of-brilinta-ticagrelor-briefing-materials/2010-07-26T10:50:15-04:00http://www.cardiobrief.org/2010/07/27/terry-ferguson-moves-to-astrazeneca/2010-07-27T10:30:10-04:00http://www.cardiobrief.org/2010/07/27/mixed-reviews-for-brilinta-prior-to-wednesdays-fda-panel/2010-07-27T11:42:03-04:00http://www.cardiobrief.org/2010/07/28/live-blogging-the-fda-brilinta-panel-morning-session/2010-07-28T12:50:23-04:00http://www.cardiobrief.org/2010/07/28/live-blogging-the-fda-brilinta-panel-afternoon-session/2010-07-28T17:13:27-04:00http://www.cardiobrief.org/2010/07/30/a-missing-piece-of-the-multaq-puzzle-finally-appears-dionysos-published-to-little-fanfare/2010-07-30T17:07:21-04:00http://www.cardiobrief.org/2010/08/01/donald-shiley-valve-inventor-dead-at-90/2010-08-01T18:04:05-04:00http://www.cardiobrief.org/2010/08/02/calcium-and-the-law-of-unintended-consequences/2010-08-02T13:33:22-04:00http://www.cardiobrief.org/2010/08/03/medicines-company-wins-key-ruling-in-effort-to-extend-patent-on-bivalirudin/2010-08-03T17:35:39-04:00http://www.cardiobrief.org/2010/08/04/at-the-dallas-valve-meeting-even-the-faculty-is-for-sale/2015-08-28T07:14:43-04:00http://www.cardiobrief.org/2010/08/06/fda-advisory-panel-will-review-meridia-sibutramine-on-september-15/2010-08-06T14:57:54-04:00http://www.cardiobrief.org/2010/08/09/shape-getting-ready-to-update-its-controversial-guidelines/2010-08-09T17:35:06-04:00http://www.cardiobrief.org/2010/08/10/dallas-valve-meeting-withdraws-previous-statements-about-its-relationship-with%c2%a0theheart-org/2010-08-09T23:26:12-04:00http://www.cardiobrief.org/2010/08/11/shape-shifting-transforming-guidelines-into-a-business-venture/2010-08-11T12:04:24-04:00http://www.cardiobrief.org/2010/08/12/crescendo-one-last-aria-for-rimonabant/2010-08-12T19:27:08-04:00http://www.cardiobrief.org/2010/08/12/ajc-editorial-seriously-proposes-that-statins-be-offered-freely-at-fast-food-restaurants/2010-08-12T16:41:09-04:00http://www.cardiobrief.org/2010/08/16/cardiobriefs-red-meat-antagonistic-people-and-chocolate/2010-08-16T18:18:31-04:00http://www.cardiobrief.org/2010/08/17/debating-medical-promotion-and-education/2010-08-17T11:24:00-04:00http://www.cardiobrief.org/2010/08/17/saving-time-and-setting-the-clock-back-in-ste/2010-08-17T21:30:08-04:00http://www.cardiobrief.org/2010/08/20/gsk-letter-to-tide-investigators-provokes-avandia-critics/2010-08-20T10:16:08-04:00http://www.cardiobrief.org/2010/08/23/cardiobrief-aha-science-advisory-calls-for-more-research-on-cvd-in-asian-americans/2010-08-23T16:57:33-04:00http://www.cardiobrief.org/2010/08/23/aha-late-breakers-ascend-hf-rocket-af-gravitas-gene-therapy-basket-prove-anacetrapib/2010-08-23T19:56:59-04:00http://www.cardiobrief.org/2010/08/30/circulation-african-americans-at-higher-risk-for-stent-thrombosis/2010-08-31T13:48:41-04:00http://www.cardiobrief.org/2010/08/26/i-guess-the-esc-is-really-happening/2010-08-26T12:30:13-04:00http://www.cardiobrief.org/2010/08/26/fda-sets-september-20-date-for-dabigatran-pradaxa-advisory-panel/2010-08-26T13:14:50-04:00http://www.cardiobrief.org/2010/08/27/the-debate-over-cme-and-industry-influence-continues/2010-09-05T17:41:57-04:00http://www.cardiobrief.org/2010/08/29/esc-alpha-omega-trial-tests-n-3-fatty-acids-in-cv-disease/2010-08-29T16:46:02-04:00http://www.cardiobrief.org/2010/08/29/esc-downshifting-heart-rate-in-hf-found-beneficial/2010-08-29T16:47:11-04:00http://www.cardiobrief.org/2010/08/29/esc-superiority-of-dabigatran-more-evident-in-places-where-inr-is-not-well-controlled/2010-08-29T16:48:59-04:00http://www.cardiobrief.org/2010/08/29/esc-genetic-substudies-of-large-trials-question-value-of-clopidogrel-genotyping/2010-08-29T16:42:37-04:00http://www.cardiobrief.org/2010/08/30/esc-4-year-findings-from-the-reach-registry/2010-08-28T21:11:05-04:00http://www.cardiobrief.org/2010/08/31/esc-no-benefits-for-low-dose-heparin-over-standard-heparin-in-futura-oasis-8/2010-08-28T21:14:14-04:00http://www.cardiobrief.org/2010/08/28/fda-approves-combination-of-aliskiren-and-amlodipine-for-treatment-of-hypertension/2010-08-28T20:58:38-04:00http://www.cardiobrief.org/2010/09/01/double-dose-clopidogrel-gains-support-in-current-oasis-7/2010-09-01T19:24:37-04:00http://www.cardiobrief.org/2010/08/29/esc-hot-line-trial-turns-out-to-be-ice-cold/2010-08-29T13:13:52-04:00http://www.cardiobrief.org/2010/08/29/esc-responds-to-controversy-over-previous-publication-of-a-hot-line-trial/2010-08-29T13:12:12-04:00http://www.cardiobrief.org/2010/09/01/nejm-editors-call-for-removal-of-sibutramine-from-the-us-market/2010-09-01T19:28:40-04:00http://www.cardiobrief.org/2010/09/01/study-examines-long-term-effect-of-intensive-bp-control-in-blacks/2010-09-01T19:28:10-04:00http://www.cardiobrief.org/2010/08/30/dronedarone-and-ticagrelor-speed-into-esc-guidelines/2010-08-30T09:02:29-04:00http://www.cardiobrief.org/2010/08/31/esc-positive-results-for-rivaroxaban-in-einstein-dvt/2010-08-31T04:17:25-04:00http://www.cardiobrief.org/2010/08/31/esc-apixaban-beats-aspirin-for-stroke-prevention-in-af/2010-08-31T16:14:46-04:00http://www.cardiobrief.org/2010/09/03/the-rise-of-the-esc-is-the-esc-anti-american-or-pro-industry/2010-09-03T16:30:10-04:00http://www.cardiobrief.org/2010/09/07/bmj-papers-increase-pressure-on-avandia/2010-09-07T11:30:24-04:00http://www.cardiobrief.org/2010/09/07/patients-still-overestimate-benefits-of-elective-pci/2010-09-07T13:02:44-04:00http://www.cardiobrief.org/2010/09/09/protective-effect-of-education-only-occurs-in-high-income-countries/2010-09-09T14:52:49-04:00http://www.cardiobrief.org/2010/09/09/medical-nonprofits-starting-to-disclose-revenue-from-industry/2010-09-09T16:34:06-04:00http://www.cardiobrief.org/2010/09/09/lancet-meta-analysis-finds-high-risk-for-carotid-stenting-in-older-patients/2010-09-10T00:17:56-04:00http://www.cardiobrief.org/2010/09/15/blue-light-special-aaa-screening-at-kmart-in-the-disease-mongering-aisle/2015-08-28T09:26:36-04:00http://www.cardiobrief.org/2010/09/10/roche-halts-use-of-taspolgutide-in-clinical-trials/2010-09-10T19:41:37-04:00http://www.cardiobrief.org/2010/09/12/syntax-at-3-years-cabg-still-winning-but-pci-acceptable-in-low-risk-patients/2010-09-11T22:06:43-04:00http://www.cardiobrief.org/2010/09/13/2-fda-rebels-criticize-inclusion-of-avandia-defenders-on-july-advisory-panel/2010-09-13T09:18:53-04:00http://www.cardiobrief.org/2010/09/13/fda-posts-briefing-material-for-meridia-death-panel/2010-09-13T11:26:30-04:00http://www.cardiobrief.org/2010/09/14/fda-posts-briefing-documents-for-diet-drug-lorcaserin-investors-get-nervous/2010-09-14T09:53:31-04:00http://www.cardiobrief.org/2010/09/15/fda-extends-review-of-ticagrelor-brilinta-until-december/2010-09-15T21:27:00-04:00http://www.cardiobrief.org/2010/09/15/treat-analysis-target-dosing-is-tricky/2010-09-15T14:53:15-04:00http://www.cardiobrief.org/2010/09/15/fda-advisory-panel-refuses-to-put-meridia-out-of-its-misery/2010-09-15T18:23:11-04:00http://www.cardiobrief.org/2010/09/16/approval-likely-for-dabigatran-as-fda-posts-positive-briefing-documents-for-advisory-panel/2010-09-16T10:16:06-04:00http://www.cardiobrief.org/2010/09/16/fda-panel-votes-9-5-against-approval-of-lorcaserin/2010-09-16T16:02:21-04:00http://www.cardiobrief.org/2010/09/17/fda-announces-safety-review-of-pioglitazone-actos-over-cancer-risk/2010-09-17T14:39:25-04:00http://www.cardiobrief.org/2010/09/18/red-light-or-green-light-for-aaa-screening/2010-09-18T16:37:46-04:00http://www.cardiobrief.org/2010/09/20/soap-opera-star-helps-bi-prepare-the-market-for-pradaxa-dabigatran/2010-09-19T17:33:29-04:00http://www.cardiobrief.org/2010/09/19/guest-post-a-rich-oasis-for-your-journal-club/2010-09-19T21:47:07-04:00http://www.cardiobrief.org/2010/09/20/fda-panel-unanimously-recommends-approval-for-dabigatran/2010-09-21T09:17:52-04:00http://www.cardiobrief.org/2010/09/22/partner-fundamental-breakthrough-for-transcatheter-aortic-valve-implantation/2010-09-22T19:57:23-04:00http://www.cardiobrief.org/2010/09/23/nejm-fondaparinux-effective-in-superficial-vein-thrombosis/2010-09-23T10:04:34-04:00http://www.cardiobrief.org/2010/09/23/fda-allows-avandia-to-remain-on-market-with-severe-restrictions/2010-09-23T16:15:58-04:00http://www.cardiobrief.org/2010/09/24/tct-briefs-xience-v-outperforms-taxus-at-2-years-acc-to-co-sponsor-tct-2011/2010-09-24T10:40:16-04:00http://www.cardiobrief.org/2010/09/24/tct-briefs-ees-versus-ses-peripheral-des/2010-09-24T18:41:25-04:00http://www.cardiobrief.org/2010/09/27/carotid-endarterectomy-still-beneficial-at-10-years/2010-09-27T14:56:41-04:00http://www.cardiobrief.org/2010/09/28/guest-post-news-you-can-use-sex-and-your-defibrillator/2010-09-28T23:11:06-04:00http://www.cardiobrief.org/2010/09/29/guest-post-my-life-as-a-mom/2010-09-29T22:05:04-04:00http://www.cardiobrief.org/2010/09/30/avandia-meridia-now-its-aranesps-turn-before-the-fda/2010-09-30T10:09:54-04:00http://www.cardiobrief.org/2010/09/30/novartis-pays-422-million-to-settle-doj-lawsuit-diovan-promotion/2010-10-01T11:34:09-04:00http://www.cardiobrief.org/2010/10/01/guest-post-a-case-of-exuberance-about-a-subgroup-in-a-clinical-trial/2010-10-01T16:30:41-04:00http://www.cardiobrief.org/2010/10/04/briefs-sleep-and-obesity-closure-device-recommendation-hypertension-in-blacks/2010-10-05T15:55:57-04:00http://www.cardiobrief.org/2010/10/05/briefs-genetic-expression-testing-cpr-guidelines/2010-10-05T16:04:32-04:00http://www.cardiobrief.org/2010/10/06/study-finds-no-evidence-for-clopidogrel-omeprazole-interaction/2010-10-06T21:21:21-04:00http://www.cardiobrief.org/2010/10/07/briefs-rolofyline-fails-genome-studies-pool-data/2010-10-07T15:49:08-04:00http://www.cardiobrief.org/2010/10/07/the-case-of-the-exploding-icd-the-disappearing-journal-article-and-a-defensive-blogger/2010-10-11T13:03:35-04:00http://www.cardiobrief.org/2010/10/08/abbott-withdraws-obesity-drug-meridia-sibutramine-from-us-market/2010-10-08T12:59:14-04:00http://www.cardiobrief.org/2010/10/09/the-plot-thickens-in-the-case-of-the-exploding-icd/2010-10-09T15:09:53-04:00http://www.cardiobrief.org/2010/10/10/guest-post-why-i-wont-blog-about-heart-failure-for-us-news-world-report/2010-10-10T15:32:48-04:00http://www.cardiobrief.org/2010/10/12/obesity-good-news-and-bad-news/2010-10-12T09:44:05-04:00http://www.cardiobrief.org/2010/10/12/heart-failure-and-resource-use-at-the-end-of-the-road/2010-10-12T16:42:38-04:00http://www.cardiobrief.org/2010/10/13/transfusions-and-cardiac-surgery-%e2%80%9ca-major-concern/2010-10-13T11:56:19-04:00http://www.cardiobrief.org/2010/10/13/guest-post-big-pharma-knows-your-private-health-matters/2010-10-13T14:10:17-04:00http://www.cardiobrief.org/2010/10/14/trick-or-treat-fda-staff-highly-critical-of-aranesp-trial/2010-10-14T18:04:59-04:00http://www.cardiobrief.org/2010/10/15/meta-analysis-lends-more-support-to-compression-only-cpr/2010-10-15T15:49:03-04:00http://www.cardiobrief.org/2010/10/16/is-the-time-right-for-a-preprint-archive-for-clinical-trials/2010-10-16T14:32:54-04:00http://www.cardiobrief.org/2010/10/18/guest-post-my-journey-with-heart-failure/2010-10-18T11:12:30-04:00http://www.cardiobrief.org/2010/10/18/fda-advisors-go-easy-on-aranesp-darbepoetin-alfa/2010-10-18T18:59:49-04:00http://www.cardiobrief.org/2010/10/19/a-propublica-investigation-docs-on-pharma-payroll-have-blemished-records-limited-credentials/2010-10-19T16:00:09-04:00http://www.cardiobrief.org/2010/10/19/fda-wont-soften-clopidogrel-omeprazole-warning/2010-10-19T17:40:53-04:00http://www.cardiobrief.org/2010/10/19/dabigatran-gains-fda-approval/2010-10-19T22:15:31-04:00http://www.cardiobrief.org/2010/10/19/fda-issues-complete-response-letter-for-bydureon-extended-release-exenatide/2010-10-19T19:15:19-04:00http://www.cardiobrief.org/2010/10/20/some-remaining-questions-about-dabigatran/2010-10-20T23:27:00-04:00http://www.cardiobrief.org/2010/10/21/news-briefs-recurrent-stroke-prevention-guidelines-vernakalant-trial-suspended-gsk-investigated-generic-enoxaparin-takes-off-kaul-speaks-midei-sues/2010-10-21T16:08:50-04:00http://www.cardiobrief.org/2010/10/22/top-new-york-city-interventional-cardiologists-now-making-3-million-a-year/2010-10-22T19:25:09-04:00http://www.cardiobrief.org/2010/10/25/can-barbers-help-fight-high-blood-pressure-in-black-men/2010-10-25T18:36:33-04:00http://www.cardiobrief.org/2010/10/26/pradaxa-dabigatran-pricing-starts-to-emerge/2010-10-26T11:57:24-04:00http://www.cardiobrief.org/2010/10/27/meta-analysis-examines-risk-associated-with-cyp2c19-genotypes/2010-10-27T15:24:01-04:00http://www.cardiobrief.org/2010/10/28/anesthesiology-paper-on-cardiopulmonary-bypass-priming-retracted-200-additional-papers-under-question/2010-10-28T19:06:48-04:00http://www.cardiobrief.org/2010/10/31/bayer-says-rivaroxaban-meets-primary-endpoint-in-rocket-af/2010-11-02T09:20:57-04:00http://www.cardiobrief.org/2010/11/01/pradaxa-dabigatran-goes-on-sale-wednesday-november-3/2010-11-01T19:03:03-04:00http://www.cardiobrief.org/2010/11/02/is-dabigatran-pradaxa-more-cost-effective-than-warfarin-in-af/2010-11-02T10:21:46-04:00http://www.cardiobrief.org/2010/11/03/cardiology-and-the-quran-controversy-erupts-over-paper-published-in-the-international-journal-of-cardiology/2010-11-03T16:07:16-04:00http://www.cardiobrief.org/2010/11/05/meta-analysis-turns-up-mixed-results-for-vitamin-e-on-stroke-subtypes/2010-11-05T10:35:32-04:00http://www.cardiobrief.org/2010/11/07/re-ly-substudy-finds-dabigatran-effective-in-secondary-stroke-prevention/2010-11-07T17:37:48-05:00http://www.cardiobrief.org/2010/11/07/guest-post-new-lipitor-ads-dis-exercise-healthy-diet-are-you-kidding-me/2010-11-07T18:16:23-05:00http://www.cardiobrief.org/2010/11/08/new-safety-questions-raised-about-multaq/2010-11-08T17:35:19-05:00http://www.cardiobrief.org/2010/11/09/statement-from-aha-acc-and-acg-reaffirms-use-of-ppis-with-antiplatelet-therapy/2010-11-09T11:31:25-05:00http://www.cardiobrief.org/2010/11/09/in-dialysis-life-saving-care-at-great-risk-and-cost/2010-11-09T19:12:27-05:00http://www.cardiobrief.org/2010/11/13/aha-study-explores-role-of-familial-af-in-risk-of-developing-new-af/2010-11-13T19:09:19-05:00http://www.cardiobrief.org/2010/11/13/hypertension-and-global-warming-are-not-the-same-thing/2010-11-13T15:18:57-05:00http://www.cardiobrief.org/2010/11/14/aha-ascend-trial-finally-resolves-the-nesiritide-conroversy/2011-07-07T09:42:51-04:00http://www.cardiobrief.org/2010/11/14/emphatic-support-for-eplerenone-in-nyha-class-ii-hf/2010-11-14T17:48:45-05:00http://www.cardiobrief.org/2010/11/14/icd-crt-found-beneficial-in-raft/2010-11-14T17:47:36-05:00http://www.cardiobrief.org/2010/11/14/lipstick-on-a-pig/2010-11-14T09:29:46-05:00http://www.cardiobrief.org/2010/11/14/new-lvad-shows-promise-as-bridge-to-transplant/2010-11-14T13:07:18-05:00http://www.cardiobrief.org/2010/11/15/omega-3-fails-to-show-benefits-in-atrial-fibrillation/2010-11-15T10:28:37-05:00http://www.cardiobrief.org/2010/11/15/study-closes-the-book-on-pfo-closure/2010-11-15T09:52:34-05:00http://www.cardiobrief.org/2010/11/17/anacetrapib-knock-your-socks-off-effect-on-hdl-and-a-jaw-dropping-effect-on-ldl/2010-11-17T09:33:22-05:00http://www.cardiobrief.org/2010/11/15/blast-off-rocket-af-hits-chicago/2010-11-15T09:56:38-05:00http://www.cardiobrief.org/2010/11/14/drinking-in-ascend-is-the-cup-half-empty-or-half-full/2010-11-14T19:59:19-05:00http://www.cardiobrief.org/2010/11/16/gravitas-no-benefit-for-clopidogrel-dosing-based-on-platelet-function-test/2010-11-16T09:18:24-05:00http://www.cardiobrief.org/2010/11/16/basket-prove-examines-stents-for-large-vessels/2010-11-16T10:20:23-05:00http://www.cardiobrief.org/2010/11/16/cardioexchange-at-the-aha-a-new-voice-emerges/2010-11-16T15:36:03-05:00http://www.cardiobrief.org/2010/11/17/will-this-be-the-hdl-decade-reveal-revealed-mixed-results-for-apo-a1/2010-11-17T14:19:26-05:00http://www.cardiobrief.org/2010/11/17/aha-2010-is-history/2010-11-17T19:44:17-05:00http://www.cardiobrief.org/2010/11/18/appraise-2-apixaban-in-acs-study-discontinued-due-to-increased-bleeding/2010-11-18T22:27:29-05:00http://www.cardiobrief.org/2010/11/20/sharp-shows-benefit-for-vytorin-in-chronic-kidney-disease/2010-11-20T14:12:12-05:00http://www.cardiobrief.org/2010/11/21/sharp-a-tale-of-two-press-releases/2010-11-22T23:37:39-05:00http://www.cardiobrief.org/2010/11/23/greek-study-offers-reassurance-about-statin-usage-in-patients-with-abnormal-liver-tests/2010-11-23T18:33:37-05:00http://www.cardiobrief.org/2010/11/23/guest-post-of-drug-talks-deception-and-denial/2010-11-23T16:56:05-05:00http://www.cardiobrief.org/2010/11/29/marine-new-fish-oil-pill-slashes-high-triglycerides/2010-11-29T15:12:44-05:00http://www.cardiobrief.org/2010/11/29/study-finds-no-link-between-cancer-and-antihypertensives-except-for-arb-ace-inhibitor-combo/2010-11-29T19:21:09-05:00http://www.cardiobrief.org/2010/11/30/new-performance-measures-for-peripheral-artery-disease-issued/2010-11-30T16:54:13-05:00http://www.cardiobrief.org/2010/12/01/heart-failure-death-statistics-don%e2%80%99t-believe-what-you-read-on-the-internet/2017-05-18T11:11:51-04:00http://www.cardiobrief.org/2010/12/02/vanity-fair-article-eviscerates-globalization-of-clinical-trials/2010-12-02T20:05:33-05:00http://www.cardiobrief.org/2010/12/04/rivaroxaban-found-safe-and-effective-for-dvt/2010-12-03T18:53:58-05:00http://www.cardiobrief.org/2010/12/03/the-possible-return-of-the-missing-case-report-of-the-exploding-icd/2010-12-03T20:51:31-05:00http://www.cardiobrief.org/2010/12/06/7167/2010-12-06T04:45:55-05:00http://www.cardiobrief.org/2010/12/06/senate-report-on-mark-midei-and-abbott-30-stents-in-1-day-pig-roasts-and-more/2010-12-06T13:38:40-05:00http://www.cardiobrief.org/2010/12/06/meta-analysis-daily-aspirin-reduces-cancer-deaths/2010-12-06T18:52:12-05:00http://www.cardiobrief.org/2010/12/07/questions-raised-about-compensation-and-conflicts-at-duke/2010-12-07T11:28:25-05:00http://www.cardiobrief.org/2010/12/07/protect-ii-study-of-impella-stopped-early-for-futility/2010-12-10T15:03:34-05:00http://www.cardiobrief.org/2010/12/07/third-time-is-the-charm-fda-panel-finally-backs-an-obesity-pill/2010-12-07T19:01:26-05:00http://www.cardiobrief.org/2010/12/08/abbott-subsidiary-pays-41-million-penalty-for-niaspanadvicor-kickbacks/2010-12-08T18:40:40-05:00http://www.cardiobrief.org/2010/12/09/meta-analysis-finds-aromatase-inhibitors-increase-risk-for-heart-disease/2010-12-09T15:04:02-05:00http://www.cardiobrief.org/2010/12/09/cdc-demotes-stroke-to-fourth-leading-cause-of-death/2010-12-09T17:14:53-05:00http://www.cardiobrief.org/2010/12/10/spinning-out-of-control-another-look-at-the-protect-ii-press-release/2011-03-28T20:38:16-04:00http://www.cardiobrief.org/2010/12/10/nmt-gets-plugged-not-in-a-good-way-by-ben-goldacre/2010-12-10T23:12:29-05:00http://www.cardiobrief.org/2010/12/11/mideis-business-as-usual-defensethis-is-the-way-its-done/2010-12-11T18:21:51-05:00http://www.cardiobrief.org/2010/12/13/false-positive-ct-angiogram-leads-to-heart-transplant/2010-12-13T16:38:25-05:00http://www.cardiobrief.org/2010/12/14/dangling-doctors-in-front-of-journalists/2010-12-14T17:35:19-05:00http://www.cardiobrief.org/2010/12/15/heart-disease-and-stroke-in-2011-mortality-continues-to-decline-but-overall-burden-remains-high/2010-12-15T16:24:21-05:00http://www.cardiobrief.org/2010/12/16/fda-delays-approval-of-brilinta-ticagrelor/2010-12-17T13:09:19-05:00http://www.cardiobrief.org/2010/12/17/fda-approves-cryoballoon-ablation-treatment-for-paroxysmal-af/2010-12-17T12:38:48-05:00http://www.cardiobrief.org/2010/12/19/cardiosource-and-medpage-today-will-collaborate-to-provide-news-coverage-of-major-cv-meetings/2010-12-19T13:37:31-05:00http://www.cardiobrief.org/2010/12/20/propublica-med-schools-flunk-at-keeping-faculty-off-pharma-speaking-circuit/2010-12-20T00:37:54-05:00http://www.cardiobrief.org/2010/12/20/dronedarone-rate-control-and-catheter-ablation-incorporated-in-updated-af-guidelines/2010-12-21T08:58:06-05:00http://www.cardiobrief.org/2010/12/21/guest-post-another-highly-dubious-article-in-the-american-journal-of-cardiology/2010-12-21T13:21:49-05:00http://www.cardiobrief.org/2010/12/22/guest-post-survey-or-advertisement/2011-01-30T23:43:36-05:00http://www.cardiobrief.org/2010/12/22/apixaban-beats-enoxaparin-for-thromboprophylaxis-after-hip-replacement/2010-12-22T16:53:34-05:00http://www.cardiobrief.org/2010/12/22/abbott-and-astrazeneca-end-efforts-to-develop-certriad-rosuvastatinfenofibric-acid/2010-12-22T19:58:13-05:00http://www.cardiobrief.org/2011/01/03/guest-post-medicare-the-mastercard-that-keeps-on-giving/2011-01-03T14:37:12-05:00http://www.cardiobrief.org/2011/01/03/plato-cabg-substudy-raises-hope-and-questions/2011-01-03T18:01:15-05:00http://www.cardiobrief.org/2011/01/04/jama-study-finds-22-5-of-icds-implanted-without-evidence-base/2011-01-04T17:07:59-05:00http://www.cardiobrief.org/2011/01/05/jj-submits-rivaroxaban-application-for-stroke-prevention-in-af/2011-01-05T13:04:05-05:00http://www.cardiobrief.org/2011/01/05/study-finds-mixed-long-term-results-for-af-catheter-ablation/2011-01-05T18:44:05-05:00http://www.cardiobrief.org/2011/01/06/bevacizumab-in-breast-cancer-linked-to-increase-in-heart-failure-risk/2011-01-06T12:51:00-05:00http://www.cardiobrief.org/2011/01/07/acc-and-hrs-downplay-data-from-their-own-registry/2011-01-07T18:32:03-05:00http://www.cardiobrief.org/2011/01/10/worlds-first-drug-eluting-bioresorbable-stent-gains-ce-mark-approval/2011-01-10T10:26:30-05:00http://www.cardiobrief.org/2011/01/11/large-meta-analysis-explores-cardiovascular-safety-of-nsaids/2011-01-12T17:02:36-05:00http://www.cardiobrief.org/2011/01/11/candesartan-beats-losartan-in-swedish-hf-registry/2011-01-11T17:08:43-05:00http://www.cardiobrief.org/2011/01/12/researchers-shed-new-light-on-hdl-cholesterol/2011-01-12T17:02:59-05:00http://www.cardiobrief.org/2011/01/13/why-do-military-doctors-have-stricter-rules-than-other-doctors/2011-01-13T09:41:22-05:00http://www.cardiobrief.org/2011/01/13/mercks-thrombin-receptor-antagonist-suffers-major-setback/2011-01-13T11:11:09-05:00http://www.cardiobrief.org/2011/01/13/sanofi-aventis-to-inform-doctors-about-liver-transplants-in-2-patients-taking-multaq-dronedarone/2011-01-14T13:35:10-05:00http://www.cardiobrief.org/2011/01/14/sanofi-aventis-provides-more-details-about-multaq-letter/2011-01-14T13:35:36-05:00http://www.cardiobrief.org/2011/01/14/fda-warns-about-severe-liver-injury-associated-with-multaq-dronedarone/2011-01-14T12:05:42-05:00http://www.cardiobrief.org/2011/01/18/study-supports-a-new-enhanced-form-of-cpr/2011-01-19T13:07:48-05:00http://www.cardiobrief.org/2011/01/19/review-raises-questions-about-statins-for-primary-prevention/2011-01-19T15:58:14-05:00http://www.cardiobrief.org/2011/01/19/guest-post-what-prospect-doesnt-tell-us/2011-01-19T17:37:06-05:00http://www.cardiobrief.org/2011/01/20/braunwald-vorapaxar-problem-based-on-intracranial-bleeding-in-patients-with-history-of-stroke/2011-01-20T11:27:08-05:00http://www.cardiobrief.org/2011/01/20/guest-post-prevention-magazine-pushes-high-tech-non-evidence-based-heart-screening-more-than-basic-prevention/2011-01-20T18:02:30-05:00http://www.cardiobrief.org/2011/01/21/heart-rhythm-society-advising-doj-in-investigation-of-icd-implants/2011-01-21T12:44:01-05:00http://www.cardiobrief.org/2011/01/24/aha-estimates-cost-of-heart-disease-will-triple-by-2030/2011-01-24T14:42:19-05:00http://www.cardiobrief.org/2011/01/25/new-study-finds-hydrochlorothiazide-inferior-to-all-other-bp-drugs/2011-01-25T11:05:12-05:00http://www.cardiobrief.org/2011/01/25/inappropriate-icd-shocks-linked-to-increased-mortality/2011-01-25T12:46:24-05:00http://www.cardiobrief.org/2011/01/26/jama-study-finds-declining-stroke-rate-after-cabg/2011-01-26T14:26:11-05:00http://www.cardiobrief.org/2011/01/26/end-of-an-era-eugene-braunwald-steps-down-marc-sabatine-assumes-chair-of-timi-group/2011-01-27T17:11:38-05:00http://www.cardiobrief.org/2011/01/27/hps-results-suggest-baseline-crp-doesnt-predict-statin-efficacy/2011-01-28T13:36:42-05:00http://www.cardiobrief.org/2011/01/28/justice-department-files-new-suit-against-boston-scientific/2011-01-28T14:11:02-05:00http://www.cardiobrief.org/2011/01/31/women-and-younger-patients-may-be-at-higher-risk-for-sprint-fidelis-failure/2011-01-31T16:47:37-05:00http://www.cardiobrief.org/2011/02/01/new-guidelines-lend-more-support-for-carotid-stenting/2011-02-01T14:45:17-05:00http://www.cardiobrief.org/2011/02/01/cdc-details-the-persistent-problem-of-hypertension-and-elevated-ldl-in-the-us/2011-02-01T20:37:23-05:00http://www.cardiobrief.org/2011/02/02/heart-failure-can-be-fixed-just-like-a-broken-leg-for-50-million/2011-02-02T18:55:19-05:00http://www.cardiobrief.org/2011/02/03/lancet-papers-outline-worldwide-trends-in-obesity-hypertension-and-cholesterol/2011-02-03T15:54:03-05:00http://www.cardiobrief.org/2011/02/03/guest-post-how-to-question-the-research-question/2011-02-03T14:08:04-05:00http://www.cardiobrief.org/2011/02/04/some-things-dont-go-better-with-coke/2011-02-04T15:02:52-05:00http://www.cardiobrief.org/2011/02/04/fda-sets-july-deadline-for-decision-on-ticagrelor-brilinta/2011-02-04T18:39:39-05:00http://www.cardiobrief.org/2011/02/07/webmd-the-800-pound-gorilla-in-the-room/2015-08-29T16:00:09-04:00http://www.cardiobrief.org/2011/02/08/biomarker-levels-post-cabg-strongly-linked-to-mortality/2011-02-08T16:16:02-05:00http://www.cardiobrief.org/2011/02/08/fda-approves-first-pacemaker-designed-for-use-with-mri/2011-02-08T15:37:22-05:00http://www.cardiobrief.org/2011/02/09/trial-finds-benefit-in-wireless-pulmonary-artery-monitoring-in-hf/2011-02-10T15:27:44-05:00http://www.cardiobrief.org/2011/02/09/acc-late-breakers-to-include-partner-a-everest-ii-stich-magellan/2011-02-09T12:45:46-05:00http://www.cardiobrief.org/2011/02/09/guest-post-retraction-reveals-downfall-of-company-where-ron-waksman-consulted/2011-02-09T17:01:00-05:00http://www.cardiobrief.org/2011/02/10/apixaban-better-than-aspirin-for-stroke-prevention-in-af-patients-unable-to-take-warfarin/2011-02-10T11:16:39-05:00http://www.cardiobrief.org/2011/02/11/scast-trial-provides-no-support-for-blood-pressure-lowering-in-acute-stroke/2011-02-14T16:51:57-05:00http://www.cardiobrief.org/2011/02/14/af-guidelines-updated-to-incorporate-dabigatran/2011-02-14T16:51:23-05:00http://www.cardiobrief.org/2011/02/12/featured-comment-on-the-ethical-code-for-federal-employees/2011-02-12T19:45:07-05:00http://www.cardiobrief.org/2011/02/15/crt-found-beneficial-in-less-severe-heart-failure-patients/2011-02-14T17:15:05-05:00http://www.cardiobrief.org/2011/02/15/aha-releases-updated-guidelines-for-the-prevention-of-cv-disease-in-women/2011-02-15T11:23:35-05:00http://www.cardiobrief.org/2011/02/16/study-sheds-light-on-racial-disparities-in-hospital-readmissions/2011-02-16T08:52:39-05:00http://www.cardiobrief.org/2011/02/16/ron-waksman-paper-on-novel-cad-test-retracted/2011-02-16T17:10:08-05:00http://www.cardiobrief.org/2011/02/17/one-quarter-of-us-adults-45-and-over-taking-statins/2011-02-17T15:04:34-05:00http://www.cardiobrief.org/2011/02/22/study-links-stent-thrombosis-to-circadian-variation/2011-02-22T10:24:11-05:00http://www.cardiobrief.org/2011/02/22/study-finds-nitroglycerin-improves-bone-density/2011-02-22T16:41:02-05:00http://www.cardiobrief.org/2011/02/23/air-pollution-and-cocaine-among-mi-triggers-analyzed-in-lancet-study/2011-02-23T16:08:05-05:00http://www.cardiobrief.org/2011/02/23/high-pacemaker-insertion-rate-observed-after-corevalve-tavi-implantation/2011-02-23T16:00:23-05:00http://www.cardiobrief.org/2011/02/24/study-probes-bmi-associated-risk-in-asia/2011-02-24T17:03:11-05:00http://www.cardiobrief.org/2011/02/25/fda-approves-azilsartan-medoxomil-edarbi-for-high-blood-pressure/2011-02-26T15:09:43-05:00http://www.cardiobrief.org/2011/02/27/the-acc-wants-you-to-know-that-nothing-is-rotten-in-the-state-of-maryland/2011-02-27T16:30:30-05:00http://www.cardiobrief.org/2011/02/28/what-is-the-role-of-cv-screening-tests-in-medicine-and-legislation/2011-02-28T16:28:00-05:00http://www.cardiobrief.org/2011/03/01/guest-post-examining-an-ad-for-a-platelet-inhibition-test/2011-02-28T22:44:17-05:00http://www.cardiobrief.org/2011/03/01/cv-patients-without-hypertension-benefit-from-antihypertensive-therapy/2011-03-01T17:53:00-05:00http://www.cardiobrief.org/2011/03/01/cv-device-trials-still-fail-to-include-more-women/2011-03-01T17:49:06-05:00http://www.cardiobrief.org/2011/03/02/5-year-followup-of-accord-still-no-support-for-intensive-glucose-lowering/2011-03-02T17:53:19-05:00http://www.cardiobrief.org/2011/03/03/pennsylvania-hospital-141-patients-received-unnecessary-stents/2011-03-03T13:12:25-05:00http://www.cardiobrief.org/2011/03/04/first-aftershocks-continue-to-shake-up-western-pennsylvania-cardiology/2011-03-04T15:55:57-05:00http://www.cardiobrief.org/2011/03/07/meta-analysis-finds-mediterranean-diet-helps-fight-metabolic-syndrome/2011-03-07T16:22:25-05:00http://www.cardiobrief.org/2011/03/08/european-study-suggests-hdl-may-protect-against-colon-cancer/2011-03-08T14:55:32-05:00http://www.cardiobrief.org/2011/03/09/active-i-examines-role-for-irbesartan-in-af-patients/2011-03-10T09:25:04-05:00http://www.cardiobrief.org/2011/03/09/guest-post-the-return-of-the-mysterious-disappearing-exploding-icd/2011-03-09T13:56:57-05:00http://www.cardiobrief.org/2011/03/10/olmesartan-helps-prevent-microalbuminuria-but-a-troubling-question-persists/2011-03-10T11:59:10-05:00http://www.cardiobrief.org/2011/03/10/howard-bauchner-to-replace-catherine-deangelis-as-jama-editor/2011-03-10T12:41:58-05:00http://www.cardiobrief.org/2011/03/10/obesity-and-cardiovascular-risk-does-size-matter/2011-03-10T19:27:03-05:00http://www.cardiobrief.org/2011/03/14/aha-offers-qualified-endorsement-of-weight-loss-surgery/2011-03-14T16:48:48-04:00http://www.cardiobrief.org/2011/03/14/taking-medical-advice-from-peggy-fleming/2011-03-14T18:22:59-04:00http://www.cardiobrief.org/2011/03/15/gravitas-published-who-gets-to-weigh-in-on-the-results/2011-03-15T16:03:40-04:00http://www.cardiobrief.org/2011/03/16/syntax-quality-of-life-substudy-finds-small-benefit-for-cabg-in-angina-relief/2011-03-16T17:56:26-04:00http://www.cardiobrief.org/2011/03/17/small-study-may-help-revive-hope-for-stem-cell-therapy/2011-03-17T17:14:09-04:00http://www.cardiobrief.org/2011/03/17/acc-and-medpage-will-provide-enhanced-news-from-20-cardiology-meetings/2011-03-17T10:40:55-04:00http://www.cardiobrief.org/2011/03/17/meta-analysis-of-observational-studies-finds-worse-outcomes-for-rosiglitazone-compared-to-pioglitazone/2011-03-17T19:21:42-04:00http://www.cardiobrief.org/2011/03/18/lilly-and-daiichi-sankyo-pull-the-trigger-and-kill-prasugrel-study/2011-03-18T18:29:52-04:00http://www.cardiobrief.org/2011/03/22/study-explores-lowering-the-troponin-diagnostic-threshold/2011-03-22T21:19:33-04:00http://www.cardiobrief.org/2011/03/21/stent-company-sues-investigator-over-trial-conduct/2011-03-21T14:59:20-04:00http://www.cardiobrief.org/2011/03/22/fibrate-prescriptions-a-tale-of-two-countries/2011-03-23T14:38:30-04:00http://www.cardiobrief.org/2011/03/22/protect-compares-unfractionated-heparin-and-dalteparin-in-critically-ill-patients/2011-03-23T14:40:08-04:00http://www.cardiobrief.org/2011/03/22/aha-releases-new-recommendations-for-management-of-acute-vte/2011-03-22T11:37:36-04:00http://www.cardiobrief.org/2011/03/22/good-news-and-bad-news-about-physical-and-sexual-activity-and-cardiac-events/2011-03-23T14:36:47-04:00http://www.cardiobrief.org/2011/03/23/new-protocol-identifies-low-risk-chest-pain-patients/2011-03-23T13:30:16-04:00http://www.cardiobrief.org/2011/03/23/the-french-set-a-new-roadblock-for-ticagrelor/2025-02-12T07:21:44-05:00http://www.cardiobrief.org/2011/03/24/merck-abandons-development-of-factor-xa-inhibitor-betrixaban/2011-03-24T09:58:58-04:00http://www.cardiobrief.org/2011/03/24/study-finds-pioglitazone-prevents-progression-to-diabetes/2011-03-24T10:53:56-04:00http://www.cardiobrief.org/2011/03/25/fda-approves-2-new-cardiac-resynchronization-therapy-pacemaker-systems-from-medtronic/2011-03-25T11:59:26-04:00http://www.cardiobrief.org/2011/03/28/updated-unstable-anginanstemi-guidelines-released-by-acc-aha/2011-03-28T16:18:19-04:00http://www.cardiobrief.org/2011/03/28/fda-approves-medtronic-protecta-icds-and-crt-ds/2011-03-28T15:12:59-04:00http://www.cardiobrief.org/2011/03/28/guest-post-supermarket-chain-gawking-quaker-products-free-cholesterol-screening/2011-03-28T21:59:42-04:00http://www.cardiobrief.org/2011/03/29/protect-ii-who-will-protect-us-from-the-protectors/2011-03-29T15:27:19-04:00http://www.cardiobrief.org/2011/03/29/conflicts-of-interest-in-cardiovascular-guidelines/2011-03-29T17:24:57-04:00http://www.cardiobrief.org/2011/03/30/fda-warns-against-repackaging-dabigatran/2011-03-31T19:25:28-04:00http://www.cardiobrief.org/2011/03/31/an-embargo-becomes-a-public-relations-tool/2011-03-31T12:24:00-04:00http://www.cardiobrief.org/2011/04/04/mitraclip-compared-to-surgery-in-everest-ii/2011-04-05T00:01:04-04:00http://www.cardiobrief.org/2011/04/04/precombat-explores-pci-versus-cabg-for-left-main-disease/2011-04-04T12:15:55-04:00http://www.cardiobrief.org/2011/04/01/laissez-le-bon-temps-roulez/2011-04-01T18:14:53-04:00http://www.cardiobrief.org/2011/04/03/2-year-outcomes-of-the-resolute-all-comers-trial/2011-04-03T14:22:32-04:00http://www.cardiobrief.org/2011/04/02/reloading-the-matrix-doris-taylor-is-growing-new-hearts/2011-04-02T18:11:17-04:00http://www.cardiobrief.org/2011/04/03/partner-a-tavr-noninferior-to-surgery-but-stroke-may-be-a-problem/2011-04-03T18:51:53-04:00http://www.cardiobrief.org/2011/04/03/partner-b-substudy-examines-cost-effectiveness-of-tavr/2011-04-03T13:55:50-04:00http://www.cardiobrief.org/2011/04/04/rival-trial-radial-vs-femoral-access/2011-04-04T16:24:16-04:00http://www.cardiobrief.org/2011/04/04/stich-illuminates-cabg-in-heart-failure-finally/2011-04-04T12:44:42-04:00http://www.cardiobrief.org/2011/04/05/magellan-higher-bleeding-rates-cloud-rivaroxabans-effect-in-vte-prevention-in-acute-medical-population/2011-04-05T11:14:59-04:00http://www.cardiobrief.org/2011/04/05/at-the-close-of-scientific-sessions-acc-announces-the-end-of-current-model-of-satellite-symposia/2011-04-05T18:41:35-04:00http://www.cardiobrief.org/2011/04/06/big-brother-err-the-acc-is-watching-you/2011-04-07T08:56:03-04:00http://www.cardiobrief.org/2011/04/09/harlem-hospitals-former-chief-of-cardiology-sues-new-york-city/2011-04-09T19:24:20-04:00http://www.cardiobrief.org/2011/04/11/acc-satellites-meet-the-new-boss-same-as-the-old-boss/2011-04-10T22:23:53-04:00http://www.cardiobrief.org/2011/04/11/phenterminetopiramate-combination-yields-significant-weight-loss/2011-04-11T17:36:13-04:00http://www.cardiobrief.org/2011/04/11/2-studies-try-to-improve-risk-prediction-for-kidney-disease-progression/2011-04-11T17:28:04-04:00http://www.cardiobrief.org/2011/04/12/particle-trap-reduces-harmful-diesel-emissions/2011-04-12T11:45:15-04:00http://www.cardiobrief.org/2011/04/13/increasing-disparity-found-in-stroke-mortality-in-europe-and-central-asia-a-period-of-rapidly-increasing-inequality-between-countries/2011-04-13T12:39:33-04:00http://www.cardiobrief.org/2011/04/13/ny-times-magazine-sugar-is-not-so-sweet/2011-04-15T12:46:05-04:00http://www.cardiobrief.org/2011/04/14/fda-officials-offer-explanation-for-absence-of-low-dose-dabigatran/2011-04-14T10:22:26-04:00http://www.cardiobrief.org/2011/04/14/fda-offers-cautious-support-for-olmesartan-benicar/2011-04-14T17:46:03-04:00http://www.cardiobrief.org/2011/04/17/evidence-the-weak-link-of-evidence-based-medicine/2011-04-17T14:43:16-04:00http://www.cardiobrief.org/2011/04/18/100-is-the-new-150-aha-lowers-optimal-triglyceride-level/2011-04-18T16:16:12-04:00http://www.cardiobrief.org/2011/04/19/non-evidence-based-icd-implants-the-debate-continues/2011-04-19T16:26:43-04:00http://www.cardiobrief.org/2011/04/19/50k-the-price-for-a-vip-dinner-for-2-with-the-cleveland-clinic-ceo/2015-08-29T16:08:12-04:00http://www.cardiobrief.org/2011/04/20/new-whi-analysis-links-calcium-supplements-to-cv-risk/2011-04-20T13:57:20-04:00http://www.cardiobrief.org/2011/04/21/the-impossible-dream-a-scientific-committee-free-of-conlicts-of-interest/2011-04-21T12:05:36-04:00http://www.cardiobrief.org/2011/04/21/cdc-half-the-us-now-protected-by-comprehensive-smoke-free-laws/2011-04-21T14:47:03-04:00http://www.cardiobrief.org/2011/04/22/mark-midei-gives-a-preview-of-his-defense/2011-04-22T19:06:39-04:00http://www.cardiobrief.org/2011/04/24/tracking-doctors-movements-and-prescriptions/2011-04-25T00:16:11-04:00http://www.cardiobrief.org/2011/04/25/acc-aha-publish-expert-consensus-document-on-hypertension-in-the-elderly/2011-04-25T15:12:33-04:00http://www.cardiobrief.org/2011/04/25/third-generation-paclitaxel-eluting-platinum-chromium-coronary-stent-approved-in-us/2011-04-25T15:33:56-04:00http://www.cardiobrief.org/2011/04/26/drug-eluting-stents-add-1-5-billion-per-year-to-medicare-costs/2011-04-26T11:25:21-04:00http://www.cardiobrief.org/2011/04/27/scientific-fraud-found-in-wayne-alexanders-research-group-at-emory/2011-04-27T08:17:13-04:00http://www.cardiobrief.org/2011/04/27/large-meta-analysis-finds-no-link-between-arbs-and-risk-of-mi/2011-04-27T15:42:57-04:00http://www.cardiobrief.org/2011/04/28/cardiologists-report-325000-median-compensation-in-survey/2011-04-28T16:15:14-04:00http://www.cardiobrief.org/2011/05/02/standard-guidelines-compared-to-individualized-guidelines/2011-05-02T17:41:47-04:00http://www.cardiobrief.org/2011/05/01/pennsylvania-hopsital-at-center-of-controversy-had-very-high-stent-volume/2011-05-01T20:50:24-04:00http://www.cardiobrief.org/2011/05/02/fda-approves-linagliptin-tradjenta-a-new-dpp-4-inhibitor/2011-05-02T16:27:16-04:00http://www.cardiobrief.org/2011/05/03/pradaxa-dabigatran-off-to-a-strong-start/2011-05-03T11:19:58-04:00http://www.cardiobrief.org/2011/05/03/cabg-takes-the-brunt-of-decline-in-revascularization-procedures/2011-05-03T16:10:58-04:00http://www.cardiobrief.org/2011/05/04/study-challenges-efforts-to-lower-salt-in-the-general-population/2011-05-03T17:54:35-04:00http://www.cardiobrief.org/2011/05/03/what-i-would-have-done-with-osama-bin-laden/2011-05-03T15:54:19-04:00http://www.cardiobrief.org/2011/05/04/study-estimates-that-af-adds-26-billion-to-yearly-us-healthcare-costs/2011-05-04T14:44:34-04:00http://www.cardiobrief.org/2011/05/04/accme-seeks-to-hide-drug-company-disclosures-in-the-fine-print/2011-05-04T15:32:57-04:00http://www.cardiobrief.org/2011/05/05/5-patients-infected-with-hepatitis-c-while-undergoing-mpi/2011-05-05T10:51:49-04:00http://www.cardiobrief.org/2011/05/05/the-acc-counts-down-to-launch-of-new-satellites/2011-05-05T16:50:50-04:00http://www.cardiobrief.org/2011/05/05/financial-ties-bind-medical-societies-to-drug-and-device-makers/2011-05-05T23:25:48-04:00http://www.cardiobrief.org/2011/05/05/heart-society%e2%80%99s-tip-sheets-fail-to-mention-risks/2011-05-05T22:50:53-04:00http://www.cardiobrief.org/2011/05/05/the-heart-rhythm-society-responds-to-propublica%e2%80%99s-questions/2011-05-05T22:54:16-04:00http://www.cardiobrief.org/2011/05/06/acc-ceo-jack-lewin-provides-the-argument-against-industry-money/2015-08-29T16:06:24-04:00http://www.cardiobrief.org/2011/05/09/higher-periprocedural-risk-of-stroke-found-in-women-undergoing-carotid-stenting/2011-05-09T11:05:11-04:00http://www.cardiobrief.org/2011/05/09/short-term-nsaid-use-linked-to-increased-cv-risk/2011-05-09T17:14:45-04:00http://www.cardiobrief.org/2011/05/10/study-finds-little-effect-of-courage-on-adoption-of-optimal-medical-therapy/2011-05-10T16:05:17-04:00http://www.cardiobrief.org/2011/05/10/trial-reveals-no-benefit-and-some-concerns-with-epo-after-primary-pci/2011-05-10T16:04:21-04:00http://www.cardiobrief.org/2011/05/12/tavi-stroke-more-details-surface-about-partner-a/2011-05-12T11:14:51-04:00http://www.cardiobrief.org/2011/05/17/part-1-the-national-lipid-association-and-the-fh-guidelines/2015-08-29T16:07:16-04:00http://www.cardiobrief.org/2011/05/13/propublica-cardiac-society-draws-bulk-of-funding-from-stent-makers/2011-05-13T14:42:52-04:00http://www.cardiobrief.org/2011/05/17/part-2-the-national-lipid-association-and-industry/2011-05-17T17:01:10-04:00http://www.cardiobrief.org/2011/05/16/sleep-deprivation-and-the-cardiac-surgeon/2011-05-16T17:15:43-04:00http://www.cardiobrief.org/2011/05/17/fda-reviewers-scrutinize-accord-and-trilipix/2011-05-17T09:41:30-04:00http://www.cardiobrief.org/2011/05/17/the-curse-of-the-egyptian-mummy-coronary-artery-disease/2011-05-17T11:46:39-04:00http://www.cardiobrief.org/2011/05/17/part-3-the-nla-responds-to-questions/2011-05-17T16:07:34-04:00http://www.cardiobrief.org/2011/05/18/fda-announces-details-of-severe-new-restrictions-on-rosiglitazone/2011-05-18T15:03:21-04:00http://www.cardiobrief.org/2011/05/19/propublica-medical-schools-plug-holes-in-conflict-of-interest-policies/2011-05-19T14:21:29-04:00http://www.cardiobrief.org/2011/05/19/fda-panel-delivers-mixed-verdict-on-trilipix-fenofibrate/2011-05-19T17:31:33-04:00http://www.cardiobrief.org/2011/05/21/annuloplasty-rings-edwards-and-the-fda-more-details-emerge/2011-05-21T19:29:25-04:00http://www.cardiobrief.org/2011/05/23/eplerenone-found-to-also-reduce-af-in-hf-patients/2011-05-23T10:01:16-04:00http://www.cardiobrief.org/2011/05/23/what-is-the-impact-of-screening-low-risk-patients-with-ct-angiography/2011-05-23T17:11:36-04:00http://www.cardiobrief.org/2011/05/24/new-onset-af-linked-to-increase-in-death-and-cv-events/2011-05-24T16:09:50-04:00http://www.cardiobrief.org/2011/05/24/copeptin-may-help-predict-cv-death-in-elderly-hf-patients/2011-05-24T16:10:15-04:00http://www.cardiobrief.org/2011/05/24/pictures-at-an-exhibition/2011-05-24T16:50:48-04:00http://www.cardiobrief.org/2011/05/25/fda-approves-xience-nano-for-small-vessels/2011-05-25T09:04:26-04:00http://www.cardiobrief.org/2011/05/25/senate-report-uncovers-sanofi-attempts-to-stifle-generic-lovenox/2011-05-26T00:26:27-04:00http://www.cardiobrief.org/2011/05/26/nhlbi-stops-the-aim-high-trial-of-niacin/2011-05-28T16:41:21-04:00http://www.cardiobrief.org/2011/05/28/national-lipid-association-aim-high-results-disappointing-but-prescribing-practices-should-not-change/2011-05-28T17:33:58-04:00http://www.cardiobrief.org/2011/05/28/comment-abbott-costello-weigh-in-on-niacin/2011-05-28T21:49:52-04:00http://www.cardiobrief.org/2011/05/31/biomarkers-dont-believe-the-hype/2011-05-31T16:17:03-04:00http://www.cardiobrief.org/2011/06/01/more-questions-raised-about-biotroniks-relationships-with-cardiologists/2011-06-01T14:39:08-04:00http://www.cardiobrief.org/2011/06/02/small-study-suggests-possible-benefits-of-fish-oil-supplements-for-pci-patients/2011-06-02T11:39:08-04:00http://www.cardiobrief.org/2011/06/02/cdc-death-rates-for-heart-disease-and-cancer-converge/2011-06-02T12:55:21-04:00http://www.cardiobrief.org/2011/06/02/fda-arbs-dont-increase-risk-of-cancer/2011-06-02T15:06:51-04:00http://www.cardiobrief.org/2011/06/05/partner-a-results-published-in-nejm/2011-06-05T19:46:07-04:00http://www.cardiobrief.org/2011/06/03/understanding-risk-tricky-business/2015-08-29T16:05:17-04:00http://www.cardiobrief.org/2011/06/06/smoking-found-to-be-potent-risk-factor-for-sympatomatic-pad/2011-06-07T09:35:40-04:00http://www.cardiobrief.org/2011/06/07/propublica-investigates-heart-check-america/2011-06-07T09:34:42-04:00http://www.cardiobrief.org/2011/06/07/fda-sets-july-20-date-for-advisory-panel-on-sapien-transcatheter-aortic-valve/2011-06-07T20:34:32-04:00http://www.cardiobrief.org/2011/06/08/sharp-results-published-in-lancet/2011-06-09T00:26:25-04:00http://www.cardiobrief.org/2011/06/08/fda-recommends-limiting-usage-of-high-dose-simvastatin/2011-06-08T17:16:41-04:00http://www.cardiobrief.org/2011/06/10/a-new-biomarker-from-the-lungs/2011-06-10T13:34:06-04:00http://www.cardiobrief.org/2011/06/09/pioglitazone-actos-suspended-in-france-over-cancer-concerns/2011-06-10T11:34:13-04:00http://www.cardiobrief.org/2011/06/13/increased-mortality-found-in-mi-patients-during-ambulance-diversion/2011-06-13T11:07:54-04:00http://www.cardiobrief.org/2011/06/14/crt-for-hf-patients-with-moderately-prolonged-qrs-interval-unethical/2011-06-14T11:13:51-04:00http://www.cardiobrief.org/2011/06/15/twice-a-stent-pioneer-jj-abandons-the-stent-market/2011-06-15T13:42:44-04:00http://www.cardiobrief.org/2011/06/15/nejm-fda-officials-explain-the-new-simvastatin-label/2011-06-16T08:55:59-04:00http://www.cardiobrief.org/2011/06/16/fda-says-pioglitazone-use-is-linked-to-bladder-cancer/2011-06-16T11:04:17-04:00http://www.cardiobrief.org/2011/06/16/fda-says-varenicline-chantix-may-increase-risk-of-cv-events/2011-06-16T11:51:01-04:00http://www.cardiobrief.org/2011/06/21/study-finds-critical-delay-in-most-mi-patients-transferred-for-primary-pci/2011-06-21T17:03:01-04:00http://www.cardiobrief.org/2011/06/21/meta-analysis-examines-risk-of-diabetes-associated-with-statins/2011-06-21T17:03:06-04:00http://www.cardiobrief.org/2011/06/22/jama-skeptical-perspectives-on-consumer-cardiac-tests-and-vitamin-d/2011-06-22T16:31:34-04:00http://www.cardiobrief.org/2011/06/22/apixaban-eliquis-meets-primary-endpoint-in-aristotle/2011-06-22T18:12:05-04:00http://www.cardiobrief.org/2011/06/25/diabetes-growth-termed-a-rising-global-hazard/2011-06-25T09:30:32-04:00http://www.cardiobrief.org/2011/06/23/pundits-declare-victory-in-anticoagulant-contest-but-its-not-over-yet/2011-06-23T12:26:18-04:00http://www.cardiobrief.org/2011/06/24/fda-recommends-more-conservative-dosing-of-esas/2011-06-24T12:46:54-04:00http://www.cardiobrief.org/2011/06/25/limited-benefit-found-for-early-aggressive-management-of-diabetes/2011-06-25T09:30:16-04:00http://www.cardiobrief.org/2011/06/27/asprin-dosage-in-us-may-explain-disparity-in-ticagrelor-results-in-plato/2011-06-27T15:12:06-04:00http://www.cardiobrief.org/2011/06/27/archives-decides-at-last-minute-not-to-publish-a-scheduled-paper/2011-06-28T16:04:33-04:00http://www.cardiobrief.org/2011/06/28/new-concerns-raised-about-withdrawn-archives-meditation-paper/2011-06-28T10:08:02-04:00http://www.cardiobrief.org/2011/06/29/very-little-new-light-shed-on-the-archives-meditation-fiasco/2011-06-30T19:35:30-04:00http://www.cardiobrief.org/2011/07/01/the-voice-of-the-patient-time-to-bring-out-the-muzzle/2011-07-01T15:13:51-04:00http://www.cardiobrief.org/2011/07/01/rivaroxaban-xarelto-gains-first-fda-approval-for-dvt-prevention/2011-07-01T15:52:24-04:00http://www.cardiobrief.org/2011/07/04/meta-analysis-finds-increased-cv-risk-associated-with-varenicline-chantix/2011-07-04T14:57:42-04:00http://www.cardiobrief.org/2011/07/05/ncdr-study-in-jama-only-half-of-nonacute-pcis-deemed-appropriate/2011-07-05T15:58:17-04:00http://www.cardiobrief.org/2011/07/05/comment-acc-circling-the-wagons-once-again/2011-07-05T17:49:19-04:00http://www.cardiobrief.org/2011/07/06/lower-sudden-cardiac-death-rates-observed-in-women-with-healthy-lifestyles/2011-07-06T14:54:05-04:00http://www.cardiobrief.org/2011/07/07/ascend-hf-no-harm-or-benefit-with-nesiritide/2011-07-07T10:49:16-04:00http://www.cardiobrief.org/2011/07/07/dronedarone-multaq-study-for-permanent-af-stopped-early/2011-07-07T11:54:47-04:00http://www.cardiobrief.org/2011/07/08/esc-congress-in-paris-hot-lines-and-clinical-trial-updates/2011-07-08T17:05:09-04:00http://www.cardiobrief.org/2011/07/07/guest-post-multaqs-off-again-on-again-then-off-again-ride/2011-07-07T14:29:29-04:00http://www.cardiobrief.org/2011/07/09/guest-post-creepy-invasion-of-pharma-into-patient-targeted-social-media-space/2011-07-09T17:23:24-04:00http://www.cardiobrief.org/2011/07/11/oat-trial-had-little-impact-on-clinical-practice/2011-07-11T16:07:25-04:00http://www.cardiobrief.org/2011/07/12/study-finds-sodium-potassium-ratio-strongly-tied-to-mortality-and-cv-disease/2011-07-12T11:23:54-04:00http://www.cardiobrief.org/2011/07/13/therapeutic-hypothermia-network-benefits-cardiac-arrest-patients/2011-07-13T13:55:38-04:00http://www.cardiobrief.org/2011/07/13/maryland-revokes-mark-mideis-medical-license/2011-07-13T18:00:01-04:00http://www.cardiobrief.org/2011/07/14/the-mark-midei-cases-patient-a/2011-07-14T17:29:27-04:00http://www.cardiobrief.org/2011/07/18/fda-releases-briefing-documents-for-advisory-panel-on-the-edwards-sapien-transcatheter-aortic-valve-implant/2011-07-18T09:46:50-04:00http://www.cardiobrief.org/2011/07/18/study-suggests-possibility-that-cetp-inhibitors-may-improve-glycemic-control/2011-07-18T17:27:21-04:00http://www.cardiobrief.org/2011/07/20/astrazeneca-ticagrelor-brilinta-gains-fda-approval/2011-07-20T17:52:03-04:00http://www.cardiobrief.org/2011/07/20/sapien-transcatheter-heart-valve-receives-strong-support-from-fda-advisory-panel/2011-07-21T11:37:24-04:00http://www.cardiobrief.org/2011/07/21/fda-and-ema-issue-updates-on-dronedarone-varenicline-and-pioglitazone/2011-07-21T15:27:32-04:00http://www.cardiobrief.org/2011/07/24/appraise-2-dashes-hope-of-adding-anticoagulant-to-antiplatelet-therapy-in-acs/2011-07-24T19:07:14-04:00http://www.cardiobrief.org/2011/07/23/less-may-be-more-but-stents-are-neither-good-nor-bad/2011-07-23T17:31:33-04:00http://www.cardiobrief.org/2011/07/25/adding-hba1c-measurements-improves-cv-risk-prediction-in-diabetics/2011-07-25T17:19:47-04:00http://www.cardiobrief.org/2011/07/26/study-finds-differences-in-heritability-of-coronary-and-cerebrovascular-disease/2011-07-26T17:02:03-04:00http://www.cardiobrief.org/2011/07/27/mixed-results-for-new-implantable-device-for-the-treatment-of-resistant-hypertension/2011-07-27T15:57:22-04:00http://www.cardiobrief.org/2011/07/27/astrazeneca-sets-premium-price-for-ticagrelor-brilinta/2011-07-27T18:57:29-04:00http://www.cardiobrief.org/2011/07/29/controversial-iom-report-highly-critical-of-510k-process/2011-07-29T13:03:06-04:00http://www.cardiobrief.org/2011/07/30/us-senate-unanimously-endorses-campaign-against-atrial-fibrillation/2011-08-01T15:02:45-04:00http://www.cardiobrief.org/2011/08/02/moderate-exercise-delivers-the-biggest-bang-for-the-buck/2011-08-02T09:49:30-04:00http://www.cardiobrief.org/2011/08/01/going-beyond-courage-nhlbi-funds-the-ischemia-study/2011-08-01T18:18:53-04:00http://www.cardiobrief.org/2011/08/03/recommended-reading-a-critical-view-of-antioxidants/2011-08-03T16:03:02-04:00http://www.cardiobrief.org/2011/08/03/pfizer-wants-to-market-otc-atorvastatin-lipitor/2011-08-03T16:41:05-04:00http://www.cardiobrief.org/2011/08/04/easy-come-easy-go-esc-to-review-dronedarones-role-in-af-guidelines/2011-08-04T13:43:49-04:00http://www.cardiobrief.org/2011/08/05/usa-today-finds-disparity-between-hospital-performance-and-public-perception/2011-08-05T13:40:28-04:00http://www.cardiobrief.org/2011/08/07/bernadine-healy-former-head-of-nih-and-american-red-cross-dead-of-a-brain-tumor/2011-08-08T16:33:21-04:00http://www.cardiobrief.org/2011/08/09/new-study-finds-wide-variation-among-hospitals-in-diagnostic-yield-for-angiography/2011-08-09T11:46:12-04:00http://www.cardiobrief.org/2011/08/10/rivaroxaban-xarelto-compared-to-warfarin-in-af-patients/2011-08-10T17:03:20-04:00http://www.cardiobrief.org/2011/08/10/a-failure-to-cooperate-wall-street-journal-looks-at-flawed-papers/2011-08-10T13:37:29-04:00http://www.cardiobrief.org/2011/08/11/danger-of-cigarettes-greater-in-women-than-in-men/2011-08-11T12:04:27-04:00http://www.cardiobrief.org/2011/08/12/guest-post-when-patients-cant-afford-a-medication/2011-08-12T12:54:25-04:00http://www.cardiobrief.org/2011/08/15/bare-metal-stents-the-next-new-thing/2011-08-14T22:55:07-04:00http://www.cardiobrief.org/2011/08/16/meta-analysis-finds-beta-blockers-may-be-less-effective-in-us-population/2011-08-16T12:32:02-04:00http://www.cardiobrief.org/2011/08/16/aha-2011-in-orlando-late-breaking-clinical-trials/2011-10-05T13:50:38-04:00http://www.cardiobrief.org/2011/08/18/is-coronary-calcium-better-than-crp-for-predicting-cv-events/2011-08-18T19:55:47-04:00http://www.cardiobrief.org/2011/08/17/details-of-updated-uk-heart-failure-guidelines-raise-some-eyebrows/2011-08-17T08:38:49-04:00http://www.cardiobrief.org/2011/08/22/cnn-abc-and-nbc-dumb-down-the-news-about-cv-screening/2011-08-22T10:08:46-04:00http://www.cardiobrief.org/2011/08/22/why-health-journalism-shouldnt-be-a-popularity-contest/2011-08-22T15:06:40-04:00http://www.cardiobrief.org/2011/08/23/door-to-balloon-time-closing-in-on-one-hour/2011-08-23T10:12:43-04:00http://www.cardiobrief.org/2011/08/23/william-kannel-former-director-of-the-framingham-heart-study-dead-at-87/2011-08-23T00:47:10-04:00http://www.cardiobrief.org/2011/08/23/ambulatory-bp-monitoring-gains-nice-recommendation-in-uk/2011-08-23T18:32:12-04:00http://www.cardiobrief.org/2011/08/26/paris-is-beautiful/2011-08-26T16:43:59-04:00http://www.cardiobrief.org/2011/08/28/aristotle-study-finds-the-golden-mean-of-anticoagulation/2011-08-28T03:55:59-04:00http://www.cardiobrief.org/2011/08/29/shortfalls-in-secondary-prevention-represent-a-colossal-human-tragedy/2011-08-29T02:54:52-04:00http://www.cardiobrief.org/2011/08/30/paris-or-orlando-a-tale-of-two-cities/2011-08-30T05:34:41-04:00http://www.cardiobrief.org/2011/08/29/not-shocking-french-studies-evaluate-remote-monitoring-of-icds/2011-08-29T07:35:02-04:00http://www.cardiobrief.org/2011/08/29/more-emphatic-benefits-found-for-high-risk-subgroups-taking-eplerenone/2011-08-29T13:10:22-04:00http://www.cardiobrief.org/2011/08/30/no-benefit-for-routine-counterpulsation-found-in-crisp-ami/2011-08-30T07:14:03-04:00http://www.cardiobrief.org/2011/08/31/new-resuscitation-strategies-fail-to-improve-outcomes-after-cardiac-arrest/2011-08-31T17:07:03-04:00http://www.cardiobrief.org/2011/09/02/rosuvastatin-fails-to-best-atorvastatin-in-ivus-study-of-atherosclerosis-progression/2011-09-02T17:23:27-04:00http://www.cardiobrief.org/2011/09/04/montreal-heart-institute-researcher-fired-after-investigation-of-retracted-papers/2011-09-04T17:16:55-04:00http://www.cardiobrief.org/2011/09/05/cnn-documentary-promises-screening-and-vegan-diet-can-eliminate-heart-attacks/2011-09-05T16:04:57-04:00http://www.cardiobrief.org/2011/09/06/fda-reviewers-recommend-against-approval-of-rivaroxaban-xarelto/2011-09-06T10:49:30-04:00http://www.cardiobrief.org/2011/09/06/fda-reviewers-recommend-complete-response-letter-for-rivaroxaban-xarelto/2011-09-06T10:43:20-04:00http://www.cardiobrief.org/2011/09/07/stenting-worse-than-medical-therapy-for-intracranial-stenosis/2011-09-07T15:47:23-04:00http://www.cardiobrief.org/2011/09/08/live-blog-fda-advisory-panel-on-rivaroxaban-xarelto/2011-09-11T13:39:58-04:00http://www.cardiobrief.org/2011/09/09/the-rivaroxaban-fda-panel-and-large-pragmatic-trials/2011-09-09T13:38:23-04:00http://www.cardiobrief.org/2011/09/12/study-finds-risks-and-costs-associated-with-infection-after-device-implantation/2011-09-12T16:02:36-04:00http://www.cardiobrief.org/2011/09/12/global-monitor-early-signs-of-possible-problems-with-icd-leads-dabigatran/2011-09-12T15:57:36-04:00http://www.cardiobrief.org/2011/09/14/study-sheds-light-on-consequences-of-bicuspid-aortic-valve/2011-09-14T08:41:31-04:00http://www.cardiobrief.org/2011/09/13/hhs-announces-initiative-to-prevent-one-million-heart-attacks-and-stroke/2011-09-13T13:28:34-04:00http://www.cardiobrief.org/2011/09/14/meta-analysis-finds-reduction-in-stent-thrombosis-with-everolimus-eluting-stents/2011-09-14T16:51:44-04:00http://www.cardiobrief.org/2011/09/15/xanthelasmata-identified-as-independent-cv-risk-factor/2011-09-15T18:31:02-04:00http://www.cardiobrief.org/2011/09/19/study-identifies-slow-spots-in-transfer-of-primary-pci-patients/2011-09-19T17:16:37-04:00http://www.cardiobrief.org/2011/09/19/fda-approves-watson-pharmaceuticals-generic-lovenox-enoxaparin/2011-09-20T13:05:30-04:00http://www.cardiobrief.org/2011/09/20/significant-declines-observed-in-cardiovascular-procedures-performed-in-hospitals/2011-09-21T13:09:30-04:00http://www.cardiobrief.org/2011/09/21/more-data-but-no-answers-about-platelet-function-testing/2011-09-21T15:00:49-04:00http://www.cardiobrief.org/2011/09/21/diet-drugs-get-a-new-slim-chance-at-approval/2011-09-22T10:50:42-04:00http://www.cardiobrief.org/2011/09/22/dronedarone-multaq-gets-another-drubbing-in-europe/2011-09-22T12:48:59-04:00http://www.cardiobrief.org/2011/09/23/rivaroxaban-xarelto-gets-positive-recommendation-for-af-and-dvt-in-europe/2011-09-23T12:52:35-04:00http://www.cardiobrief.org/2011/09/23/former-nejm-editor-criticizes-publication-and-peer-review-of-aristotle-trial/2011-11-02T08:50:40-04:00http://www.cardiobrief.org/2011/09/26/statins-for-primary-prevention-the-debate-continues/2011-09-26T16:12:57-04:00http://www.cardiobrief.org/2011/09/27/experience-counts-in-carotid-artery-stenting/2011-09-27T16:21:17-04:00http://www.cardiobrief.org/2011/09/28/the-pen-is-mightier-than-the-scold/2011-09-28T07:51:44-04:00http://www.cardiobrief.org/2011/10/07/industry-medicine-its-not-so-simple/2015-08-29T16:19:26-04:00http://www.cardiobrief.org/2011/09/28/easy-come-easy-go-esc-to-review-dronedarones-role-in-af-guidelines-2/2011-09-28T16:01:36-04:00http://www.cardiobrief.org/2011/09/29/study-finds-noncardiac-sources-of-positive-troponin-t-tests/2011-09-29T11:43:24-04:00http://www.cardiobrief.org/2011/09/29/meta-analysis-explores-real-world-cv-risk-of-nsaids/2011-09-29T17:32:56-04:00http://www.cardiobrief.org/2011/10/03/guidelines-for-peripheral-artery-disease-updated/2011-10-03T10:39:11-04:00http://www.cardiobrief.org/2011/09/29/atlas-acs-timi-51of-rivaroxaban-in-acs-meets-primary-endpoint/2011-09-29T21:05:33-04:00http://www.cardiobrief.org/2011/10/04/same-day-discharge-after-pci-safe-but-rarely-used/2011-10-04T16:20:57-04:00http://www.cardiobrief.org/2011/10/05/rivaroxaban-roundup-nejm-perspective-on-fda-panel-atlas-acs-will-be-an-aha-late-breaker/2011-10-05T18:09:43-04:00http://www.cardiobrief.org/2011/10/05/jj-pleads-guilty-and-pays-85-million-to-settle-natrecor-case/2011-10-05T22:23:49-04:00http://www.cardiobrief.org/2011/10/06/disease-mongering-du-jour-heart-disease-in-young-women-red-competing-with-pink/2011-10-06T13:03:59-04:00http://www.cardiobrief.org/2011/10/07/fda-approves-juvisync-combination-of-sitagliptin-and-simvastatin/2011-10-07T12:31:25-04:00http://www.cardiobrief.org/2011/10/12/national-lipid-association-expert-panel-has-many-deep-ties-to-industry/2011-10-17T16:06:41-04:00http://www.cardiobrief.org/2011/10/10/ttop-af-trial-demonstrates-efficacy-of-rf-ablation-system-but-fails-to-prove-safety/2011-10-10T16:45:07-04:00http://www.cardiobrief.org/2011/10/11/cardiologist-who-accused-famed-surgeon-of-misconduct-is-fired-by-northwestern-university/2011-10-11T12:01:37-04:00http://www.cardiobrief.org/2011/10/13/coronary-heart-disease-prevalence-in-us-continues-to-decline/2011-10-13T13:57:54-04:00http://www.cardiobrief.org/2011/10/13/fda-panel-recommends-first-des-for-pad/2011-10-13T19:03:58-04:00http://www.cardiobrief.org/2011/10/17/sapien-transcatheter-heart-valve-may-be-delayed/2011-10-17T12:44:57-04:00http://www.cardiobrief.org/2011/10/18/heart-failure-hospitalization-rate-drops-30-in-10-years/2011-10-18T16:09:57-04:00http://www.cardiobrief.org/2011/10/19/first-trimester-hypertension-not-ace-inhibitors-linked-to-birth-defects/2013-03-17T21:55:03-04:00http://www.cardiobrief.org/2011/10/19/uk-registry-tracks-long-term-tavi-outcomes/2011-10-19T16:09:19-04:00http://www.cardiobrief.org/2011/10/20/cdc-and-aha-tussle-over-just-how-bad-the-salt-problem-really-is/2011-10-20T14:41:24-04:00http://www.cardiobrief.org/2011/10/20/emas-chmp-finds-no-cancer-link-for-arbs/2011-10-20T13:23:46-04:00http://www.cardiobrief.org/2011/10/24/midlife-obesity-increases-risk-for-chd-mortality/2011-10-24T16:02:20-04:00http://www.cardiobrief.org/2011/10/24/new-study-proposes-possible-causative-role-for-hpv-in-atherosclerosis/2011-10-24T17:38:11-04:00http://www.cardiobrief.org/2011/10/25/genetic-and-clinical-factors-linked-to-stent-thrombosis/2011-10-25T16:13:21-04:00http://www.cardiobrief.org/2011/10/25/danish-study-clarifies-vte-risk-associated-with-newer-progestogens-in-oral-contraceptives/2011-10-25T18:33:49-04:00http://www.cardiobrief.org/2011/10/26/belgian-study-supports-use-of-ffr-to-guide-therapy-in-intermediate-lad-lesions/2011-10-26T16:38:09-04:00http://www.cardiobrief.org/2011/10/27/fda-advisory-panel-votes-8-2-against-approval-of-medtronic-af-ablation-system/2011-10-27T18:29:22-04:00http://www.cardiobrief.org/2011/10/30/fda-gives-favorable-review-to-sharp-ahead-of-vytorin-advisory-panel/2011-10-30T16:59:39-04:00http://www.cardiobrief.org/2011/11/01/large-study-finds-no-increased-risk-of-cv-events-for-adhd-drugs/2011-11-01T12:34:25-04:00http://www.cardiobrief.org/2011/10/31/waiting-for-tavi-on-all-hallows-eve/2011-10-31T18:49:31-04:00http://www.cardiobrief.org/2011/11/01/daily-show-asks-why-the-aha-killed-a-bill-encouraging-healthy-behavior/2011-11-01T13:24:30-04:00http://www.cardiobrief.org/2011/11/01/fda-approves-abbotts-xience-prime-drug-eluting-stent/2011-11-01T18:42:33-04:00http://www.cardiobrief.org/2011/11/03/tavi-approval-an-alternate-perspective-guest-post/2011-11-03T15:06:23-04:00http://www.cardiobrief.org/2011/11/02/fda-advisory-committee-recommends-approval-for-vytorin-in-pre-dialysis-ckd-patients/2011-11-02T16:53:57-04:00http://www.cardiobrief.org/2011/11/02/sapien-transcatheter-aortic-heart-valve-gains-fda-approval/2011-11-02T20:23:17-04:00http://www.cardiobrief.org/2011/11/04/aha-and-acc-update-secondary-prevention-guidelines/2011-11-03T23:20:04-04:00http://www.cardiobrief.org/2011/11/04/vytorin-yesterday%e2%80%99s-news-guest-post/2011-11-04T12:26:02-04:00http://www.cardiobrief.org/2011/11/04/fda-approves-rivaroxaban-for-stroke-prevention-in-af/2011-11-04T18:18:30-04:00http://www.cardiobrief.org/2011/11/07/acc-and-aha-release-new-pci-and-cabg-guidelines/2011-11-07T14:37:20-05:00http://www.cardiobrief.org/2011/11/08/financial-incentives-increase-utilization-of-stress-tests/2011-11-08T17:24:47-05:00http://www.cardiobrief.org/2011/11/09/obstructive-lesions-found-in-patients-with-calcium-score-of-zero/2011-11-09T16:06:33-05:00http://www.cardiobrief.org/2011/11/09/18-months-after-accord-fda-says-fenofibrate-may-not-lower-mi-or-stroke/2011-11-09T12:38:22-05:00http://www.cardiobrief.org/2011/11/10/cardiobrief-poll-should-the-acc-train-industry-reps/2011-11-10T17:30:14-05:00http://www.cardiobrief.org/2011/11/10/tavi-at-tct-enthusiasm-tempered-by-poor-transapical-outcomes/2011-11-11T06:38:53-05:00http://www.cardiobrief.org/2011/11/13/atlas-acs-2-timi-51-rivaroxaban-beneficial-in-low-risk-acs-population/2011-11-13T08:09:43-05:00http://www.cardiobrief.org/2011/11/13/adopt-fails-to-support-extended-oral-anticoagulation-with-apixabanin-high-risk-post-discharge-patients/2011-12-31T14:25:22-05:00http://www.cardiobrief.org/2011/11/13/tracer-novel-anticoagulant-vorapaxar-runs-into-trouble-in-acs/2011-11-13T08:26:58-05:00http://www.cardiobrief.org/2011/11/12/controversy-over-cholesterol-testing-for-children/2011-11-12T10:52:56-05:00http://www.cardiobrief.org/2011/11/12/the-aha-starts-on-sunday/2011-11-12T11:52:08-05:00http://www.cardiobrief.org/2011/11/14/pallas-poor-results-for-dronedarone-in-permanent-af/2011-11-14T13:29:30-05:00http://www.cardiobrief.org/2011/11/14/mi-freee-how-much-do-free-medications-really-cost/2011-11-14T09:01:10-05:00http://www.cardiobrief.org/2011/11/15/saturn-regression-trial-gorilla-statin-and-statin-king-battle-to-a-draw/2011-11-15T08:20:46-05:00http://www.cardiobrief.org/2011/11/15/aim-high-no-benefit-for-niacin-on-top-of-statins/2011-11-15T08:22:09-05:00http://www.cardiobrief.org/2011/11/15/hype-aside-hope-for-stem-cell-therapy-may-be-emerging-from-hibernation/2011-11-15T11:11:58-05:00http://www.cardiobrief.org/2011/11/15/experts-clash-over-interpretation-and-value-of-aim-high/2011-11-15T15:33:57-05:00http://www.cardiobrief.org/2011/11/16/elevate-timi-56-one-new-piece-of-the-clopidogrel-puzzle/2011-11-16T13:02:12-05:00http://www.cardiobrief.org/2011/11/17/prominent-dutch-cardiovascular-researcher-fired-for-scientific-misconduct/2012-07-29T15:51:54-04:00http://www.cardiobrief.org/2011/11/20/more-details-emerge-about-the-dutch-research-scandal/2011-11-21T11:59:55-05:00http://www.cardiobrief.org/2011/11/22/long-term-followup-of-hps-shows-extended-benefits-of-statins/2011-11-22T11:59:38-05:00http://www.cardiobrief.org/2011/11/22/merck-pleads-guilty-and-pays-950-million-for-illegal-promotion-of-vioxx/2011-11-22T16:29:42-05:00http://www.cardiobrief.org/2011/11/23/fda-investigating-conduct-of-cardiomems-champion-trial-ahead-of-advisory-committee-meeting/2011-11-23T17:56:21-05:00http://www.cardiobrief.org/2011/11/23/esc-may-re-examine-guidelines-in-wake-of-poldermans-dismissal/2011-11-23T13:54:19-05:00http://www.cardiobrief.org/2011/11/28/long-transfer-delays-for-stemi-patients-at-most-hospitals-without-primary-pci/2011-11-28T17:52:13-05:00http://www.cardiobrief.org/2011/11/28/study-finds-10-of-pci-patients-readmitted-to-hospital-within-30-days/2011-11-29T10:06:54-05:00http://www.cardiobrief.org/2011/11/29/apixaban-gains-priority-fda-review-for-stroke-and-vte-prevention-in-af/2011-11-29T11:43:16-05:00http://www.cardiobrief.org/2011/11/30/generic-atorvastatin-hits-the-market/2011-11-30T10:23:33-05:00http://www.cardiobrief.org/2011/12/01/meta-analysis-finds-benefits-for-self-monitoring-in-some-warfarin-patients/2011-12-01T08:52:51-05:00http://www.cardiobrief.org/2011/12/01/acc-and-sts-announce-launch-of-tavr-registry/2011-12-01T12:32:49-05:00http://www.cardiobrief.org/2011/12/02/one-more-thought-about-lipitor/2011-12-02T14:38:12-05:00http://www.cardiobrief.org/2011/12/04/cms-tightening-the-screws-on-unnecessary-procedures-in-florida-and-10-other-states/2011-12-04T17:05:43-05:00http://www.cardiobrief.org/2011/12/05/fda-reviewers-raise-questions-about-cardiomems-champion-trial-ahead-of-advisory-panel/2011-12-05T14:53:13-05:00http://www.cardiobrief.org/2011/12/06/change-in-fitness-more-important-than-bmi-over-time/2011-12-06T12:46:15-05:00http://www.cardiobrief.org/2011/12/07/cv-risk-of-prostate-cancer-therapy-underappreciated/2011-12-07T18:50:14-05:00http://www.cardiobrief.org/2011/12/07/fda-undertakes-safety-review-of-dabigatran-pradaxa/2011-12-07T14:23:16-05:00http://www.cardiobrief.org/2011/12/08/oops-she-did-it-again-fda-disinvites-another-advisor/2011-12-08T07:49:17-05:00http://www.cardiobrief.org/2011/12/08/fda-advisory-panel-votes-against-implantable-cardiomems-hf-pressure-measurement-system/2011-12-08T19:21:34-05:00http://www.cardiobrief.org/2011/12/12/large-analysis-confirms-safety-of-adhd-medications/2011-12-12T11:44:55-05:00http://www.cardiobrief.org/2011/12/10/from-the-archives-understanding-risk-tricky-business/2011-12-10T11:23:45-05:00http://www.cardiobrief.org/2011/12/13/meta-analysis-finds-no-danger-for-pci-performed-at-centers-without-surgical-backup/2011-12-13T16:08:09-05:00http://www.cardiobrief.org/2011/12/14/study-examines-new-onset-atrial-fibrillation-after-tavi/2011-12-14T16:07:28-05:00http://www.cardiobrief.org/2011/12/14/investigation-in-poldermans-case-expands-to-leiden-university-medical-center/2011-12-14T20:19:05-05:00http://www.cardiobrief.org/2011/12/15/the-good-the-bad-and-the-ugly-aha-releases-update-of-heart-and-stroke-statistics/2011-12-15T16:17:56-05:00http://www.cardiobrief.org/2011/12/18/letter-from-jail-a-cautionary-tale/2015-08-29T16:19:50-04:00http://www.cardiobrief.org/2011/12/19/more-uncertainty-about-vitamin-d-supplements/2011-12-19T17:29:17-05:00http://www.cardiobrief.org/2011/12/19/fda-adds-new-warnings-to-dronedarone-multaq-label/2011-12-19T15:52:25-05:00http://www.cardiobrief.org/2011/12/20/22-years-later-study-shows-life-prolonging-effect-of-antihypertensive-therapy/2011-12-20T16:24:40-05:00http://www.cardiobrief.org/2011/12/20/altitude-study-of-aliskiren-terminated-early-by-novartis/2011-12-20T12:23:13-05:00http://www.cardiobrief.org/2011/12/21/study-examines-changes-in-resting-heart-rate-over-time/2011-12-21T15:12:20-05:00http://www.cardiobrief.org/2011/12/22/ray-of-light-for-the-physician-payment-sunshine-act/2011-12-23T14:41:48-05:00http://www.cardiobrief.org/2011/12/23/study-finds-mr-superior-to-spect-but-clinical-role-is-uncertain/2011-12-23T10:45:06-05:00http://www.cardiobrief.org/2011/12/27/study-finds-role-for-new-troponin-test-in-diagnosis-of-mi/2011-12-27T16:04:00-05:00http://www.cardiobrief.org/2011/12/27/clopidogrel-testing-comes-under-fire/2011-12-27T16:10:28-05:00http://www.cardiobrief.org/2011/12/27/nissen-and-topol-clash-over-genetics-and-personalized-medicine/2011-12-27T16:35:39-05:00http://www.cardiobrief.org/2011/12/28/no-mortality-benefit-found-for-low-molecular-weight-heparin-in-acutely-ill-patients/2011-12-28T17:02:48-05:00http://www.cardiobrief.org/2011/12/29/jj-submits-nda-for-acs-indication-for-rivaroxaban-xarelto/2011-12-29T23:23:07-05:00http://www.cardiobrief.org/2011/12/31/2011-in-review-rivaroxaban-sapien-mark-midei-conflicts-of-interest-and-much-more/2011-12-31T17:01:12-05:00http://www.cardiobrief.org/2012/01/03/measuring-in-hospital-mortality-favors-hospitals-with-short-stays/2012-01-03T10:50:21-05:00http://www.cardiobrief.org/2012/01/03/bariatric-surgery-cuts-cardiovascular-deaths-and-events/2012-01-04T11:35:31-05:00http://www.cardiobrief.org/2012/01/04/missing-data-the-elephant-thats-not-in-the-room-guest-post/2012-01-04T01:28:17-05:00http://www.cardiobrief.org/2012/01/04/high-stemi-readmission-rate-in-us-linked-to-shorter-hospital-stays/2012-01-04T12:55:35-05:00http://www.cardiobrief.org/2012/01/05/diets-differ-in-effect-on-weight-gain-and-fat-and-lean-mass/2012-01-05T14:32:57-05:00http://www.cardiobrief.org/2012/01/05/researchers-report-a-new-placebo-effect-manipulating-clinical-trials/2012-01-05T22:31:01-05:00http://www.cardiobrief.org/2012/01/09/excess-risk-of-cardiac-events-associated-with-dabigatran/2012-01-09T16:59:36-05:00http://www.cardiobrief.org/2012/01/09/statins-elevate-risk-of-diabetes-in-postmenopausal-women/2012-01-09T14:20:03-05:00http://www.cardiobrief.org/2012/01/10/researcher-find-lower-sweet-spot-for-potassium-levels-in-mi/2012-01-10T20:04:39-05:00http://www.cardiobrief.org/2012/01/11/assert-sheds-light-on-the-role-of-subclinical-af-in-stroke/2012-01-11T17:00:26-05:00http://www.cardiobrief.org/2012/01/11/director-of-uconn-cv-research-center-accused-of-scientific-misconduct/2012-01-11T18:44:40-05:00http://www.cardiobrief.org/2012/01/12/the-safety-of-the-long-distance-runner/2012-01-12T14:59:58-05:00http://www.cardiobrief.org/2012/01/16/resveratrol-and-fraud/2012-01-16T17:28:54-05:00http://www.cardiobrief.org/2012/01/17/cangrelor-proposed-as-bridge-to-surgery/2012-01-17T16:41:20-05:00http://www.cardiobrief.org/2012/01/18/new-enrollment-in-fame-ii-halted-after-interim-analysis-shows-benefits-of-ffr/2012-01-18T13:14:19-05:00http://www.cardiobrief.org/2012/01/18/fame-ii-additional-thoughts-about-ffr-in-the-real-world/2012-01-18T13:13:03-05:00http://www.cardiobrief.org/2012/01/18/guest-post-a-critical-analysis-of-abc-bill-weirs-lifesaving-test-story/2012-01-18T15:14:31-05:00http://www.cardiobrief.org/2012/01/19/ct-angiography-found-less-helpful-in-patients-with-high-calcium-scores/2012-01-19T13:57:43-05:00http://www.cardiobrief.org/2012/01/21/guest-post-report-from-the-riata-icd-lead-summit/2013-09-07T09:03:47-04:00http://www.cardiobrief.org/2012/01/23/rita-redberg-and-roger-blumenthal-clash-over-statins-for-primary-prevention-in-the-wall-street-journal/2012-01-23T13:06:49-05:00http://www.cardiobrief.org/2012/01/24/black-tea-found-to-lower-blood-pressure/2012-01-24T09:36:29-05:00http://www.cardiobrief.org/2012/01/23/st-jude-medical-statement-on-the-riata-icd-lead-summit/2012-01-23T14:01:22-05:00http://www.cardiobrief.org/2012/01/24/whistleblower-lawsuit-filed-against-5-cardiologists-in-pennsylvania/2012-01-24T11:41:28-05:00http://www.cardiobrief.org/2012/01/25/fda-rejects-proposed-chronic-kidney-disease-indication-for-vytorin/2012-01-25T14:24:02-05:00http://www.cardiobrief.org/2012/01/25/huge-study-finds-risk-factors-do-in-fact-predict-risk/2012-01-25T16:27:38-05:00http://www.cardiobrief.org/2012/01/26/big-drop-in-incidence-and-fatality-of-mis-in-england/2012-01-26T11:15:52-05:00http://www.cardiobrief.org/2012/01/26/nhlbi-launches-two-large-cardiac-arrest-treatment-trials/2012-01-26T12:20:55-05:00http://www.cardiobrief.org/2012/01/27/lancet-editor-richard-horton-tweets-dark-view-of-contemporary-medicine/2012-02-01T13:18:12-05:00http://www.cardiobrief.org/2012/01/27/acc-2012-roster-of-late-breaking-clinical-trials/2012-01-27T14:02:17-05:00http://www.cardiobrief.org/2012/01/30/very-large-observational-study-finds-significant-mortality-advantage-for-cabg-over-pci-in-high-risk-patients/2012-02-01T13:17:08-05:00http://www.cardiobrief.org/2012/01/30/appropriate-use-criteria-for-revascularization-updated/2012-02-01T13:14:50-05:00http://www.cardiobrief.org/2012/01/30/robert-harrington-leaving-duke-for-stanford-university/2012-02-01T13:11:45-05:00http://www.cardiobrief.org/2012/01/31/consensus-document-provides-roadmap-to-uptake-of-tavi-in-us/2012-02-01T13:10:21-05:00http://www.cardiobrief.org/2012/02/01/meta-analysis-confirms-benefits-of-statins-in-women/2012-02-01T12:55:03-05:00http://www.cardiobrief.org/2012/02/02/study-explores-role-of-periprocedural-dabigatran-in-af-ablation/2012-02-02T19:16:38-05:00http://www.cardiobrief.org/2012/02/02/cms-releases-details-of-proposed-national-coverage-for-tavr/2012-02-03T20:14:25-05:00http://www.cardiobrief.org/2012/02/06/women-and-icds-more-complications-and-fewer-benefits/2012-02-06T17:22:27-05:00http://www.cardiobrief.org/2012/02/07/bleeding-problems-continue-to-bedevil-novel-antiplatelet-agent-vorapaxar/2012-02-07T11:10:54-05:00http://www.cardiobrief.org/2012/02/08/prominent-interventionalists-attack-appropriate-use-criteria-for-pci/2012-02-09T00:20:54-05:00http://www.cardiobrief.org/2012/02/09/the-y-chromosome-may-explain-why-men-have-earlier-coronary-disease/2012-02-09T13:19:43-05:00http://www.cardiobrief.org/2012/02/12/guest-post-industry-sponsored-editorial-assistance/2012-02-16T11:50:58-05:00http://www.cardiobrief.org/2012/02/13/metaanalysis-raises-more-questions-about-routine-use-of-aspirin-for-primary-prevention/2012-02-13T14:56:48-05:00http://www.cardiobrief.org/2012/02/14/a-defense-of-professional-medical-writers/2012-02-16T12:30:36-05:00http://www.cardiobrief.org/2012/02/14/guest-post-what-are-the-lessons-of-the-riata-icd-lead-recall/2012-02-14T15:06:28-05:00http://www.cardiobrief.org/2012/02/14/metaanalysis-air-pollutants-raise-short-term-risk-of-mi/2012-02-14T16:09:30-05:00http://www.cardiobrief.org/2012/02/15/aha-scientific-statement-spotlights-peripheral-artery-disease-in-women/2012-02-15T16:25:22-05:00http://www.cardiobrief.org/2012/02/15/japanese-researcher-with-harvard-connections-retracts-3-articles-in-aha-journals/2012-02-15T20:15:05-05:00http://www.cardiobrief.org/2012/02/16/industry-supported-editorial-assistance-the-debate-continues/2012-02-16T11:53:37-05:00http://www.cardiobrief.org/2012/02/17/fda-approves-medtronics-resolute-drug-eluting-stent-for-treatment-of-cad-including-diabetics/2012-02-17T18:00:27-05:00http://www.cardiobrief.org/2012/02/21/more-rigorous-family-history-improves-cv-risk-assessment/2012-02-21T11:47:07-05:00http://www.cardiobrief.org/2012/02/22/guest-post-more-lessons-from-the-riata-icd-lead-recall/2012-05-20T00:29:17-04:00http://www.cardiobrief.org/2012/02/22/fda-advisory-panel-gives-green-light-to-qnexa-diet-pill/2012-02-22T18:00:00-05:00http://www.cardiobrief.org/2012/02/23/youtube-nejm-whitney-houston-and-alpha-male-monkeys/2012-02-23T12:00:40-05:00http://www.cardiobrief.org/2012/02/27/meta-analysis-finds-no-advantages-for-pci-over-medical-therapy-in-stable-patients/2012-02-27T16:00:48-05:00http://www.cardiobrief.org/2012/02/28/slow-uptake-of-transcatheter-aortic-valves-learning-from-history/2012-03-08T17:16:27-05:00http://www.cardiobrief.org/2012/02/28/fda-grants-priority-review-to-rivaroxaban-xarelto-for-acs-patients/2012-02-28T12:24:42-05:00http://www.cardiobrief.org/2012/02/28/fda-revises-the-safety-labeling-of-statins/2012-02-28T14:56:35-05:00http://www.cardiobrief.org/2012/02/29/decision-on-apixaban-eliquis-pushed-back-by-three-months/2012-03-01T17:19:46-05:00http://www.cardiobrief.org/2012/04/08/mark-midei-cant-get-a-job-taking-blood-pressure-at-a-walmart/2015-09-08T16:34:28-04:00http://www.cardiobrief.org/2012/03/02/four-cardiovascular-societies-release-criteria-for-tavr-programs-and-operators/2012-03-02T13:37:56-05:00http://www.cardiobrief.org/2012/03/05/statins-and-diabetes-real-concern-or-much-ado-about-nothing/2012-03-05T19:16:58-05:00http://www.cardiobrief.org/2012/03/05/eric-topol-megamind/2012-03-05T22:42:29-05:00http://www.cardiobrief.org/2012/03/06/guest-post-another-round-in-the-debate-on-diabetes-and-statins/2012-03-08T11:15:18-05:00http://www.cardiobrief.org/2012/03/07/software-tool-could-provide-early-warning-of-icd-lead-failure/2012-03-07T16:32:30-05:00http://www.cardiobrief.org/2012/03/08/michael-ezekowitz-leaves-lankenau-to-join-cardiovascular-research-foundation-in-new-york-city/2012-03-08T14:46:00-05:00http://www.cardiobrief.org/2012/03/12/bad-news-for-red-meat-lovers/2012-03-12T16:27:25-04:00http://www.cardiobrief.org/2012/03/13/prominent-japanese-cardiologist-accused-of-scientific-misconduct/2012-03-13T11:05:05-04:00http://www.cardiobrief.org/2012/03/14/angioplasty-pioneer-geoffrey-hartzler-dead-at-65/2012-03-14T10:45:04-04:00http://www.cardiobrief.org/2012/03/14/achieving-closure-final-act-of-pfo-closure-device/2012-03-14T16:17:48-04:00http://www.cardiobrief.org/2012/03/15/studies-provide-strongest-evidence-to-date-for-causative-role-of-inflammation-in-heart-disease/2012-03-15T15:42:42-04:00http://www.cardiobrief.org/2012/03/18/a-case-of-plagiarism-raises-blood-pressures/2012-04-05T12:06:35-04:00http://www.cardiobrief.org/2012/03/19/questions-raised-about-antiplatelet-therapy-in-chronic-kidney-disease/2012-03-19T17:27:22-04:00http://www.cardiobrief.org/2012/03/19/merck-drops-development-of-oral-vernakalant-for-atrial-fibrillation/2012-03-19T14:17:31-04:00http://www.cardiobrief.org/2012/03/20/meta-analysis-adds-new-evidence-for-cancer-benefits-of-daily-aspirin/2012-03-20T18:44:13-04:00http://www.cardiobrief.org/2012/03/21/promising-phase-1-results-for-new-monoclonal-antibody-to-pcsk9/2012-03-21T17:04:17-04:00http://www.cardiobrief.org/2012/03/22/large-meta-analysis-finds-very-low-thrombosis-rates-for-xience-stent/2012-03-22T18:40:05-04:00http://www.cardiobrief.org/2012/03/26/what-to-do-when-federal-investigators-knock-on-the-door/2012-03-27T13:12:50-04:00http://www.cardiobrief.org/2012/03/23/welcome-to-chicago/2012-03-23T13:28:15-04:00http://www.cardiobrief.org/2012/03/24/novel-antiplatelet-agent-reduces-events-but-increases-bleeding/2012-03-24T09:41:30-04:00http://www.cardiobrief.org/2012/03/25/study-supports-pci-without-onsite-surgical-backup/2012-03-25T11:03:38-04:00http://www.cardiobrief.org/2012/03/26/study-supports-coronary-ct-angiography-for-rule-out-chest-pain-patients/2012-03-26T09:18:27-04:00http://www.cardiobrief.org/2012/03/24/eric-peterson-to-succeed-bob-harrington-as-director-of-the-duke-clinical-research-institute/2012-03-25T21:20:54-04:00http://www.cardiobrief.org/2012/03/26/rivaroxaban-found-safe-and-effective-for-pulmonary-embolism/2012-03-25T22:12:00-04:00http://www.cardiobrief.org/2012/03/26/partner-tavr-results-appear-durable-at-two-years/2012-03-26T09:04:48-04:00http://www.cardiobrief.org/2012/03/26/bariatric-surgery-turns-back-the-clock-on-diabetes/2012-03-26T22:57:50-04:00http://www.cardiobrief.org/2012/03/27/ascert-observational-study-finds-long-term-advantage-for-pci-over-cabg-in-high-risk-cases/2012-03-27T09:10:21-04:00http://www.cardiobrief.org/2012/03/28/proof-of-concept-for-bedside-rapid-genotyping-test-of-cyp2c19/2012-03-28T18:57:17-04:00http://www.cardiobrief.org/2012/03/27/rolling-up-the-carpets-at-the-acc/2012-03-27T18:38:30-04:00http://www.cardiobrief.org/2012/03/28/20-deaths-linked-to-new-problem-with-riata-leads/2012-03-28T01:23:54-04:00http://www.cardiobrief.org/2012/03/29/and-the-2012-award-for-the-most-dumbass-drug-promotion-goes-to/2012-03-29T09:54:40-04:00http://www.cardiobrief.org/2012/03/30/guest-post-lessons-from-the-riata-recall-part-iii/2012-05-20T00:29:08-04:00http://www.cardiobrief.org/2012/04/02/improved-survival-after-non-shockable-cardiac-arrest-with-new-cpr-guidelines/2012-04-02T16:18:07-04:00http://www.cardiobrief.org/2012/04/04/st-jude-withdraws-older-lv-crt-leads-from-market/2012-04-04T10:03:00-04:00http://www.cardiobrief.org/2012/04/04/medical-societies-release-lists-of-overused-tests-and-procedures/2012-04-04T10:49:07-04:00http://www.cardiobrief.org/2012/04/04/suicide-and-cv-death-increase-after-diagnosis-of-cancer/2012-04-04T17:03:53-04:00http://www.cardiobrief.org/2012/04/05/investigation-begins-in-the-korean-plagiarism-case/2012-04-05T12:12:06-04:00http://www.cardiobrief.org/2012/04/05/nih-appoints-gary-gibbons-as-next-director-of-the-nhlbi/2012-04-05T11:18:31-04:00http://www.cardiobrief.org/2012/04/06/failure-of-another-trial-testing-guided-antiplatelet-therapy-prompts-debate/2012-04-07T23:13:42-04:00http://www.cardiobrief.org/2012/04/06/st-jude-seeks-retraction-of-hauser-article-on-riata-leads/2012-04-06T17:54:06-04:00http://www.cardiobrief.org/2012/04/10/round-two-heart-rhythm-editor-rejects-st-jude-request-to-retract-riata-paper/2012-04-10T15:01:12-04:00http://www.cardiobrief.org/2012/04/11/study-evaluates-losartan-efficacy-in-heart-failure/2012-04-11T17:18:43-04:00http://www.cardiobrief.org/2012/04/13/guest-post-after-an-unprecedented-request-for-a-retraction-a-close-look-at-the-data/2012-05-20T00:28:55-04:00http://www.cardiobrief.org/2012/04/16/million-dollar-bonuses-for-five-ohio-state-university-electrophysiologists/2012-04-16T13:30:05-04:00http://www.cardiobrief.org/2012/04/18/preoperative-statins-found-to-reduce-af-and-length-of-stay-but-not-mortality/2012-04-18T09:50:18-04:00http://www.cardiobrief.org/2012/04/17/new-perspective-on-the-dutch-cardiovascular-research-scandal/2012-04-17T16:00:58-04:00http://www.cardiobrief.org/2012/04/18/periodontal-disease-and-cv-disease-just-friends/2012-04-18T16:24:53-04:00http://www.cardiobrief.org/2012/04/19/arizona-cardiac-surgeons-pay-100000-to-settle-hipaa-violations/2012-04-19T16:00:07-04:00http://www.cardiobrief.org/2012/04/20/aliskiren-tekturna-gets-new-warning-and-contraindication-from-fda/2012-04-20T13:23:35-04:00http://www.cardiobrief.org/2012/04/23/fda-posts-results-of-cameron-subcutaneous-icd-pivotal-trial/2012-04-23T13:46:18-04:00http://www.cardiobrief.org/2012/04/23/meta-analysis-compares-drug-eluting-and-bare-metal-stents-for-primary-angioplasty/2012-04-23T16:51:51-04:00http://www.cardiobrief.org/2012/04/24/study-sheds-light-on-cardiac-device-infective-endocarditis/2012-04-24T16:28:10-04:00http://www.cardiobrief.org/2012/04/25/when-youre-hot-youre-hot-salim-yusuf-second-most-influential-scientist-in-2011/2012-04-25T12:47:40-04:00http://www.cardiobrief.org/2012/04/25/the-medicines-company-collaborates-with-astrazeneca-to-sell-brilinta-ticagrelor/2012-04-25T15:13:17-04:00http://www.cardiobrief.org/2012/04/25/fda-advisory-panel-gives-green-light-to-heartware-ventricular-assist-system/2012-04-25T20:37:22-04:00http://www.cardiobrief.org/2012/04/26/cameron-healths-subcutaneous-icd-sails-through-fda-advisory-panel/2012-04-26T17:28:30-04:00http://www.cardiobrief.org/2012/04/30/heart-rhythm-editor-douglas-zipes-defends-peer-review/2012-04-30T14:21:48-04:00http://www.cardiobrief.org/2012/05/01/half-the-news-thats-fit-to-print-ny-times-on-ecg-screening-for-student-athletes/2015-09-08T16:34:57-04:00http://www.cardiobrief.org/2012/05/01/cms-issues-national-coverage-decision-for-tavr/2012-05-01T16:54:42-04:00http://www.cardiobrief.org/2012/05/02/guest-post-the-dark-side-of-ekg-screening-in-athletes/2012-05-02T14:27:42-04:00http://www.cardiobrief.org/2012/05/03/warcef-no-advantage-for-warfarin-over-aspirin-in-heart-failure/2012-05-03T09:35:27-04:00http://www.cardiobrief.org/2012/05/03/company-fails-to-disclose-details-about-heart-failure-risk-of-drug/2012-05-03T17:29:02-04:00http://www.cardiobrief.org/2012/05/04/politics-and-transcatheter-aortic-valve-replacement/2015-09-08T16:36:08-04:00http://www.cardiobrief.org/2012/05/07/roche-terminates-development-of-cetp-inhibitor-dalcetrapib/2012-05-07T07:58:16-04:00http://www.cardiobrief.org/2012/05/08/all-dressed-up-and-no-place-to-go-false-positive-activation-of-the-cath-lab-for-primary-pci/2012-05-08T09:30:57-04:00http://www.cardiobrief.org/2012/05/08/persistent-concerns-about-lorcaserin-lorqess-from-fda-reviewers/2012-05-08T11:38:00-04:00http://www.cardiobrief.org/2012/05/08/in-af-women-have-a-bigger-risk-of-stroke-than-men/2012-05-09T12:29:59-04:00http://www.cardiobrief.org/2012/05/09/atorvastatin-lifts-ranbaxy-while-pfizer-abandons-its-lipitor-marketing-efforts/2012-05-09T19:02:54-04:00http://www.cardiobrief.org/2012/05/10/guest-post-shedding-light-on-riata-at-the-heart-rhythm-society-meeting/2012-05-20T00:28:47-04:00http://www.cardiobrief.org/2012/05/10/fda-advisory-panel-recommends-approval-for-weight-loss-drug-lorcaserin/2012-05-10T16:43:22-04:00http://www.cardiobrief.org/2012/05/12/hrs-2012-more-clarity-on-doj-icd-investigation-incidental-pcis-still-excluded/2012-05-20T00:28:24-04:00http://www.cardiobrief.org/2012/05/14/revascularization-in-new-york-state-high-questionable-rates-for-pci-but-not-cabg/2012-05-20T00:35:48-04:00http://www.cardiobrief.org/2012/05/14/returning-to-detroit-william-oneill-heads-to-henry-ford-hospital/2012-05-14T17:40:19-04:00http://www.cardiobrief.org/2012/05/15/no-benefit-found-for-exercise-echocardiography-in-asymptomatic-patients-following-cabg-or-pci/2012-05-15T12:05:42-04:00http://www.cardiobrief.org/2012/05/15/xience-stents-gain-european-nod-for-three-month-dual-antiplatelet-therapy/2012-05-15T10:57:56-04:00http://www.cardiobrief.org/2012/05/16/large-metaanalysis-statins-effective-in-low-risk-patients/2012-05-17T10:38:19-04:00http://www.cardiobrief.org/2012/05/16/robert-hauser-icd-watchdog-offers-viewpoint-on-riata-controversy-at-hrs/2012-07-15T19:00:47-04:00http://www.cardiobrief.org/2012/05/17/fda-approves-generic-clopidogrels-as-plavix-loses-patent-protection/2012-05-17T15:10:26-04:00http://www.cardiobrief.org/2012/05/18/you-know-nothing-dr-snow-why-medicine-cant-be-more-like-facebook/2015-09-08T16:38:06-04:00http://www.cardiobrief.org/2012/05/21/rivaroxaban-for-acs-gets-positive-fda-review-but-questions-about-atlas-trial-conduct-persist/2012-05-21T14:25:19-04:00http://www.cardiobrief.org/2012/05/22/studies-probe-effect-of-cpap-and-sleep-apnea-on-hypertesnion/2012-05-22T16:06:06-04:00http://www.cardiobrief.org/2012/05/23/live-blog-the-fda-advisory-panel-for-rixaroxaban-for-acs/2012-05-23T17:25:13-04:00http://www.cardiobrief.org/2012/05/23/fda-advisory-committee-recommends-against-acs-indication-for-rivaroxaban/2012-05-23T17:22:18-04:00http://www.cardiobrief.org/2012/05/24/aspirin-found-to-prevent-recurrent-venous-thromboembolism/2012-05-24T11:08:52-04:00http://www.cardiobrief.org/2012/05/27/guest-post-data-drugs-and-deception-a-true-story/2012-05-27T15:09:22-04:00http://www.cardiobrief.org/2012/05/30/fascinating-debate-over-statins-for-primary-prevention/2012-05-30T13:20:17-04:00http://www.cardiobrief.org/2012/05/31/this-week-in-medicine-stop-exercising-and-eat-chocolate/2012-05-31T19:07:41-04:00http://www.cardiobrief.org/2012/06/04/subway-meals-get-american-heart-association-endorsement/2012-06-04T23:59:45-04:00http://www.cardiobrief.org/2012/06/04/observational-study-finds-possible-long-term-mortality-advantage-for-rhythm-control-drugs-in-atrial-fibrillation/2012-06-04T16:10:41-04:00http://www.cardiobrief.org/2012/06/05/troponin-t-test-helps-assess-risk-following-noncardiac-surgery/2012-06-05T16:09:35-04:00http://www.cardiobrief.org/2012/06/06/real-world-bleeding-risk-of-aspirin-in-primary-prevention-examined/2012-06-06T16:10:56-04:00http://www.cardiobrief.org/2012/06/07/growing-popularity-of-dabigatran-leads-to-increased-complications/2012-06-07T13:00:54-04:00http://www.cardiobrief.org/2012/06/09/transient-glucose-regulation-helps-prevent-progression-to-diabetes-in-prediabetics/2012-06-08T18:42:49-04:00http://www.cardiobrief.org/2012/06/11/basal-insulin-and-omega-3-fatty-acids-fail-to-improve-outcomes-in-diabetics-and-prediabetics/2012-06-11T15:26:35-04:00http://www.cardiobrief.org/2012/06/11/fda-reviewers-raise-questions-about-sapien-heart-valve-system/2012-06-11T14:34:40-04:00http://www.cardiobrief.org/2012/06/12/acc-releases-appropriate-use-criteria-for-noninvasive-peripheral-tests/2012-06-12T11:24:25-04:00http://www.cardiobrief.org/2012/06/12/single-case-report-casts-new-doubts-about-st-jude-durata-icd-leads/2012-06-13T07:13:53-04:00http://www.cardiobrief.org/2012/06/13/live-blog-fda-advisory-panel-for-edwards-sapien-transcatheter-heart-valve/2012-06-13T18:10:19-04:00http://www.cardiobrief.org/2012/06/14/fda-advisory-panel-recommends-expanded-indication-for-sapien-transcatheter-heart-valve/2012-06-14T10:36:08-04:00http://www.cardiobrief.org/2012/06/15/guest-post-industry-editorial-makes-outlandish-claim-about-impact-of-medical-devices/2012-06-15T14:53:09-04:00http://www.cardiobrief.org/2012/06/18/the-grim-impact-of-loneliness-and-living-alone/2012-06-18T17:57:44-04:00http://www.cardiobrief.org/2012/06/19/is-chronic-kidney-disease-a-chd-risk-equivalent/2012-06-19T15:36:03-04:00http://www.cardiobrief.org/2012/06/19/new-uses-found-for-a-traditional-walking-test/2012-06-19T18:56:44-04:00http://www.cardiobrief.org/2012/06/20/guest-post-reality-check-the-origin-of-spin-in-a-randomized-trial/2012-06-20T15:56:48-04:00http://www.cardiobrief.org/2012/06/21/olmesartan-use-associated-with-gi-disorder-that-mimics-celiac-disease/2012-06-21T19:12:18-04:00http://www.cardiobrief.org/2012/06/21/fda-rejects-acs-indication-for-rivaroxaban-xarelto/2012-06-21T18:51:21-04:00http://www.cardiobrief.org/2012/06/25/fda-once-again-delays-approval-of-apixaban-eliquis/2012-06-25T12:09:12-04:00http://www.cardiobrief.org/2012/06/25/are-statins-equally-effective-in-women-and-in-men/2012-06-25T16:12:30-04:00http://www.cardiobrief.org/2012/06/27/good-sciencebad-science-contrasting-papers-on-dietary-compositon-in-jama-and-bmj/2015-09-08T16:40:45-04:00http://www.cardiobrief.org/2012/06/27/fda-approves-a-new-weight-loss-drug-breaking-a-13-year-drought/2012-06-27T14:05:51-04:00http://www.cardiobrief.org/2012/06/29/linagliptin-and-glimepiride-compared-in-type-two-diabetes/2012-06-29T09:39:24-04:00http://www.cardiobrief.org/2012/06/28/who-really-won-today-two-views-on-roberts-and-the-commerce-clause/2012-06-28T17:37:56-04:00http://www.cardiobrief.org/2012/07/02/severe-blood-conservation-appears-safe-in-cardiac-surgery-for-jehovahs-witnesses/2012-07-02T16:49:31-04:00http://www.cardiobrief.org/2012/07/03/many-chf-patients-not-receiving-or-getting-benefits-from-high-dose-ace-inhibitors-and-arbs/2012-07-03T14:45:11-04:00http://www.cardiobrief.org/2012/07/03/one-readers-negative-view-of-mark-midei/2012-07-03T15:30:26-04:00http://www.cardiobrief.org/2012/07/05/stem-cell-therapy-company-hypes-preliminary-results/2012-07-06T10:23:30-04:00http://www.cardiobrief.org/2012/07/06/esc-hot-line-sessions/2012-07-06T23:08:47-04:00http://www.cardiobrief.org/2012/07/09/aha-and-ada-cautiously-endorse-non-nutritive-sweeteners/2012-07-09T13:26:42-04:00http://www.cardiobrief.org/2012/07/09/coca-cola-the-olympic-torch-and-the-american-college-of-cardiology/2012-07-09T15:07:02-04:00http://www.cardiobrief.org/2012/07/10/drug-eluting-stents-often-used-in-patients-at-low-risk-of-restenosis/2012-07-10T14:37:30-04:00http://www.cardiobrief.org/2012/07/12/the-name-game-why-did-tavi-suddenly-become-tavr/2012-07-12T10:53:52-04:00http://www.cardiobrief.org/2012/07/14/ny-times-fda-officials-spied-on-its-own-scientists/2012-07-14T19:32:37-04:00http://www.cardiobrief.org/2012/07/16/new-icd-lead-technology-creates-new-set-of-problems-a-perspective-from-one-electrophysiologist/2012-07-16T09:33:10-04:00http://www.cardiobrief.org/2012/07/16/ticagrelor-joins-clopidogrel-and-prasugrel-in-updated-nstemi-guidelines/2012-07-19T10:15:39-04:00http://www.cardiobrief.org/2012/07/17/still-the-one-cleveland-clinic-retains-top-spot-on-us-news-world-report-heart-hospital-rankings/2012-07-17T15:04:49-04:00http://www.cardiobrief.org/2012/07/17/fda-approves-another-new-weight-loss-drug/2012-07-17T20:24:34-04:00http://www.cardiobrief.org/2012/07/19/guest-post-the-bmjs-amazing-shock-and-awe-assault-on-sport-drink-science/2012-07-19T22:57:28-04:00http://www.cardiobrief.org/2012/07/23/elevated-risk-of-acute-mi-following-total-hip-and-knee-replacement-surgery/2012-07-23T16:09:55-04:00http://www.cardiobrief.org/2012/07/23/st-jude-ceo-spills-the-beans-on-pfo-closure-trial/2012-07-23T18:35:26-04:00http://www.cardiobrief.org/2012/07/25/romicat-ii-provokes-divergent-views-of-ct-angiography-in-the-emergency-department/2012-07-25T16:59:32-04:00http://www.cardiobrief.org/2012/07/26/esc-position-paper-advocates-population-based-strategies-to-reduce-cardiovascular-deaths/2012-07-26T10:41:34-04:00http://www.cardiobrief.org/2012/07/26/fda-approves-vascepa-a-new-fish-oil-pill-from-amarin/2012-07-26T20:32:23-04:00http://www.cardiobrief.org/2012/07/30/authors-retract-article-about-websites-that-sell-statins-without-prescriptions/2012-07-30T10:42:56-04:00http://www.cardiobrief.org/2012/07/30/uspstf-maintains-recommendation-against-ecg-screening-of-asymptomatic-low-risk-adults/2012-07-30T17:08:01-04:00http://www.cardiobrief.org/2012/07/31/tavi-belgian-researchers-slam-evidence-base-and-overuse-in-europe/2012-07-31T21:01:19-04:00http://www.cardiobrief.org/2012/08/01/rifle-steacs-radial-access-improves-outcome-in-early-invasive-therapy/2012-08-01T15:44:24-04:00http://www.cardiobrief.org/2012/08/01/cardiologist-william-maisel-arrested-in-prostitution-sting-operation/2012-08-01T19:00:42-04:00http://www.cardiobrief.org/2012/08/03/industry-pr-efforts-influence-debate-on-cholesterol-screening-guidelines-for-children/2012-08-03T15:07:57-04:00http://www.cardiobrief.org/2012/08/02/guest-post-an-electrophysiologist-looks-at-the-new-hrsaccf-pacemaker-guidelines/2012-08-02T16:59:41-04:00http://www.cardiobrief.org/2012/08/03/guest-post-universal-screening-for-dyslipidemia-in-children-a-debate-with-equipoise-but-tarnished-by-industry-influence/2012-08-03T23:57:47-04:00http://www.cardiobrief.org/2012/08/06/doj-investigating-interventional-cardiology-services-at-hca/2012-08-06T14:01:30-04:00http://www.cardiobrief.org/2012/08/06/hydrochlorothiazide-and-nifedipine-linked-to-increased-incidence-of-lip-cancer/2012-08-06T16:48:50-04:00http://www.cardiobrief.org/2012/08/07/guest-post-feds-turn-corner-in-icd-investigation-hospital-liability-divided-into-categories/2012-08-07T07:23:49-04:00http://www.cardiobrief.org/2012/08/06/ny-times-hca-concealed-significant-problems-at-lucrative-cardiac-centers/2012-08-06T23:15:25-04:00http://www.cardiobrief.org/2012/08/10/why-hca-is-like-barclays-and-jp-morgan/2012-08-10T13:07:37-04:00http://www.cardiobrief.org/2012/08/07/survey-finds-significant-drop-in-cholesterol-levels-in-youths/2012-08-07T17:33:14-04:00http://www.cardiobrief.org/2012/08/08/risks-and-benefits-of-pediatric-vad-explored/2012-08-08T16:38:06-04:00http://www.cardiobrief.org/2012/08/09/reports-from-jupiter-and-taiwan-benefits-of-statins-outweigh-risk-of-diabetes/2012-08-09T18:47:25-04:00http://www.cardiobrief.org/2012/08/10/guest-post-is-it-the-right-time-to-introduce-real-supervision-into-medical-practice/2012-08-10T14:24:20-04:00http://www.cardiobrief.org/2012/08/13/troponin-test-may-allow-rapid-mi-rule-out-in-the-emergency-department/2012-08-13T19:12:38-04:00http://www.cardiobrief.org/2012/08/15/guest-post-children-should-have-their-cholesterol-checked/2012-08-14T20:57:18-04:00http://www.cardiobrief.org/2012/08/15/observational-study-fills-gaps-in-understanding-af-patients-with-kidney-disease/2012-08-15T17:10:33-04:00http://www.cardiobrief.org/2012/08/16/guest-post-fda-calls-for-x-ray-screening-of-riata-leads-and-additional-followup-studies/2012-08-17T12:24:27-04:00http://www.cardiobrief.org/2012/08/17/guest-post-why-is-the-national-library-of-medicine-still-indexing-reviews-in-cardiovascular-medicine/2012-08-16T22:51:16-04:00http://www.cardiobrief.org/2012/08/17/guest-post-fda-clarifies-riata-imaging-recommendations/2012-08-17T12:18:37-04:00http://www.cardiobrief.org/2012/08/20/tnf-inhibitors-linked-to-reduction-in-mi-in-psoriasis-patients/2012-08-20T18:55:20-04:00http://www.cardiobrief.org/2012/08/21/cardiovascular-risk-prediction-two-more-studies-little-progress/2012-08-21T17:00:42-04:00http://www.cardiobrief.org/2012/08/21/guest-post-new-questions-raised-about-latest-generation-st-jude-icd-leads/2012-08-21T21:44:21-04:00http://www.cardiobrief.org/2012/08/22/nhlbi-announces-7000-patient-trial-testing-inflammation-hypothesis/2012-08-22T13:36:43-04:00http://www.cardiobrief.org/2012/08/26/trilogy-at-esc-no-advantage-for-prasugrel-over-clopidogrel-in-medical-acs-patients/2012-08-26T04:43:45-04:00http://www.cardiobrief.org/2012/08/28/fame-2-can-ffr-save-pci-from-medical-therapy/2012-08-28T05:53:04-04:00http://www.cardiobrief.org/2012/08/25/greetings-from-esc-2012-in-munich/2012-08-25T04:18:07-04:00http://www.cardiobrief.org/2012/08/25/new-universal-definition-of-mi-unveiled-at-esc-2012/2012-08-25T05:07:08-04:00http://www.cardiobrief.org/2012/08/27/esc-trial-finds-no-benefit-for-intraaortic-balloon-counterpulsation-in-cardiogenic-shock/2012-09-03T15:37:34-04:00http://www.cardiobrief.org/2012/08/26/first-detailed-look-at-why-aliskiren-failed-in-altitude/2012-08-26T06:51:20-04:00http://www.cardiobrief.org/2012/08/27/the-return-of-vorapaxar-this-time-for-post-mi-patients/2012-08-27T06:03:36-04:00http://www.cardiobrief.org/2012/08/28/woest-get-rid-of-the-aspirin-in-triple-therapy/2012-08-28T06:54:21-04:00http://www.cardiobrief.org/2012/08/29/pilot-study-demonstrates-feasibility-of-mri-guided-catheterization/2012-08-29T10:02:25-04:00http://www.cardiobrief.org/2012/08/30/icd-investigation-doj-sends-resolution-model-to-hospitals/2012-08-30T19:56:05-04:00http://www.cardiobrief.org/2012/09/04/esc-trials-the-best-and-the-worst/2012-09-03T22:32:42-04:00http://www.cardiobrief.org/2012/09/04/danish-survey-finds-clopidogrel-less-effective-in-diabetics/2012-09-04T16:31:11-04:00http://www.cardiobrief.org/2012/09/04/cdc-35-million-americans-have-uncontrolled-hypertension/2012-09-04T13:22:26-04:00http://www.cardiobrief.org/2012/09/05/unrecognized-mi-more-prevalent-and-dangerous-than-previously-suspected/2012-09-05T16:44:03-04:00http://www.cardiobrief.org/2012/09/06/plagiarism-of-hypertension-article-in-korean-journal-results-in-retraction/2012-09-06T10:16:02-04:00http://www.cardiobrief.org/2012/09/14/news-flash-company-issues-incredibly-boring-press-release/2015-09-15T19:11:26-04:00http://www.cardiobrief.org/2012/09/07/news-briefs-cholesterol-trends-aha-late-breakers-fda-updates-on-rivaroxaban-and-heartware-hvad/2012-09-07T12:56:30-04:00http://www.cardiobrief.org/2012/09/10/new-concerns-over-pregnant-women-taking-antihypertensives/2012-09-10T16:59:24-04:00http://www.cardiobrief.org/2012/09/11/updated-rhythm-device-guidelines-clarify-and-expand-crt-criteria/2012-09-11T10:55:56-04:00http://www.cardiobrief.org/2012/09/11/more-evidence-that-omega-3-supplements-dont-work/2012-09-11T16:01:47-04:00http://www.cardiobrief.org/2012/09/12/study-predicts-renal-denervation-will-be-cost-effective-in-resistant-hypertension/2012-09-12T15:35:17-04:00http://www.cardiobrief.org/2012/09/12/a-manhattan-project-to-end-the-obesity-epidemic/2012-09-12T17:28:52-04:00http://www.cardiobrief.org/2012/09/13/meta-analysis-links-stress-at-work-and-heart-disease/2012-09-13T20:43:31-04:00http://www.cardiobrief.org/2012/09/17/international-cardiology-groups-push-for-aggressive-public-health-goals/2012-09-17T18:01:00-04:00http://www.cardiobrief.org/2012/09/18/screening-for-aaa-comes-under-renewed-scrutiny-and-criticism/2012-09-18T13:29:29-04:00http://www.cardiobrief.org/2012/09/19/studies-examine-less-burdensome-dual-antiplatelet-regimens/2012-09-19T16:14:55-04:00http://www.cardiobrief.org/2012/09/21/apixaban-eliquis-for-atrial-fibrillation-gets-positive-european-recommendation/2012-09-21T11:08:14-04:00http://www.cardiobrief.org/2012/09/25/aha-urges-more-education-and-support-for-icd-patients/2012-09-25T14:31:56-04:00http://www.cardiobrief.org/2012/09/24/dramatic-increase-in-bleeding-accompanies-addition-of-oral-anticoagulant-therapy-in-acs/2012-09-24T16:33:54-04:00http://www.cardiobrief.org/2012/09/25/another-one-bites-the-dust-generic-valsartan-hits-the-streets/2012-09-25T13:03:05-04:00http://www.cardiobrief.org/2012/09/24/novartis-announces-top-line-results-for-phase-3-trial-of-new-acute-heart-failure-drug/2012-09-24T16:26:05-04:00http://www.cardiobrief.org/2012/09/26/merck-returns-to-cardiome-all-rights-to-atrial-fibrillation-drug-vernakalant/2012-09-26T15:24:44-04:00http://www.cardiobrief.org/2012/09/27/fda-sets-new-decision-date-for-eliquis-aprixaban/2012-09-27T15:30:56-04:00http://www.cardiobrief.org/2012/09/28/subcutaneous-icd-gains-fda-approval/2012-09-28T19:08:54-04:00http://www.cardiobrief.org/2012/09/30/walking-with-the-american-heart-association-valerie-bertinelli-and-chester-cheetah/2015-09-15T19:10:44-04:00http://www.cardiobrief.org/2012/10/02/registry-study-raises-questions-about-cardioprotective-effect-of-beta-blockers/2012-10-02T16:02:07-04:00http://www.cardiobrief.org/2012/10/03/what-is-the-benefit-of-adding-crp-to-risk-factor-assessment/2012-10-03T16:58:37-04:00http://www.cardiobrief.org/2012/10/04/uk-study-casts-doubts-on-value-of-type-2-diabetes-screening/2012-10-04T16:07:36-04:00http://www.cardiobrief.org/2012/10/09/erasmus-medical-center-releases-final-report-on-cardiovascular-research-scandal/2012-10-09T10:26:44-04:00http://www.cardiobrief.org/2012/10/08/observational-study-links-common-household-chemical-to-cardiovascular-disease/2012-10-08T12:09:52-04:00http://www.cardiobrief.org/2012/10/09/pci-utilization-lower-in-states-with-public-reporting-of-outcomes/2012-10-09T20:12:27-04:00http://www.cardiobrief.org/2012/10/10/danish-study-gives-a-boost-to-hormone-replacement-therapy-timing-hypothesis/2012-10-10T14:07:14-04:00http://www.cardiobrief.org/2012/10/10/chocolate-and-nobel-prizes-go-together/2012-10-10T17:01:47-04:00http://www.cardiobrief.org/2012/10/15/don-poldermans-and-the-dutch-research-scandal/2015-09-15T19:12:29-04:00http://www.cardiobrief.org/2012/10/12/free-cardiac-and-spine-surgery-for-walmart-employees-at-six-hospitals/2012-10-12T15:31:19-04:00http://www.cardiobrief.org/2012/10/15/fda-reviewers-raise-no-new-red-flags-over-lomitapide/2012-10-15T13:05:09-04:00http://www.cardiobrief.org/2012/10/15/fda-warns-about-fungal-meningitis-in-transplant-patients-who-received-necc-cardioplegia-solution/2012-10-16T11:08:05-04:00http://www.cardiobrief.org/2012/10/16/fda-review-raises-safety-concerns-about-mipomersen/2012-10-16T12:25:08-04:00http://www.cardiobrief.org/2012/10/17/fda-reviewers-recommend-approval-for-lomitapide-for-homozygous-familial-hypercholesterolemia/2012-10-17T16:28:27-04:00http://www.cardiobrief.org/2012/10/18/fda-panel-recommends-approval-of-mipomersen-for-familial-hypercholesterolemia/2012-10-18T15:46:04-04:00http://www.cardiobrief.org/2012/10/19/nih-trial-of-lifestyle-intervention-for-type-2-diabetes-stopped-for-futility-after-11-years/2012-10-19T16:09:41-04:00http://www.cardiobrief.org/2012/10/19/fda-approves-the-sapien-transcatheter-heart-valve-for-high-risk-patients/2012-10-19T15:49:20-04:00http://www.cardiobrief.org/2012/10/22/high-rate-of-warfarin-discontinuation-observed-in-study/2012-10-23T10:40:18-04:00http://www.cardiobrief.org/2012/10/22/jeffrey-moses-accused-of-cocaine-use-and-domestic-violence/2012-12-21T22:37:51-05:00http://www.cardiobrief.org/2012/10/23/setback-for-trial-studying-dabigatran-after-mechanical-valve-surgery/2012-10-23T22:39:24-04:00http://www.cardiobrief.org/2012/10/24/atrial-fibrillation-radiofrequency-catheter-ablation-and-antiarrhythmic-drug-therapy-compared/2012-10-24T17:12:27-04:00http://www.cardiobrief.org/2012/10/24/tct-impressive-survival-benefit-for-tavr-in-inoperable-patients-at-3-years/2012-10-24T15:08:19-04:00http://www.cardiobrief.org/2012/10/25/tct-two-pfo-closure-trials-miss-primary-endpoints/2012-10-25T15:39:11-04:00http://www.cardiobrief.org/2012/10/26/research-and-denial-at-st-jude-medical/2012-10-26T14:50:44-04:00http://www.cardiobrief.org/2012/10/29/l-a-confidential-preview-of-aha-scientific-sessions-2012/2012-10-29T12:47:45-04:00http://www.cardiobrief.org/2012/10/29/the-research-agrees-smoking-is-really-bad-for-you/2012-10-29T16:26:45-04:00http://www.cardiobrief.org/2012/10/31/pcsk9-inhibitor-enhances-cholesterol-lowering-effect-of-atorvastatin/2012-10-31T17:00:53-04:00http://www.cardiobrief.org/2012/11/01/doj-investigating-abiomed-for-improper-marketing-of-impella-2-5/2012-11-01T13:22:35-04:00http://www.cardiobrief.org/2012/11/03/altitude-autopsy-shows-what-went-wrong-with-aliskiren/2012-11-03T18:44:53-04:00http://www.cardiobrief.org/2012/11/04/aspire-aspirin-an-attractive-alternative-after-first-vte/2012-11-04T19:08:04-05:00http://www.cardiobrief.org/2012/11/02/fda-investigation-finds-no-excess-bleeding-risk-for-dabigatran/2012-11-02T13:15:13-04:00http://www.cardiobrief.org/2012/11/02/rivaroxaban-gains-fda-indications-for-the-treatment-and-prevention-of-dvt-and-pe/2012-11-02T17:29:57-04:00http://www.cardiobrief.org/2012/11/04/freedom-lends-strong-support-to-cabg-for-diabetics-with-multivessel-disease/2012-11-04T18:42:38-05:00http://www.cardiobrief.org/2012/11/04/arctic-blows-a-cold-wind-on-platelet-function-tests/2012-11-04T19:09:32-05:00http://www.cardiobrief.org/2012/11/03/aha-2012-welcome-to-la/2012-11-03T16:40:43-04:00http://www.cardiobrief.org/2012/11/04/nih-trial-gives-surprising-boost-to-chelation-therapy/2012-11-04T19:36:31-05:00http://www.cardiobrief.org/2012/11/05/dalcetrapib-another-hdl-raising-cetp-inhibitor-bites-the-dust/2012-11-05T15:48:30-05:00http://www.cardiobrief.org/2012/11/05/early-look-new-methods-to-enhance-cholesterol-efflux/2012-11-05T20:15:17-05:00http://www.cardiobrief.org/2012/11/06/relax-ahf-stirs-interest-in-novel-drug-for-acute-heart-failure/2013-03-06T14:40:38-05:00http://www.cardiobrief.org/2012/11/06/ultrafiltration-fails-to-show-benefit-in-acute-heart-failure/2012-11-06T20:13:33-05:00http://www.cardiobrief.org/2012/11/06/block-hf-a-game-changer-for-cardiac-pacing/2012-11-06T19:07:30-05:00http://www.cardiobrief.org/2012/11/07/statins-use-linked-to-reduction-in-cancer-mortality/2012-11-07T17:00:06-05:00http://www.cardiobrief.org/2012/11/11/nine-italian-cardiologists-arrested-in-broad-investigation-of-research-fraud-and-misconduct/2012-11-11T19:57:56-05:00http://www.cardiobrief.org/2012/11/12/nonfasting-lipid-testing-gains-growing-acceptance/2012-11-12T16:05:58-05:00http://www.cardiobrief.org/2012/11/13/expert-consensus-document-offers-advice-on-troponin-tests/2012-11-13T12:00:08-05:00http://www.cardiobrief.org/2012/11/13/mysterious-disappearing-paper-finally-reappears-in-another-journal/2015-09-15T19:16:10-04:00http://www.cardiobrief.org/2012/11/15/fda-approves-zilver-ptx-drug-eluting-stent-for-peripheral-arterial-disease/2012-11-15T15:59:47-05:00http://www.cardiobrief.org/2012/11/19/comprehensive-guidelines-for-stable-ischemic-heart-disease-released/2012-11-19T17:25:59-05:00http://www.cardiobrief.org/2012/11/27/the-doctor-at-the-center-of-the-insider-trading-scandal/2012-11-27T09:00:30-05:00http://www.cardiobrief.org/2012/11/20/heartware-lvad-approved-by-fda-for-transplant-patients/2012-11-20T23:53:27-05:00http://www.cardiobrief.org/2012/11/21/whats-the-best-treatment-for-abdominal-aortic-aneurysm/2012-11-21T17:00:24-05:00http://www.cardiobrief.org/2012/11/20/investigator-defends-controversial-transcendental-meditation-paper/2012-11-20T16:42:52-05:00http://www.cardiobrief.org/2012/11/23/from-barack-to-rupert-a-thanksgiving-message/2012-11-23T14:15:54-05:00http://www.cardiobrief.org/2012/11/25/yet-another-look-at-the-transcendental-meditation-paper/2015-09-15T19:18:43-04:00http://www.cardiobrief.org/2012/11/26/model-finds-high-cost-for-ecg-screening-of-athletes/2012-11-26T15:42:24-05:00http://www.cardiobrief.org/2012/11/27/longer-warfarin-therapy-after-bioprosthetic-aortic-valve-replacement-may-be-beneficial/2012-11-27T16:04:43-05:00http://www.cardiobrief.org/2012/11/27/statins-and-exercise-independently-beneficial-even-better-in-combination/2012-11-28T21:41:00-05:00http://www.cardiobrief.org/2012/11/30/the-dangers-of-going-too-fast/2012-11-30T10:00:35-05:00http://www.cardiobrief.org/2012/11/29/following-earlier-recall-ranbaxy-halts-manufacturing-atorvastatin/2012-11-29T11:04:37-05:00http://www.cardiobrief.org/2012/12/03/exercise-and-the-limitations-of-observational-studies/2015-09-15T19:16:23-04:00http://www.cardiobrief.org/2012/12/03/scientific-statement-examines-role-of-social-media-in-fighting-childhood-obesity/2012-12-03T16:20:09-05:00http://www.cardiobrief.org/2012/12/05/study-suggests-aspirin-resistance-may-be-pseudoresistance/2012-12-05T15:03:35-05:00http://www.cardiobrief.org/2012/12/06/should-body-weight-influence-choice-of-antihypertensive-therapy/2012-12-06T16:00:55-05:00http://www.cardiobrief.org/2012/12/08/prolonged-anticoagulation-with-apixaban-found-beneficial-in-venous-thromboembolism/2012-12-08T14:07:43-05:00http://www.cardiobrief.org/2012/12/11/no-surprise-smoking-and-sudden-cardiac-death-closely-tied/2012-12-11T16:46:43-05:00http://www.cardiobrief.org/2012/12/12/state-of-the-heart-aha-publishes-year-end-statistical-update/2012-12-12T16:17:22-05:00http://www.cardiobrief.org/2012/12/12/boehringer-ends-phase-2-trial-of-dabigatran-in-mechanical-valve-patients/2012-12-12T14:06:22-05:00http://www.cardiobrief.org/2012/12/12/fda-safety-review-finds-small-nonsignificant-increased-risk-with-chantix-varenicline/2012-12-12T16:53:31-05:00http://www.cardiobrief.org/2012/12/13/hypertension-and-smoking-top-list-of-global-risk-factors/2012-12-13T14:59:51-05:00http://www.cardiobrief.org/2012/12/14/chmp-recommends-against-approval-for-mipomersen-in-europe/2012-12-14T16:23:03-05:00http://www.cardiobrief.org/2012/12/24/2012-in-review-a-bad-year-for-conventional-wisdom/2012-12-25T15:20:19-05:00http://www.cardiobrief.org/2012/12/17/american-heart-association-lists-top-10-research-advances/2012-12-17T11:08:08-05:00http://www.cardiobrief.org/2012/12/17/new-guidelines-define-state-of-the-art-stemi-care/2012-12-17T15:20:29-05:00http://www.cardiobrief.org/2012/12/17/jacc-issues-notice-of-concern-over-three-poldermans-papers/2012-12-17T23:10:08-05:00http://www.cardiobrief.org/2012/12/18/promising-one-year-results-for-renal-denervation-in-resistant-hypertension-spark-hype/2012-12-18T16:13:57-05:00http://www.cardiobrief.org/2012/12/18/amgen-pleads-guilty-to-misbranding-anemia-drug-aranesp/2012-12-18T14:36:48-05:00http://www.cardiobrief.org/2012/12/18/pradaxa-to-be-contraindicated-in-patients-with-mechanical-heart-valves/2012-12-18T22:23:09-05:00http://www.cardiobrief.org/2012/12/20/hps2-thrive-no-benefit-signal-of-harm-for-niacin-therapy/2012-12-21T00:04:18-05:00http://www.cardiobrief.org/2012/12/25/autopsy-studies-find-large-and-dramatic-drop-in-early-atherosclerosis-over-60-years/2012-12-25T16:00:21-05:00http://www.cardiobrief.org/2012/12/21/new-york-post-disavows-portions-of-article-about-jeffrey-moses/2012-12-21T22:24:03-05:00http://www.cardiobrief.org/2012/12/23/2012-in-review-social-media-in-cardiology/2012-12-23T17:10:49-05:00http://www.cardiobrief.org/2012/12/24/fda-approves-lomitapide-for-homozygous-familial-hypercholesterolemia/2012-12-24T09:54:42-05:00http://www.cardiobrief.org/2012/12/28/fda-approves-eliquis-apixaban-for-stroke-prevention-in-af/2012-12-28T21:17:06-05:00http://www.cardiobrief.org/2013/01/02/missouri-board-issues-emergency-suspension-of-cardiologist-accused-of-implanting-unnecessary-stents/2013-01-01T22:24:36-05:00http://www.cardiobrief.org/2013/01/02/cabg-highly-cost-effective-in-diabetics-with-multivessel-disease/2013-01-02T15:47:35-05:00http://www.cardiobrief.org/2013/01/03/mercks-combination-of-ezetimibe-and-atorvastatin-combo-back-on-nda-path/2013-01-03T10:36:17-05:00http://www.cardiobrief.org/2013/01/04/a-time-for-change-a-letter-to-readers/2013-01-04T16:02:35-05:00http://www.cardiobrief.org/2013/01/04/whats-next-for-the-iphone-ecg-following-regulatory-clearance/2013-01-04T16:30:20-05:00http://www.cardiobrief.org/2013/01/04/ohio-hospital-and-cardiology-group-pay-4-4-million-to-settle-charges-over-unnecessary-pcis/2013-01-04T23:12:58-05:00http://www.cardiobrief.org/2013/01/07/timing-of-heart-attacks-shifted-in-new-orleans-after-katrina/2013-01-07T13:29:12-05:00http://www.cardiobrief.org/2013/01/07/richard-lehman-on-icds-in-clinical-practice-and-serelaxin-for-hf/2013-08-06T14:36:18-04:00http://www.cardiobrief.org/2013/01/08/two-retractions-for-embattled-chief-investigator-of-kyoto-heart-study/2013-01-08T11:57:39-05:00http://www.cardiobrief.org/2013/01/09/observation-units-for-heart-failure-could-reduce-unnecessary-hospitalizations/2013-01-09T13:42:28-05:00http://www.cardiobrief.org/2013/01/08/are-cardiologists-worried-about-being-accused-of-unnecessary-pci/2013-09-08T23:32:05-04:00http://www.cardiobrief.org/2013/01/08/early-results-antiplatelet-drug-cangrelor-appears-effective-for-pci/2013-09-08T23:31:10-04:00http://www.cardiobrief.org/2013/01/09/should-niacin-still-be-prescribed-william-boden-versus-harlan-krumholz/2013-09-05T14:44:06-04:00http://www.cardiobrief.org/2013/01/10/acute-kidney-injury-associated-with-dual-antihypertensive-therapy-and-nsaids/2013-01-10T16:21:20-05:00http://www.cardiobrief.org/2013/01/11/merck-starts-to-suspend-worldwide-availability-of-tredaptive/2013-09-05T14:42:29-04:00http://www.cardiobrief.org/2013/01/17/becoming-your-own-doctor-in-the-brave-new-world-of-personalized-medicine/2015-04-02T17:17:28-04:00http://www.cardiobrief.org/2013/01/14/atrial-fibrillation-linked-to-increased-risk-for-sudden-cardiac-death/2013-01-14T15:30:44-05:00http://www.cardiobrief.org/2013/01/15/large-meta-analysis-finds-no-harm-associated-with-eggs/2013-01-15T12:48:06-05:00http://www.cardiobrief.org/2013/01/14/uk-politician-urges-more-use-of-ticagrelor-to-preserve-astrazeneca-jobs-in-uk/2013-01-14T18:31:47-05:00http://www.cardiobrief.org/2013/01/16/fda-releases-st-jude-warning-letter/2013-08-06T14:31:22-04:00http://www.cardiobrief.org/2013/01/16/amgen-trial-fails-to-show-benefit-of-anemia-drug-in-heart-failure-patients/2013-01-16T17:48:25-05:00http://www.cardiobrief.org/2013/01/17/two-experts-help-sort-out-the-new-generation-of-anticoagulants/2013-08-06T14:30:24-04:00http://www.cardiobrief.org/2013/01/25/the-best-doctor-blog-on-the-internet/2015-09-15T19:25:45-04:00http://www.cardiobrief.org/2013/01/22/trials-of-niacin-and-atrial-fibrillation-device-will-headline-american-college-of-cardiology-program/2013-01-22T13:05:56-05:00http://www.cardiobrief.org/2013/01/22/renal-denervation-delineating-its-uses-misuses-and-possibilities/2013-01-22T15:48:35-05:00http://www.cardiobrief.org/2013/01/25/the-big-gamble-of-cetp-inhibitors/2013-01-25T11:00:16-05:00http://www.cardiobrief.org/2013/01/28/study-warns-against-dual-blockade-of-renin-angiotensin-system-in-heart-failure-and-hypertension/2013-01-28T12:23:05-05:00http://www.cardiobrief.org/2013/01/28/esc-gives-a-shot-in-the-arm-to-radial-access-for-pci-procedures-the-new-default/2013-01-28T18:19:15-05:00http://www.cardiobrief.org/2013/01/29/popular-antidepressants-may-put-patients-at-risk-for-serious-arrhythmias/2013-01-29T15:37:30-05:00http://www.cardiobrief.org/2013/01/29/fda-approves-mipomersen-for-homozygous-familial-hypercholesterolemia/2013-01-29T19:09:47-05:00http://www.cardiobrief.org/2013/01/30/small-study-suggests-yoga-may-benefit-af-patients/2013-01-30T16:00:04-05:00http://www.cardiobrief.org/2013/01/31/whistleblower-lawsuit-yields-2-4-million-for-new-jersey-cardiologist/2013-01-31T15:52:41-05:00http://www.cardiobrief.org/2013/02/01/no-sunshine-for-continuing-medical-education/2013-02-01T18:10:43-05:00http://www.cardiobrief.org/2013/02/02/european-heart-journal-retracts-main-paper-of-the-kyoto-heart-study/2013-02-02T11:58:54-05:00http://www.cardiobrief.org/2013/02/03/should-physicians-be-business-partners-with-medical-device-salesmen/2013-02-03T14:36:38-05:00http://www.cardiobrief.org/2013/02/05/walking-improves-with-ace-inhibitor-in-people-with-peripheral-artery-disease/2013-02-05T16:05:27-05:00http://www.cardiobrief.org/2013/02/05/back-to-the-future-resurrected-data-from-1960s-trial-might-impact-contemporary-dietary-fat-debate/2013-02-06T17:35:33-05:00http://www.cardiobrief.org/2013/02/06/large-study-finds-genetic-links-to-aortic-valve-calcification/2013-02-06T17:12:41-05:00http://www.cardiobrief.org/2013/02/07/rivaroxaban-effective-in-medically-ill-patients-but-at-high-bleeding-cost/2013-02-07T16:20:05-05:00http://www.cardiobrief.org/2013/02/07/should-radial-artery-access-be-the-default-choice-for-pci/2013-02-07T10:54:26-05:00http://www.cardiobrief.org/2013/02/11/seeking-cardiovascular-safety-data-fda-blocks-approval-of-novo-nordisks-long-acting-insulin/2013-02-11T01:12:43-05:00http://www.cardiobrief.org/2013/02/12/acc-and-sts-break-new-ground-to-test-tavr-for-unapproved-uses/2013-02-12T10:34:26-05:00http://www.cardiobrief.org/2013/02/12/somebody-has-finally-twigged-that-the-heart-and-the-lungs-are-joined-up-to-each-other-and-live-in-this-space-called-the-chest/2013-02-12T14:47:33-05:00http://www.cardiobrief.org/2013/02/13/bias-in-choosing-the-question-is-a-much-bigger-issue-than-lying-about-the-data/2013-02-12T15:49:09-05:00http://www.cardiobrief.org/2013/02/13/fda-approves-second-generation-mri-friendly-pacemaker-system/2013-02-13T16:15:24-05:00http://www.cardiobrief.org/2013/02/15/amid-rising-tide-of-diabetes-more-patients-reach-treatment-goals/2013-02-15T16:25:31-05:00http://www.cardiobrief.org/2013/02/15/st-jude-raises-the-stakes-in-renal-denervation-with-an-outcomes-study/2013-02-15T18:37:39-05:00http://www.cardiobrief.org/2013/02/17/400-patients-sue-kentucky-hospital-and-11-cardiologists-over-unnecessary-procedures/2013-02-17T17:10:52-05:00http://www.cardiobrief.org/2013/02/20/new-studies-examine-prolonged-anticoagulation-for-vte-recurrence/2013-02-20T14:07:41-05:00http://www.cardiobrief.org/2013/02/20/small-study-explores-expanded-use-for-tavi-in-native-valve-aortic-regurgitation/2013-02-20T15:37:53-05:00http://www.cardiobrief.org/2013/02/21/study-casts-doubt-on-value-of-genetic-testing-for-familial-hypercholesterolemia/2013-02-21T18:34:09-05:00http://www.cardiobrief.org/2013/02/22/are-most-people-with-complex-coronary-disease-getting-the-best-treatment/2013-02-22T16:44:27-05:00http://www.cardiobrief.org/2013/02/25/large-trial-shows-cardiovascular-benefits-of-mediterranean-diet/2013-02-25T09:56:37-05:00http://www.cardiobrief.org/2013/02/25/the-mediterranean-diet-the-new-gold-standard/2013-02-25T17:43:04-05:00http://www.cardiobrief.org/2013/02/26/mixed-results-for-spironolactone-in-heart-failure-with-preserved-ejection-fraction/2013-02-26T16:39:22-05:00http://www.cardiobrief.org/2013/02/27/hps2-thrive-coming-attraction-first-look-at-what-went-wrong-with-niacin/2013-02-27T00:40:15-05:00http://www.cardiobrief.org/2013/02/28/fda-issues-warning-letter-to-corevalve-investigator/2013-02-28T15:01:01-05:00http://www.cardiobrief.org/2013/03/01/three-experts-weigh-in-on-the-mediterranean-diet/2013-03-01T10:08:58-05:00http://www.cardiobrief.org/2013/03/01/bad-pharma-and-the-statin-wars/2013-03-01T18:13:04-05:00http://www.cardiobrief.org/2013/03/04/veterans-study-finds-hiv-to-be-an-independent-risk-factor-for-mi/2013-03-04T16:38:13-05:00http://www.cardiobrief.org/2013/03/04/fda-again-rejects-acs-indication-for-rivaroxaban-xarelto/2013-03-04T19:49:20-05:00http://www.cardiobrief.org/2013/03/05/late-breaking-news-confusion-over-acc-late-breaker-trial/2013-03-05T11:25:50-05:00http://www.cardiobrief.org/2013/03/10/fibrinolysis-may-benefit-late-arriving-stemi-patients/2013-03-10T14:26:57-04:00http://www.cardiobrief.org/2013/03/10/another-negative-trial-with-darbepoetin-alfa/2013-03-10T20:01:30-04:00http://www.cardiobrief.org/2013/03/11/two-trials-explore-on-pump-versus-off-pump-bypass-surgery/2013-03-11T13:34:35-04:00http://www.cardiobrief.org/2013/03/07/hospitals-seeing-rapidly-growing-numbers-of-adults-with-congenital-heart-disease/2013-03-07T15:25:05-05:00http://www.cardiobrief.org/2013/03/06/acc-prevails-upon-boston-scientific-to-present-more-data-at-late-breaker/2013-03-06T17:20:57-05:00http://www.cardiobrief.org/2013/03/09/hps2-thrive-a-disappointing-but-clear-result/2013-03-09T14:21:39-05:00http://www.cardiobrief.org/2013/03/10/cangrelor-during-pci-may-reduce-ischemic-events/2013-03-10T12:40:24-04:00http://www.cardiobrief.org/2013/03/09/following-an-embargo-break-prevail-trial-wont-be-presented-at-acc/2013-03-09T14:24:01-05:00http://www.cardiobrief.org/2013/03/10/eplerenone-may-help-prevent-heart-failure-in-acute-stemi-patients/2013-03-11T01:36:55-04:00http://www.cardiobrief.org/2013/03/10/was-atherosclerosis-the-real-curse-of-the-mummy/2013-03-10T17:13:15-04:00http://www.cardiobrief.org/2013/03/13/radiotherapy-for-breast-cancer-increases-heart-disease-risk/2013-03-13T13:59:01-04:00http://www.cardiobrief.org/2013/03/13/fda-officials-calm-concerns-over-excessive-bleeding-with-dabigatran/2013-03-13T17:15:19-04:00http://www.cardiobrief.org/2013/03/17/the-prevail-fail-revisited-spinning-the-truth/2015-09-15T19:26:56-04:00http://www.cardiobrief.org/2013/03/18/vena-cava-filters-little-evidence-and-wide-variation-in-use/2013-03-18T17:17:57-04:00http://www.cardiobrief.org/2013/03/19/high-potency-statins-linked-to-increased-risk-for-acute-kidney-injury/2013-03-20T19:48:23-04:00http://www.cardiobrief.org/2013/03/20/controversial-pfo-closure-trials-published-in-nejm/2013-03-20T17:05:38-04:00http://www.cardiobrief.org/2013/03/20/fda-panel-gives-tepid-endorsement-to-abbotts-mitraclip/2013-03-20T23:02:09-04:00http://www.cardiobrief.org/2013/03/24/embers-of-poldermans-case-still-smoldering/2013-03-24T18:53:30-04:00http://www.cardiobrief.org/2013/03/22/chmp-and-fda-diverge-on-mipomersen-and-rivaroxaban/2013-03-22T10:54:31-04:00http://www.cardiobrief.org/2013/03/22/fda-proposes-higher-regulatory-scrutiny-for-automatic-external-defibrillators/2013-03-22T16:21:54-04:00http://www.cardiobrief.org/2013/03/25/emerging-biomarkers-how-reliable-is-the-evidence/2013-03-25T16:03:04-04:00http://www.cardiobrief.org/2013/03/25/once-again-fda-rejects-oral-treprostinil-for-pulmonary-arterial-hypertension/2013-03-25T16:36:00-04:00http://www.cardiobrief.org/2013/03/26/controversial-nih-chelation-trial-published-in-jama/2013-03-26T16:35:42-04:00http://www.cardiobrief.org/2013/03/27/guest-post-case-report-of-durata-lead-failure-raises-fresh-concerns/2013-03-27T11:07:07-04:00http://www.cardiobrief.org/2013/03/27/79-year-old-cardiologist-sentenced-to-6-years-in-prison-for-fen-phen-fraud/2013-03-27T12:27:57-04:00http://www.cardiobrief.org/2013/04/04/registry-study-offers-reassurance-about-safety-and-efficacy-of-dabigatran/2013-04-04T10:46:56-04:00http://www.cardiobrief.org/2013/04/02/a-guide-to-the-raging-debate-over-the-nihs-tact-chelation-trial/2013-04-02T13:59:09-04:00http://www.cardiobrief.org/2013/03/29/fda-approves-first-sglt2-inhibitor-for-diabetes/2013-03-29T15:23:58-04:00http://www.cardiobrief.org/2013/04/02/lifelong-statin-sentence-now-includes-furloughs/2013-04-02T16:20:04-04:00http://www.cardiobrief.org/2013/04/09/quinidine-unavailable-in-most-of-the-world/2013-04-09T15:45:27-04:00http://www.cardiobrief.org/2013/04/07/researchers-find-new-pathway-linking-heart-disease-to-carnitine/2013-04-12T09:56:24-04:00http://www.cardiobrief.org/2013/04/08/scientific-misconduct-from-darwin-and-mendel-to-poldermans-and-matsubara/2013-04-08T16:47:37-04:00http://www.cardiobrief.org/2013/04/10/a-closer-look-at-a-case-of-duplicate-publication-in-jacc/2013-04-10T13:54:50-04:00http://www.cardiobrief.org/2013/04/10/cuban-history-offers-important-lessons-for-global-health-today/2013-04-10T16:59:21-04:00http://www.cardiobrief.org/2013/04/11/new-york-area-cardiologist-admits-19-million-fraud/2013-04-11T10:33:11-04:00http://www.cardiobrief.org/2013/04/12/is-red-meat-a-fish-story-why-you-should-never-believe-health-headlines/2013-04-12T15:58:22-04:00http://www.cardiobrief.org/2013/04/12/fda-schedules-another-2-day-avandia-advisory-panel/2013-04-12T17:56:45-04:00http://www.cardiobrief.org/2013/04/13/more-reasons-why-health-hype-stories-are-bad/2013-04-13T14:16:35-04:00http://www.cardiobrief.org/2013/04/16/blood-sample-mismatch-leads-anguished-authors-to-retract-three-lipitor-papers/2013-04-16T13:01:14-04:00http://www.cardiobrief.org/2013/04/17/advice-for-physicians-how-to-behave-online/2013-04-17T17:42:20-04:00http://www.cardiobrief.org/2013/04/22/the-fda-surrogate-endpoints-and-blood-pressure-drugs/2015-09-15T19:30:09-04:00http://www.cardiobrief.org/2013/04/22/actelion-executive-to-head-american-college-of-cardiology/2013-04-22T13:05:44-04:00http://www.cardiobrief.org/2013/04/23/study-suggests-benefit-for-beta-blockers-during-noncardiac-surgery/2013-04-23T16:10:03-04:00http://www.cardiobrief.org/2013/04/24/block-hf-crt-superior-to-conventional-pacing-in-heart-failure-patients-with-av-block/2013-04-24T17:04:30-04:00http://www.cardiobrief.org/2013/04/24/another-cleveland-clinic-study-links-tmao-to-atherosclerosis/2013-04-24T17:15:32-04:00http://www.cardiobrief.org/2013/04/25/conflicting-results-from-two-trials-of-cardiac-resynchronization-therapy/2013-04-25T18:00:55-04:00http://www.cardiobrief.org/2013/04/26/edwards-ceo-sold-stock-2-weeks-before-it-tanked/2013-04-26T22:19:42-04:00http://www.cardiobrief.org/2013/04/29/unconventional-analysis-finds-threshold-for-ldl-reduction-with-statins/2013-04-29T16:09:35-04:00http://www.cardiobrief.org/2013/04/30/anticoagulation-update-new-agent-for-urgent-anticoagulation-reversal-pradaxa-label-revised/2013-04-30T11:28:43-04:00http://www.cardiobrief.org/2013/04/30/wsj-article-fails-to-raise-key-questions-about-cardiovascular-risk-in-children/2013-04-30T17:08:29-04:00http://www.cardiobrief.org/2013/05/01/fda-warns-that-tolvaptan-can-lead-to-serious-liver-injury/2013-05-01T13:51:59-04:00http://www.cardiobrief.org/2013/05/01/danish-study-finds-no-increased-cv-risk-with-azithromycin-in-general-population/2013-05-01T18:55:12-04:00http://www.cardiobrief.org/2013/05/02/japanese-research-scandal-expands-to-a-second-trial-and-a-novartis-employee/2013-05-02T17:26:22-04:00http://www.cardiobrief.org/2013/05/03/scrutiny-of-sodium-meta-analysis-in-heart-uncovers-duplicated-and-missing-data/2013-05-03T10:22:36-04:00http://www.cardiobrief.org/2013/05/03/fda-approves-combination-of-ezetimibe-and-atorvastatin/2013-05-03T15:57:58-04:00http://www.cardiobrief.org/2013/05/06/metaanalysis-finds-same-day-discharge-for-low-risk-pci-may-be-feasible/2013-05-06T14:34:41-04:00http://www.cardiobrief.org/2013/05/07/burton-sobel-towering-cardiologist-dead-at-75/2013-05-07T10:19:27-04:00http://www.cardiobrief.org/2013/05/07/longer-detection-time-helps-prevent-unnecessary-icd-shocks/2013-05-07T16:54:31-04:00http://www.cardiobrief.org/2013/05/08/another-disappointing-study-for-fish-oil-supplements/2013-05-08T17:32:32-04:00http://www.cardiobrief.org/2013/05/09/bruise-control-continued-warfarin-beats-heparin-bridging-during-device-implantation/2013-05-09T14:57:29-04:00http://www.cardiobrief.org/2013/05/10/encouraging-4-year-results-for-watchman-device-in-af-patients/2013-05-10T13:10:56-04:00http://www.cardiobrief.org/2013/05/10/suspicions-raised-about-another-japanese-cardiovascular-researcher/2013-05-10T17:11:39-04:00http://www.cardiobrief.org/2013/05/12/our-limitless-capacity-for-self-deception/2013-05-12T14:50:54-04:00http://www.cardiobrief.org/2013/05/13/novel-leadless-pacemaker-makes-debut-at-hrs-2013/2013-05-13T13:30:17-04:00http://www.cardiobrief.org/2013/05/14/study-questions-role-of-dual-chamber-icds-for-primary-prevention/2013-05-14T16:49:11-04:00http://www.cardiobrief.org/2013/05/27/candidate-therapeutic-target-for-pulmonary-arterial-hypertension-identified/2013-05-27T17:27:08-04:00http://www.cardiobrief.org/2013/05/16/salt-report-from-iom-sparks-much-heat-only-a-little-light/2013-05-16T11:42:28-04:00http://www.cardiobrief.org/2013/05/17/instagram-for-heart-attacks-iphone-app-speeds-ecg-transmission-to-hospital/2013-05-17T15:13:57-04:00http://www.cardiobrief.org/2013/05/20/similar-cardiovascular-risk-observed-with-copd-drugs/2013-05-20T16:51:14-04:00http://www.cardiobrief.org/2013/05/20/european-medicines-agency-starts-review-of-combined-use-of-drugs-that-block-the-renin-angiotensin-system/2013-05-20T17:34:53-04:00http://www.cardiobrief.org/2013/05/21/athletes-with-defibrillators-dont-need-to-quit-sports/2013-05-21T14:41:19-04:00http://www.cardiobrief.org/2013/05/22/small-study-suggests-statins-may-blunt-benefits-of-exercise/2013-05-22T17:31:20-04:00http://www.cardiobrief.org/2013/05/23/novartis-acknowledges-employees-participated-in-independent-trials/2013-05-23T11:13:02-04:00http://www.cardiobrief.org/2013/05/24/spinning-record-battle-over-rosiglitazone-heats-up-two-weeks-before-crucial-fda-meeting/2013-05-24T09:51:32-04:00http://www.cardiobrief.org/2013/05/24/rivaroxaban-gains-approval-in-europe-for-acs-indication/2013-05-24T16:14:54-04:00http://www.cardiobrief.org/2013/05/28/interpretations-differ-over-study-of-coenzyme-q10-in-heart-failure/2013-05-28T22:52:30-04:00http://www.cardiobrief.org/2013/05/29/independent-re-adjudication-of-record-confirms-safety-of-rosiglitazone/2013-05-29T01:23:19-04:00http://www.cardiobrief.org/2013/05/30/large-meta-analysis-quantifies-risk-of-nsaids-and-coxibs/2013-05-30T17:20:53-04:00http://www.cardiobrief.org/2013/05/31/two-fda-officials-quarrel-over-safety-of-angiotensin-receptor-blockers/2013-05-31T00:14:55-04:00http://www.cardiobrief.org/2013/06/02/a-cme-program-begs-the-question-promotion-or-education/2013-06-02T18:18:59-04:00http://www.cardiobrief.org/2013/06/03/with-one-big-exception-fda-reviewers-back-more-benign-view-of-avandia-trial/2013-06-03T14:52:32-04:00http://www.cardiobrief.org/2013/06/04/study-finds-more-musculoskeletal-problems-in-people-who-take-statins/2013-06-04T15:59:51-04:00http://www.cardiobrief.org/2013/06/06/fda-advisory-panel-backs-looser-restrictions-on-avandia/2013-06-06T17:17:32-04:00http://www.cardiobrief.org/2013/06/10/dramatic-increase-in-use-of-radial-artery-access-for-pci-in-the-u-s/2013-06-10T16:12:04-04:00http://www.cardiobrief.org/2013/06/11/people-with-sleep-apnea-at-increased-risk-for-sudden-cardiac-death/2013-06-11T15:53:05-04:00http://www.cardiobrief.org/2013/06/12/too-much-too-fast-cross-country-skiing-and-heart-arrhythmias/2013-06-12T16:04:42-04:00http://www.cardiobrief.org/2013/06/13/new-trend-free-tablet-computers-for-all-registrants-at-tct-meeting/2013-06-13T12:06:35-04:00http://www.cardiobrief.org/2013/06/14/new-european-hypertension-guidelines-released-with-simplified-blood-pressure-target/2013-06-14T15:52:53-04:00http://www.cardiobrief.org/2013/06/18/hot-line-trials-for-european-society-of-cardiology-congress-announced/2013-06-18T10:58:11-04:00http://www.cardiobrief.org/2013/06/18/fda-raises-concerns-about-the-cybersecurity-of-medical-devices/2013-06-18T12:39:51-04:00http://www.cardiobrief.org/2013/06/19/top-line-results-no-cardiovascular-benefits-found-for-saxagliptin/2013-06-19T13:30:45-04:00http://www.cardiobrief.org/2013/06/19/hypertension-and-cholesterol-guidelines-delayed-again-as-nhlbi-gets-out-of-the-guidelines-business/2013-06-19T16:55:01-04:00http://www.cardiobrief.org/2013/06/21/roller-coaster-path-to-approval-for-eliquis-uncovered-by-fda-documents/2013-06-21T08:32:38-04:00http://www.cardiobrief.org/2013/06/24/large-nih-trial-finds-no-cardiovascular-benefits-for-weight-loss-and-exercise-in-type-2-diabetics/2013-12-19T13:48:08-05:00http://www.cardiobrief.org/2013/07/02/paper-raises-hundreds-of-questions-about-the-integrity-of-stem-cell-research-group/2015-09-15T19:33:42-04:00http://www.cardiobrief.org/2013/06/26/some-patients-with-minor-stroke-or-tia-may-benefit-from-early-clopidogrel-and-aspirin/2013-06-26T16:05:26-04:00http://www.cardiobrief.org/2013/06/27/novel-heart-failure-drug-from-novartis-gains-breakthrough-therapy-designation-from-fda/2013-06-27T14:24:01-04:00http://www.cardiobrief.org/2013/06/28/fda-turns-back-new-indication-for-rivaroxaban-to-prevent-stent-thrombosis-in-acs-patients/2013-06-28T13:14:18-04:00http://www.cardiobrief.org/2013/06/28/more-bad-news-for-hdl-therapies-assure-trial-misses-primary-endpoint/2013-06-28T14:52:00-04:00http://www.cardiobrief.org/2013/06/30/new-anticoagulant-found-safe-and-effective-in-acute-venous-thromboembolism/2013-06-30T16:04:24-04:00http://www.cardiobrief.org/2013/07/03/fda-warns-that-popular-blood-pressure-drug-can-cause-severe-diarrhea/2013-07-03T14:46:14-04:00http://www.cardiobrief.org/2013/07/08/recent-e23-million-biotech-ipo-relied-heavily-on-questionable-research/2015-09-15T19:33:29-04:00http://www.cardiobrief.org/2013/07/09/low-rate-of-problems-with-statins-in-study-of-quarter-million-patients/2013-07-09T16:11:30-04:00http://www.cardiobrief.org/2013/07/10/a-plane-just-crashed-at-sfo/2013-07-10T17:06:53-04:00http://www.cardiobrief.org/2013/07/11/link-to-prostate-cancer-brings-more-bad-news-for-fish-oil-story/2013-07-11T13:52:12-04:00http://www.cardiobrief.org/2013/07/12/medtronic-faces-removal-of-corevalve-transcatheter-heart-valve-from-german-market/2013-07-12T13:34:08-04:00http://www.cardiobrief.org/2013/07/12/diovan-data-was-fabricated-say-japanese-health-minister-and-university-officials/2013-07-12T16:06:11-04:00http://www.cardiobrief.org/2013/07/17/take-your-blood-pressure-pills-or-increase-your-risk-of-stroke/2013-07-17T00:08:59-04:00http://www.cardiobrief.org/2013/07/17/a-glimpse-of-the-future-of-cardiology-including-star-wars-holograms/2013-07-17T18:22:37-04:00http://www.cardiobrief.org/2013/07/22/studies-suggest-most-widely-used-cardiac-imaging-technique-is-overused/2013-07-22T17:44:55-04:00http://www.cardiobrief.org/2013/07/23/cardiology-goes-better-with-coke/2013-07-23T10:50:57-04:00http://www.cardiobrief.org/2013/07/23/funding-for-landmark-framingham-heart-study-slashed-by-4-million/2013-07-23T16:10:06-04:00http://www.cardiobrief.org/2013/07/24/novel-pulmonary-hypertension-drug-from-bayer-shows-modest-promise-in-phase-3-trials/2013-07-24T17:01:48-04:00http://www.cardiobrief.org/2013/07/25/possible-cognitive-benefits-found-in-dementia-patients-taking-centrally-acting-ace-inhibitors/2013-07-25T19:09:54-04:00http://www.cardiobrief.org/2013/07/29/sex-and-the-cardiac-patient-should-not-be-a-taboo-subject/2013-07-29T16:26:58-04:00http://www.cardiobrief.org/2013/07/30/more-bad-news-for-novartis-blood-pressure-drug/2013-07-30T11:22:09-04:00http://www.cardiobrief.org/2013/07/31/european-heart-guidelines-based-on-disgraced-research-may-have-caused-thousands-of-deaths/2013-07-31T03:12:07-04:00http://www.cardiobrief.org/2013/08/05/faint-praise-13-year-delay-in-publication-of-a-major-clinical-trial-sparks-criticism/2013-08-05T15:36:53-04:00http://www.cardiobrief.org/2013/08/05/deja-vu-all-over-again-study-links-calcium-channel-blockers-to-breast-cancer/2013-08-05T16:21:48-04:00http://www.cardiobrief.org/2013/08/06/questions-about-president-george-w-bushs-stent/2013-08-06T10:35:14-04:00http://www.cardiobrief.org/2013/08/07/a-pr-pitch-for-the-worst-diet-in-the-world/2013-08-09T15:58:07-04:00http://www.cardiobrief.org/2013/08/07/fda-panel-recommends-approval-for-pulmonary-hypertension-drug-from-bayer/2013-08-07T15:30:44-04:00http://www.cardiobrief.org/2013/08/09/the-guidelines-are-dead-long-live-the-guidelines/2013-08-09T12:08:59-04:00http://www.cardiobrief.org/2013/08/13/observational-study-lends-support-to-crt-guidelines/2013-08-13T17:50:07-04:00http://www.cardiobrief.org/2013/08/15/fuster-to-succeed-demaria-as-editor-of-jacc/2013-08-15T16:46:19-04:00http://www.cardiobrief.org/2013/08/15/can-inflating-a-blood-pressure-cuff-improve-outcomes-following-bypass-surgery/2013-08-15T18:54:04-04:00http://www.cardiobrief.org/2013/08/20/kaiser-program-yields-big-improvements-in-hypertension-control/2013-08-20T17:11:13-04:00http://www.cardiobrief.org/2013/08/26/new-subcutaneous-icd-said-to-pose-existential-crisis-for-older-icds/2013-08-26T16:54:47-04:00http://www.cardiobrief.org/2013/08/27/american-heart-association-announces-late-breaking-clinical-trials/2013-08-27T19:56:05-04:00http://www.cardiobrief.org/2013/08/28/14482/2013-08-28T17:24:06-04:00http://www.cardiobrief.org/2013/09/01/positive-results-for-new-anticoagulant-from-daiichi-sankyo/2013-08-30T23:03:05-04:00http://www.cardiobrief.org/2013/09/01/disappointing-results-with-dabigatran-for-mechanical-valves/2013-09-01T02:27:27-04:00http://www.cardiobrief.org/2013/09/01/a-disruptive-taste-of-the-future/2013-09-01T02:20:13-04:00http://www.cardiobrief.org/2013/09/01/pretreatment-with-prasugrel-not-indicated-in-nstemi/2013-09-01T03:33:32-04:00http://www.cardiobrief.org/2013/09/02/cardiovascular-outcome-studies-in-diabetes-drugs-finally-arrive/2013-09-02T02:06:08-04:00http://www.cardiobrief.org/2013/09/02/automatic-wireless-monitoring-shows-benefits-in-chronic-heart-failure/2013-09-02T08:51:08-04:00http://www.cardiobrief.org/2013/09/03/study-fails-to-support-broader-patient-population-for-cardiac-resynchronization-therapy/2013-09-03T02:16:49-04:00http://www.cardiobrief.org/2013/09/03/speedy-tour-de-france-racers-slower-to-die/2013-09-03T09:21:10-04:00http://www.cardiobrief.org/2013/09/04/new-test-could-speed-heart-attack-treatment-in-the-emergency-department/2013-09-04T12:00:53-04:00http://www.cardiobrief.org/2013/09/04/too-much-emphasis-on-door-to-balloon-time/2013-09-04T18:42:24-04:00http://www.cardiobrief.org/2013/09/05/lancet-formally-retracts-jikei-heart-study-with-valsartan/2013-09-05T19:55:17-04:00http://www.cardiobrief.org/2013/09/09/clear-cpr-in-the-hospital-is-not-always-good-for-the-patient/2013-09-09T16:17:34-04:00http://www.cardiobrief.org/2013/09/10/realistic-expectations-for-new-breakthrough-blood-pressure-technology/2016-01-12T12:20:28-05:00http://www.cardiobrief.org/2013/09/12/colchicine-found-effective-in-acute-pericarditis/2013-09-12T11:30:40-04:00http://www.cardiobrief.org/2013/09/16/no-dean-ornish-and-elizabeth-blackburn-have-not-discovered-the-fountain-of-youth/2013-09-16T16:22:56-04:00http://www.cardiobrief.org/2013/09/17/younger-women-with-acute-coronary-syndromes-less-likely-to-have-classic-chest-pain/2013-09-17T18:13:46-04:00http://www.cardiobrief.org/2013/09/18/both-overuse-and-underuse-explain-disparities-in-heart-procedures/2013-09-18T15:57:57-04:00http://www.cardiobrief.org/2013/09/19/editor-close-to-10-of-the-papers-we-receive-show-some-sign-of-academic-misconduct/2013-09-19T13:10:13-04:00http://www.cardiobrief.org/2013/09/20/a-clear-eyed-view-of-statins-and-cataracts/2013-09-20T16:29:51-04:00http://www.cardiobrief.org/2013/09/23/using-registry-data-fda-expands-indication-for-edwards-sapien-transcatheter-heart-valves/2013-09-23T16:31:03-04:00http://www.cardiobrief.org/2013/09/24/study-raises-questions-about-digoxin-use-today/2013-09-24T11:12:46-04:00http://www.cardiobrief.org/2013/09/25/increase-in-deaths-linked-to-first-line-treatment-with-sulfonylureas/2013-09-25T18:15:21-04:00http://www.cardiobrief.org/2013/09/27/saying-sorry-may-not-be-good-enough-for-novartis/2013-09-27T13:34:50-04:00http://www.cardiobrief.org/2013/10/01/long-terms-study-results-offer-broad-perspective-on-hormone-replacement-therapy-for-women/2013-10-01T16:16:17-04:00http://www.cardiobrief.org/2013/10/02/new-questions-raised-about-italian-cardiologists-already-under-cloud-of-suspicion/2013-10-17T13:38:30-04:00http://www.cardiobrief.org/2013/10/02/news-from-our-statin-civilization-high-dose-statins-found-to-reduce-gum-disease-inflammation/2013-10-02T15:54:07-04:00http://www.cardiobrief.org/2013/10/03/a-vision-unfulfilled-reflections-on-the-death-of-theheart-org-1999-2013/2015-09-15T19:36:56-04:00http://www.cardiobrief.org/2013/10/07/study-supports-loosening-guidelines-for-surgery-after-stent-implantation/2013-10-07T17:10:30-04:00http://www.cardiobrief.org/2013/10/08/people-who-live-near-airports-at-increased-risk-for-cardiovascular-disease/2013-10-08T18:38:23-04:00http://www.cardiobrief.org/2013/10/08/new-drug-for-pulmonary-hypertension-approved-by-fda/2013-10-08T19:15:43-04:00http://www.cardiobrief.org/2013/10/09/prevalence-of-cardiovascular-disease-likely-to-increase-despite-gains-in-treatment/2013-10-09T17:29:38-04:00http://www.cardiobrief.org/2013/10/09/cardiomems-heart-failure-device-gets-mixed-reception-from-fda-advisory-panel/2013-10-09T19:08:22-04:00http://www.cardiobrief.org/2013/10/14/why-the-fda-probably-wont-approve-an-expanded-indication-for-amarins-vascepa/2013-10-14T19:25:52-04:00http://www.cardiobrief.org/2013/10/15/former-acc-ceo-takes-reins-of-cardiovascular-research-foundation/2013-10-15T13:09:45-04:00http://www.cardiobrief.org/2013/10/15/first-leadless-pacemaker-gains-approval-in-europe/2013-10-15T16:37:30-04:00http://www.cardiobrief.org/2013/10/16/fda-advisory-panel-no-expanded-indication-for-vascepa-without-outcomes-trial/2013-10-16T15:55:50-04:00http://www.cardiobrief.org/2013/10/17/new-insights-into-surgery-versus-stents-for-diabetics-with-multivessel-disease/2013-10-17T12:42:19-04:00http://www.cardiobrief.org/2013/10/18/fda-approves-new-pulmonary-hypertension-drug-from-actelion/2013-10-18T18:14:21-04:00http://www.cardiobrief.org/2013/10/19/could-terrorists-have-hacked-dick-cheneys-icd/2013-10-19T18:18:03-04:00http://www.cardiobrief.org/2013/10/21/no-support-for-broad-screening-of-chronic-kidney-disease/2013-10-21T18:34:10-04:00http://www.cardiobrief.org/2013/10/22/a-paper-in-the-american-journal-of-cardiology-about-a-study-that-was-not-real/2013-10-22T08:45:59-04:00http://www.cardiobrief.org/2013/10/22/fda-approves-first-new-atherectomy-device-in-20-years/2013-10-22T16:22:10-04:00http://www.cardiobrief.org/2013/10/22/flu-vaccine-may-help-prevent-cardiovascular-events/2013-10-22T19:03:47-04:00http://www.cardiobrief.org/2013/10/23/surgery-preferable-to-stents-in-elderly-people-with-carotid-disease/2013-10-23T17:01:40-04:00http://www.cardiobrief.org/2013/10/24/the-good-the-bad-and-the-ugly-stents-in-the-news/2013-10-24T14:38:15-04:00http://www.cardiobrief.org/2013/10/25/fda-approves-abbots-mitraclip-for-patients-at-prohibitive-surgical-risk/2013-10-25T10:33:13-04:00http://www.cardiobrief.org/2013/10/28/radiation-dose-linked-to-cardiac-risk-in-breast-cancer-patients/2013-10-28T16:17:07-04:00http://www.cardiobrief.org/2013/10/29/pivotal-results-for-medtronics-corevalve/2013-10-29T14:14:32-04:00http://www.cardiobrief.org/2013/10/29/fda-throws-more-cold-water-on-amarins-hopes-for-vascepa/2013-10-29T19:00:01-04:00http://www.cardiobrief.org/2013/10/30/euromax-meets-primary-endpoint-but-editorialist-raises-questions/2013-10-30T16:10:50-04:00http://www.cardiobrief.org/2013/10/31/prolonged-dual-antiplatelet-therapy-may-not-be-necessary-for-second-generation-drug-eluting-stents/2013-10-31T13:00:09-04:00http://www.cardiobrief.org/2013/11/02/invest-in-pharma-maybe-go-to-vegas-instead/2015-09-15T19:37:58-04:00http://www.cardiobrief.org/2013/11/04/healthy-diet-in-middle-age-leads-to-healthier-old-age/2013-11-04T17:24:34-05:00http://www.cardiobrief.org/2013/11/05/should-you-be-worried-about-the-treatment-for-low-t/2013-11-05T16:58:57-05:00http://www.cardiobrief.org/2013/11/07/fda-seeks-to-eliminate-trans-fats-from-food-in-the-us/2013-11-07T11:11:26-05:00http://www.cardiobrief.org/2013/11/09/yet-another-blow-to-combination-renin-angiotensin-aldosterone-system-blockade/2013-11-09T09:44:03-05:00http://www.cardiobrief.org/2013/11/11/the-italian-research-scandal-grows-new-questions-and-more-confusion/2015-09-15T19:39:38-04:00http://www.cardiobrief.org/2013/11/12/promising-gsk-heart-drug-misses-primary-endpoint-in-15000-patient-trial/2013-11-12T10:53:17-05:00http://www.cardiobrief.org/2013/11/12/after-long-wait-updated-us-cardiovascular-guidelines-now-emphasize-risk-instead-of-targets/2013-11-12T16:19:28-05:00http://www.cardiobrief.org/2013/11/15/hypertension-treatment-flowchart-fills-in-for-missing-guideline/2013-11-15T14:35:08-05:00http://www.cardiobrief.org/2013/11/14/the-fate-of-new-cholesterol-drugs-depends-on-improve-it/2015-09-15T19:39:16-04:00http://www.cardiobrief.org/2013/11/18/no-evidence-that-statins-impact-cognitive-function/2013-11-16T13:12:26-05:00http://www.cardiobrief.org/2013/11/18/replacement-versus-repair-for-mitral-valve-regurgitation/2013-11-18T12:01:56-05:00http://www.cardiobrief.org/2013/11/18/controversy-erupts-over-accuracy-of-cardiovascular-risk-calculator-for-guidelines/2013-11-18T13:43:04-05:00http://www.cardiobrief.org/2013/11/18/no-value-for-renal-artery-stenting-in-coral/2013-11-18T16:42:28-05:00http://www.cardiobrief.org/2013/11/18/no-evidence-that-statins-impact-cognitive-function-2/2013-11-18T17:53:54-05:00http://www.cardiobrief.org/2013/11/19/tact-substudy-suggests-possible-strong-benefit-for-chelation-in-diabetics/2013-11-19T10:45:17-05:00http://www.cardiobrief.org/2013/11/19/new-anticoagulant-from-daiichi-sankyo-works-well-in-af-patients/2013-11-19T11:52:01-05:00http://www.cardiobrief.org/2013/11/19/tact-principal-investigator-reflects-on-a-long-and-contentious-journey/2013-11-19T13:01:47-05:00http://www.cardiobrief.org/2013/11/20/go-nuts-consumption-of-nuts-linked-to-mortality-benefit/2013-11-20T17:24:41-05:00http://www.cardiobrief.org/2013/11/25/slouching-toward-phase-3-progress-report-on-new-cholesterol-drugs-at-the-aha/2013-11-25T08:52:20-05:00http://www.cardiobrief.org/2013/11/25/fda-spanks-23andme-grants-breakthrough-status-to-factor-xa-inhibitor-and-approves-promus-premier-stent/2013-11-25T13:08:58-05:00http://www.cardiobrief.org/2013/11/25/fda-removes-restrictions-on-avandia/2013-11-25T18:26:05-05:00http://www.cardiobrief.org/2013/11/26/little-difference-in-chest-pain-between-men-and-women/2013-11-26T15:24:20-05:00http://www.cardiobrief.org/2013/11/27/surgeons-report-alarming-increase-in-lvad-pump-thrombosis/2013-11-27T17:09:43-05:00http://www.cardiobrief.org/2013/12/02/new-guideline-recommends-conservative-treatment-for-heart-patients-with-anemia/2013-12-02T17:18:08-05:00http://www.cardiobrief.org/2013/12/03/stents-lose-in-comparisons-with-surgery-and-medical-therapy/2013-12-03T14:38:34-05:00http://www.cardiobrief.org/2013/12/04/can-personalized-medicine-and-an-adaptive-trial-design-salvage-this-hard-luck-drug/2013-12-04T17:39:28-05:00http://www.cardiobrief.org/2013/12/05/large-study-finds-favorable-risk-benefit-profile-for-the-new-anticoagulants/2013-12-05T14:47:58-05:00http://www.cardiobrief.org/2013/12/06/why-is-actelion-suppressing-phase-iii-data/2013-12-06T17:04:50-05:00http://www.cardiobrief.org/2013/12/09/european-air-pollution-standards-may-need-to-be-strengthened/2013-12-09T14:52:13-05:00http://www.cardiobrief.org/2013/12/10/boston-scientific-may-face-a-tough-fda-panel/2013-12-10T16:59:27-05:00http://www.cardiobrief.org/2013/12/12/fda-panel-gives-support-to-novel-stroke-prevention-device-from-boston-scientific/2013-12-12T11:09:59-05:00http://www.cardiobrief.org/2013/12/13/dispatch-from-the-wild-frontier-of-the-statin-wars/2013-12-13T09:03:20-05:00http://www.cardiobrief.org/2013/12/16/possible-new-lease-on-life-for-two-cardiology-drugs-from-merck-and-jj/2013-12-16T13:05:40-05:00http://www.cardiobrief.org/2013/12/16/case-closed-multivitamins-should-not-be-used/2013-12-16T19:15:21-05:00http://www.cardiobrief.org/2013/12/17/behind-the-curtain-study-reveals-big-role-of-medical-communication-companies/2013-12-17T16:25:13-05:00http://www.cardiobrief.org/2013/12/18/new-trial-confirms-role-for-pradaxa-in-venous-thromboembolism/2013-12-18T10:23:30-05:00http://www.cardiobrief.org/2013/12/18/missing-high-blood-pressure-guideline-turns-up-in-jama/2013-12-18T13:51:46-05:00http://www.cardiobrief.org/2013/12/19/studies-suggest-you-can-help-your-heart-by-walking-more-and-eating-more-fiber/2013-12-19T18:44:20-05:00http://www.cardiobrief.org/2013/12/26/3-more-retractions-for-emory-cardiology-group/2013-12-26T16:16:36-05:00http://www.cardiobrief.org/2013/12/26/cardiology-in-2013-like-a-wrecking-ball/2013-12-26T17:10:39-05:00http://www.cardiobrief.org/2013/12/31/big-sugar-tips-the-balance-of-the-research-scale/2013-12-31T17:06:58-05:00http://www.cardiobrief.org/2014/01/02/two-views-of-death-the-scientist-and-the-novelist/2014-01-02T12:19:42-05:00http://www.cardiobrief.org/2014/01/03/fda-plans-new-safety-assessment-of-dabigatran-pradaxa/2014-01-03T09:59:58-05:00http://www.cardiobrief.org/2014/01/05/is-cancer-by-far-the-harder-problem/2014-01-05T12:16:09-05:00http://www.cardiobrief.org/2014/01/05/massive-heart-attack-or-massive-journalistic-irresponsibility/2014-01-05T17:30:26-05:00http://www.cardiobrief.org/2014/01/06/apple-patent-could-add-heart-sensor-to-iphones/2014-01-06T11:09:01-05:00http://www.cardiobrief.org/2014/01/06/mediterranean-diet-protects-against-diabetes-regardless-of-weight-loss/2014-01-06T17:07:50-05:00http://www.cardiobrief.org/2014/01/07/fda-advisory-panel-to-review-new-heart-failure-drug-from-novartis/2014-01-07T11:53:45-05:00http://www.cardiobrief.org/2014/01/08/first-retraction-in-the-don-poldermans-case/2014-01-08T12:02:53-05:00http://www.cardiobrief.org/2014/01/08/hospital-quality-helps-explain-some-of-the-racial-disparities-in-outcomes-after-cabg/2014-01-08T16:23:44-05:00http://www.cardiobrief.org/2014/01/09/pivotal-medtronic-trial-for-breakthrough-blood-pressure-device-goes-down-the-tubes/2014-01-09T11:19:37-05:00http://www.cardiobrief.org/2014/01/09/justice-department-investigating-aegerion-over-marketing-of-new-cholesterol-drug/2014-01-09T22:29:09-05:00http://www.cardiobrief.org/2014/01/13/mercks-vorapaxar-gets-positive-fda-review/2014-01-13T15:27:10-05:00http://www.cardiobrief.org/2014/01/13/minority-report-five-guideline-authors-reject-change-in-blood-pressure-goal/2014-01-13T17:15:23-05:00http://www.cardiobrief.org/2014/01/14/packaging-defect-leads-merck-to-recall-all-lots-of-liptruzet-in-us/2014-01-14T13:08:57-05:00http://www.cardiobrief.org/2014/01/14/rivaroxaban-faces-uphill-battle-at-fda-advisory-panel/2014-01-14T14:55:38-05:00http://www.cardiobrief.org/2014/01/15/medicine-or-mass-murder-guideline-based-on-discredited-research-may-have-caused-800000-deaths-in-europe-over-the-last-5-years/2015-09-15T19:43:40-04:00http://www.cardiobrief.org/2014/01/15/fda-advisory-panel-votes-in-favor-of-approval-for-mercks-vorapaxar/2014-01-15T17:14:40-05:00http://www.cardiobrief.org/2014/01/16/fda-panel-once-again-rejects-new-indication-for-rivaroxaban/2014-01-16T17:33:51-05:00http://www.cardiobrief.org/2014/01/17/fda-grants-earlier-than-expected-approval-for-medtronics-corevalve/2014-01-17T17:56:48-05:00http://www.cardiobrief.org/2014/01/21/dangerous-rapid-calcification-observed-in-pediatric-patients-after-aortic-valve-replacement/2014-01-21T16:37:01-05:00http://www.cardiobrief.org/2014/01/22/surviving-a-heart-attack-location-and-time-make-a-big-difference/2014-01-22T18:35:17-05:00http://www.cardiobrief.org/2014/01/23/stent-remains-available-despite-trial-showing-dangers/2014-01-23T17:34:09-05:00http://www.cardiobrief.org/2014/01/24/european-setback-for-novartis-heart-failure-drug/2014-01-24T12:22:12-05:00http://www.cardiobrief.org/2014/01/28/problems-persist-despite-gains-in-oral-anticoagulant-use/2014-01-28T14:39:59-05:00http://www.cardiobrief.org/2014/01/30/johnson-johnson-will-share-clinical-trial-data/2014-01-30T00:07:56-05:00http://www.cardiobrief.org/2014/01/31/american-college-of-cardiology-announces-late-breaking-clinical-trials/2014-01-31T10:31:47-05:00http://www.cardiobrief.org/2014/01/31/14948/2014-01-31T17:09:47-05:00http://www.cardiobrief.org/2014/02/03/the-not-so-sweet-facts-about-sugar/2014-02-03T16:22:45-05:00http://www.cardiobrief.org/2014/02/03/more-guideline-controversy-blood-pressure-expert-decries-political-correctness/2014-02-03T16:57:04-05:00http://www.cardiobrief.org/2014/02/04/blood-pressure-trajectory-over-25-years-predicts-atherosclerosis-risk/2014-02-04T19:00:25-05:00http://www.cardiobrief.org/2014/02/05/eric-topol-to-be-atts-chief-medical-advisor/2014-02-05T15:14:51-05:00http://www.cardiobrief.org/2014/02/09/this-blog-is-not-suitable-for-dissemination-through-the-internet/2015-09-15T19:45:27-04:00http://www.cardiobrief.org/2014/02/10/leading-european-cardiologist-accused-of-plagiarism/2015-09-15T19:45:11-04:00http://www.cardiobrief.org/2014/02/10/fda-reviewers-deliver-split-opinion-on-the-medicines-companys-cangrelor/2014-02-10T16:04:08-05:00http://www.cardiobrief.org/2014/02/11/fda-investigating-heart-failure-risk-linked-to-onglyza/2014-02-11T13:13:15-05:00http://www.cardiobrief.org/2014/02/12/fda-advisory-panel-recommends-against-approval-of-cangrelor/2014-02-12T16:52:37-05:00http://www.cardiobrief.org/2014/02/14/fda-once-again-rejects-new-indication-for-rivaroxaban/2014-02-14T10:40:10-05:00http://www.cardiobrief.org/2014/02/17/no-an-apple-device-wont-tell-you-if-youre-having-a-heart-attack/2014-02-17T14:58:11-05:00http://www.cardiobrief.org/2014/02/18/artery-zapping-little-better-than-drugs-in-atrial-fibrillation-patients/2014-02-18T16:59:13-05:00http://www.cardiobrief.org/2014/02/19/victor-dzau-leaving-duke-to-head-the-institute-of-medicine/2014-02-19T13:15:39-05:00http://www.cardiobrief.org/2014/02/19/newly-elected-president-of-institute-of-medicine-is-on-the-pepsico-board-of-directors/2014-02-19T14:41:00-05:00http://www.cardiobrief.org/2014/02/20/wall-street-journal-op-ed-on-sham-surgery-gets-it-wrong/2017-03-10T12:05:12-05:00http://www.cardiobrief.org/2014/02/24/lower-blood-pressure-found-in-vegetarians/2014-02-24T16:08:28-05:00http://www.cardiobrief.org/2014/02/24/vitamin-supplements-come-up-short-once-again/2014-02-24T17:03:04-05:00http://www.cardiobrief.org/2014/02/25/fda-approves-new-catheter-for-treatment-of-atrial-fibrillation/2014-02-25T11:10:39-05:00http://www.cardiobrief.org/2014/02/25/study-raises-questions-about-transfusions-in-pci-patients/2014-02-25T18:17:12-05:00http://www.cardiobrief.org/2014/02/27/steve-jobs-rejected-the-first-medical-app-in-1977/2015-09-15T19:47:31-04:00http://www.cardiobrief.org/2014/02/27/tooth-extraction-prior-to-cardiac-surgery-may-not-be-a-good-idea/2014-02-27T17:15:28-05:00http://www.cardiobrief.org/2014/03/02/pfizer-starts-testing-for-over-the-counter-lipitor/2014-03-02T19:46:56-05:00http://www.cardiobrief.org/2014/03/03/heart-societies-issue-new-guidelines-for-valve-disease/2014-03-03T16:13:08-05:00http://www.cardiobrief.org/2014/03/04/warfarin-benefits-extended-to-patients-with-chronic-kidney-disease/2014-03-04T16:30:00-05:00http://www.cardiobrief.org/2014/03/04/4-deaths-linked-to-thoratec-heart-system/2014-03-04T18:45:45-05:00http://www.cardiobrief.org/2014/03/05/aegerion-warns-about-negative-impact-of-doj-investigation/2014-03-05T14:59:02-05:00http://www.cardiobrief.org/2014/03/06/what-ails-mt-sinai-hospital-ails-the-entire-us-healthcare-system/2014-03-06T19:31:14-05:00http://www.cardiobrief.org/2014/03/07/fda-sprinkles-some-rain-on-the-pcsk9-inhibitor-parade/2014-03-07T17:12:01-05:00http://www.cardiobrief.org/2014/03/11/cardiologist-tapped-to-run-the-smithsonian-institution/2014-03-11T08:00:30-04:00http://www.cardiobrief.org/2014/03/11/french-surgeons-perform-first-aortic-valve-surgery-without-opening-the-chest/2014-03-11T19:27:54-04:00http://www.cardiobrief.org/2014/03/12/heart-failure-the-missing-800-pound-gorilla-in-diabetes-trials/2014-03-12T20:11:23-04:00http://www.cardiobrief.org/2014/03/13/us-patients-more-likely-than-english-patients-to-receive-life-saving-surgery/2014-03-13T19:20:57-04:00http://www.cardiobrief.org/2014/03/14/apixaban-gains-indication-for-dvt-prophylaxis-after-knee-and-hip-replacement-surgery/2014-03-14T15:33:05-04:00http://www.cardiobrief.org/2014/03/14/reassuring-news-about-statins-from-two-very-different-studies/2014-03-14T20:20:12-04:00http://www.cardiobrief.org/2014/03/17/phase-4-actelion-study-misses-primary-endpoint/2014-03-17T13:45:35-04:00http://www.cardiobrief.org/2014/03/17/studies-provide-little-support-for-guidelines-on-dietary-fats-and-supplements/2014-03-17T17:26:30-04:00http://www.cardiobrief.org/2014/03/19/12-8-million-more-adults-now-eligible-for-statin-therapy/2014-03-19T17:12:10-04:00http://www.cardiobrief.org/2014/03/24/what-to-expect-at-the-american-college-of-cardiology-meeting/2014-03-24T10:53:02-04:00http://www.cardiobrief.org/2014/03/25/fda-reviewers-recommend-against-approval-for-novartis-heart-failure-drug/2014-03-25T11:02:13-04:00